
<html lang="en"     class="pb-page"  data-request-id="76eb8a48-57f4-4520-b5bf-767f77d94c45"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b01961;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials" /></meta><meta name="dc.Creator" content="Rozalia&#xA;A.  Dodean" /></meta><meta name="dc.Creator" content="Papireddy  Kancharla" /></meta><meta name="dc.Creator" content="Yuexin  Li" /></meta><meta name="dc.Creator" content="Victor  Melendez" /></meta><meta name="dc.Creator" content="Lisa  Read" /></meta><meta name="dc.Creator" content="Charles E.  Bane" /></meta><meta name="dc.Creator" content="Brian  Vesely" /></meta><meta name="dc.Creator" content="Mara  Kreishman-Deitrick" /></meta><meta name="dc.Creator" content="Chad  Black" /></meta><meta name="dc.Creator" content="Qigui  Li" /></meta><meta name="dc.Creator" content="Richard J.  Sciotti" /></meta><meta name="dc.Creator" content="Raul  Olmeda" /></meta><meta name="dc.Creator" content="Thu-Lan  Luong" /></meta><meta name="dc.Creator" content="Heather  Gaona" /></meta><meta name="dc.Creator" content="Brittney  Potter" /></meta><meta name="dc.Creator" content="Jason  Sousa" /></meta><meta name="dc.Creator" content="Sean  Marcsisin" /></meta><meta name="dc.Creator" content="Diana  Caridha" /></meta><meta name="dc.Creator" content="Lisa  Xie" /></meta><meta name="dc.Creator" content="Chau  Vuong" /></meta><meta name="dc.Creator" content="Qiang  Zeng" /></meta><meta name="dc.Creator" content="Jing  Zhang" /></meta><meta name="dc.Creator" content="Ping  Zhang" /></meta><meta name="dc.Creator" content="Hsiuling  Lin" /></meta><meta name="dc.Creator" content="Kirk  Butler" /></meta><meta name="dc.Creator" content="Norma  Roncal" /></meta><meta name="dc.Creator" content="Lacy  Gaynor-Ohnstad" /></meta><meta name="dc.Creator" content="Susan E.  Leed" /></meta><meta name="dc.Creator" content="Christina  Nolan" /></meta><meta name="dc.Creator" content="Stephanie J.  Huezo" /></meta><meta name="dc.Creator" content="Stephanie A.  Rasmussen" /></meta><meta name="dc.Creator" content="Melissa T.  Stephens" /></meta><meta name="dc.Creator" content="John C.  Tan" /></meta><meta name="dc.Creator" content="Roland A.  Cooper" /></meta><meta name="dc.Creator" content="Martin J.  Smilkstein" /></meta><meta name="dc.Creator" content="Sovitj  Pou" /></meta><meta name="dc.Creator" content="Rolf W.  Winter" /></meta><meta name="dc.Creator" content="Michael K.  Riscoe" /></meta><meta name="dc.Creator" content="Jane X.  Kelly" /></meta><meta name="dc.Description" content="Malaria remains one of the deadliest diseases in the world today. Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda. We have discovered..." /></meta><meta name="Description" content="Malaria remains one of the deadliest diseases in the world today. Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda. We have discovered..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 10, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01961" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01961" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01961" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01961" /></link>
        
    
    

<title>Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01961" /></meta><meta property="og:title" content="Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0016.jpeg" /></meta><meta property="og:description" content="Malaria remains one of the deadliest diseases in the world today. Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda. We have discovered a novel antimalarial acridone chemotype with dual-stage activity against both liver-stage and blood-stage malaria. Several lead compounds generated from structural optimization of a large library of novel acridones exhibit efficacy in the following systems: (1) picomolar inhibition of in vitro Plasmodium falciparum blood-stage growth against multidrug-resistant parasites; (2) curative efficacy after oral administration in an erythrocytic Plasmodium yoelii murine malaria model; (3) prevention of in vitro Plasmodium berghei sporozoite-induced development in human hepatocytes; and (4) protection of in vivo P. berghei sporozoite-induced infection in mice. This study offers the first account of liver-stage antimalarial activity in an acridone chemotype. Details of the design, chemistry, structure–activity relationships, safety, metabolic/pharmacokinetic studies, and mechanistic investigation are presented herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01961"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01961">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01961&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01961&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01961&amp;href=/doi/10.1021/acs.jmedchem.8b01961" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3475-3502</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01951" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01972" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Rozalia A. Dodean</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rozalia A. Dodean</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rozalia%0AA.++Dodean">Rozalia A. Dodean</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5002-4607" title="Orcid link">http://orcid.org/0000-0001-5002-4607</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Papireddy Kancharla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Papireddy Kancharla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Papireddy++Kancharla">Papireddy Kancharla</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6381-1236" title="Orcid link">http://orcid.org/0000-0002-6381-1236</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuexin Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuexin Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuexin++Li">Yuexin Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Victor Melendez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor Melendez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor++Melendez">Victor Melendez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa Read</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Read</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Read">Lisa Read</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles E. Bane</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles E. Bane</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Bane">Charles E. Bane</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian Vesely</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian Vesely</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Vesely">Brian Vesely</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mara Kreishman-Deitrick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mara Kreishman-Deitrick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mara++Kreishman-Deitrick">Mara Kreishman-Deitrick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chad Black</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chad Black</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chad++Black">Chad Black</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qigui Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qigui Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qigui++Li">Qigui Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard J. Sciotti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard J. Sciotti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Sciotti">Richard J. Sciotti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raul Olmeda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raul Olmeda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raul++Olmeda">Raul Olmeda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thu-Lan Luong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thu-Lan Luong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thu-Lan++Luong">Thu-Lan Luong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heather Gaona</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather Gaona</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Gaona">Heather Gaona</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brittney Potter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brittney Potter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brittney++Potter">Brittney Potter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason Sousa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Sousa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Sousa">Jason Sousa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sean Marcsisin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean Marcsisin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Marcsisin">Sean Marcsisin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diana Caridha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diana Caridha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Caridha">Diana Caridha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Xie">Lisa Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chau Vuong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chau Vuong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chau++Vuong">Chau Vuong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiang Zeng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiang Zeng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Zeng">Qiang Zeng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhang">Jing Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ping Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ping Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Zhang">Ping Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hsiuling Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hsiuling Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hsiuling++Lin">Hsiuling Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kirk Butler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirk Butler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirk++Butler">Kirk Butler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Norma Roncal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Norma Roncal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Norma++Roncal">Norma Roncal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lacy Gaynor-Ohnstad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lacy Gaynor-Ohnstad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lacy++Gaynor-Ohnstad">Lacy Gaynor-Ohnstad</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susan E. Leed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan E. Leed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan+E.++Leed">Susan E. Leed</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christina Nolan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Nolan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Nolan">Christina Nolan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephanie J. Huezo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephanie J. Huezo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie+J.++Huezo">Stephanie J. Huezo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephanie A. Rasmussen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephanie A. Rasmussen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie+A.++Rasmussen">Stephanie A. Rasmussen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melissa T. Stephens</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melissa T. Stephens</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomics Core Facility, University of Notre Dame, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melissa+T.++Stephens">Melissa T. Stephens</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John C. Tan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John C. Tan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomics Core Facility,  Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana 46556, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Tan">John C. Tan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland A. Cooper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland A. Cooper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland+A.++Cooper">Roland A. Cooper</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin J. Smilkstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin J. Smilkstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin+J.++Smilkstein">Martin J. Smilkstein</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sovitj Pou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sovitj Pou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sovitj++Pou">Sovitj Pou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rolf W. Winter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rolf W. Winter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rolf+W.++Winter">Rolf W. Winter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael K. Riscoe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael K. Riscoe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Riscoe">Michael K. Riscoe</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jane X. Kelly</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane X. Kelly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#89e2ece5e5f0e3e8c9e6e1fafca7ecedfc"><span class="__cf_email__" data-cfemail="c1aaa4adadb8aba081aea9b2b4efa4a5b4">[email protected]</span></a>. Tel: 503-220-8262 ex 54356. Fax: 502-721-1084.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane+X.++Kelly">Jane X. Kelly</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8871-0207" title="Orcid link">http://orcid.org/0000-0001-8871-0207</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01961&amp;href=/doi/10.1021%2Facs.jmedchem.8b01961" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3475–3502</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 10, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 December 2018</li><li><span class="item_label"><b>Published</b> online</span>10 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01961</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3475%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRozalia%250AA.%2BDodean%252C%2BPapireddy%2BKancharla%252C%2BYuexin%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b01961%26title%3DDiscovery%2Band%2BStructural%2BOptimization%2Bof%2BAcridones%2Bas%2BBroad-Spectrum%2BAntimalarials%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3502%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01961"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1453</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01961" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rozalia\nA.&quot;,&quot;last_name&quot;:&quot;Dodean&quot;},{&quot;first_name&quot;:&quot;Papireddy&quot;,&quot;last_name&quot;:&quot;Kancharla&quot;},{&quot;first_name&quot;:&quot;Yuexin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;Melendez&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Read&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Bane&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Vesely&quot;},{&quot;first_name&quot;:&quot;Mara&quot;,&quot;last_name&quot;:&quot;Kreishman-Deitrick&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;Black&quot;},{&quot;first_name&quot;:&quot;Qigui&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Sciotti&quot;},{&quot;first_name&quot;:&quot;Raul&quot;,&quot;last_name&quot;:&quot;Olmeda&quot;},{&quot;first_name&quot;:&quot;Thu-Lan&quot;,&quot;last_name&quot;:&quot;Luong&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Gaona&quot;},{&quot;first_name&quot;:&quot;Brittney&quot;,&quot;last_name&quot;:&quot;Potter&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Sousa&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Marcsisin&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Caridha&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Chau&quot;,&quot;last_name&quot;:&quot;Vuong&quot;},{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hsiuling&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Kirk&quot;,&quot;last_name&quot;:&quot;Butler&quot;},{&quot;first_name&quot;:&quot;Norma&quot;,&quot;last_name&quot;:&quot;Roncal&quot;},{&quot;first_name&quot;:&quot;Lacy&quot;,&quot;last_name&quot;:&quot;Gaynor-Ohnstad&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;E. Leed&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Nolan&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;J. Huezo&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;A. Rasmussen&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;T. Stephens&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Tan&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;A. Cooper&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;J. Smilkstein&quot;},{&quot;first_name&quot;:&quot;Sovitj&quot;,&quot;last_name&quot;:&quot;Pou&quot;},{&quot;first_name&quot;:&quot;Rolf&quot;,&quot;last_name&quot;:&quot;W. Winter&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Riscoe&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;X. Kelly&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3475-3502&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01961&quot;},&quot;abstract&quot;:&quot;Malaria remains one of the deadliest diseases in the world today. Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda. We have discovered a novel antimalarial acridone chemotype with dual-stage activity against both liver-stage and blood-stage malaria. Several lead compounds generated from structural optimization of a large library of novel acridones exhibit efficacy in the following systems: (1) picomolar inhibition of in vitro Plasmodium falciparum blood-stage growth against multidrug-resistant parasites; (2) curative efficacy after oral administration in an erythrocytic Plasmodium yoelii murine malaria model; (3) prevention of in vitro Plasmodium berghei sporozoite-induced development in human hepatocytes; and (4) protection of in vivo P. berghei sporozoite-induced infection in mice. This study offers the first account of liver-stage antimalarial activity in an acridone chemotype. Details of the design, chemistry, structure–activity relationships,&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01961" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01961&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01961" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01961&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01961" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01961&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01961&amp;href=/doi/10.1021/acs.jmedchem.8b01961" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01961" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01961" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01961%26sid%3Dliteratum%253Aachs%26pmid%3D30852885%26genre%3Darticle%26aulast%3DDodean%26date%3D2019%26atitle%3DDiscovery%2Band%2BStructural%2BOptimization%2Bof%2BAcridones%2Bas%2BBroad-Spectrum%2BAntimalarials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3475%26epage%3D3502%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Malaria remains one of the deadliest diseases in the world today. Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda. We have discovered a novel antimalarial acridone chemotype with dual-stage activity against both liver-stage and blood-stage malaria. Several lead compounds generated from structural optimization of a large library of novel acridones exhibit efficacy in the following systems: (1) picomolar inhibition of in vitro <i>Plasmodium falciparum</i> blood-stage growth against multidrug-resistant parasites; (2) curative efficacy after oral administration in an erythrocytic <i>Plasmodium yoelii</i> murine malaria model; (3) prevention of in vitro <i>Plasmodium berghei</i> sporozoite-induced development in human hepatocytes; and (4) protection of in vivo <i>P. berghei</i> sporozoite-induced infection in mice. This study offers the first account of liver-stage antimalarial activity in an acridone chemotype. Details of the design, chemistry, structure–activity relationships, safety, metabolic/pharmacokinetic studies, and mechanistic investigation are presented herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria is an infectious disease caused by <i>Plasmodium</i> parasites, among which <i>Plasmodium falciparum</i> is the most dangerous, with the highest rate of complications and mortality. It remains one of the world’s deadliest diseases, and the global effort to eradicate malaria is compromised by lack of effective vaccine, emergence of artemisinin resistance,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> and the escalated burden of <i>Plasmodium vivax</i>.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6−10)</a> Each year, malaria causes about 200 million clinical cases and claims nearly half a million lives, mostly children under the age of five and pregnant women.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although the burden of malaria is primarily borne by those living in developing countries, dramatic increases in international travel now place approximately 125 million Western travelers at risk of infection annually. More than 10 000 of these are reported to acquire malaria each year.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> In the absence of a clinically useful vaccine,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> there will continue to be the need for new, low-cost, effective, and safe malaria preventive measures and treatments, particularly for the most vulnerable populations: pregnant women and young children in endemic countries, as well as for nonimmune travelers traveling into the areas of risk.</div><div class="NLM_p">Liver-stage malaria is the first step of any natural infection, a symptomatically silent but obligatory phase before the onset of the clinical symptoms of disease, which makes it an attractive target for prophylactic antimalarial intervention strategies and the development of an antimalarial vaccine.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17−22)</a> Drugs targeting liver-stage malaria (often referred to as causal prophylactics) are highly sought after as they offer many advantages over drugs that merely target the blood-stage infection, but remain a formidable challenge.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Previously, we reported the discovery of dual-function acridones with both intrinsic antimalarial activity and resistance-counteracting ability.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> We made modifications with acridones lacking the (dialkylamino)alkyl moiety at the N-10 position of the middle ring (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), and intriguingly, they demonstrated broad-spectrum efficacy against both liver-stage and blood-stage infections of malaria. Lead optimization effort followed, focusing on the structure–activity relationship (SAR) studies with various substituents on ring-A and ring-B. The in vitro and in vivo blood-stage and liver-stage antimalarial activities/efficacies of broad-spectrum acridones are described in this report, as well as safety profiles and metabolic/pharmacokinetic (PK) parameters. Notably, this study produced highly potent drug candidates with picomolar half-maximal inhibitory concentration (IC<sub>50</sub>) values against a panel of multidrug-resistant (MDR) <i>Plasmodium</i> parasites, as well as full protection of liver-stage infection at low oral doses in an animal model.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0018.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transition from a dual-function acridone to a broad-spectrum acridone chemotype.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Initially, a series of acridones <b>7</b>–<b>15</b>, <b>23</b>, and <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with a substitution at the 3 position of ring-A and various (alkylamino)alkyl ethers at the 6 position of ring-B were synthesized starting with commercially available 2-chlorobenzoic acid precursors <b>1a</b>–<b>d</b> or methyl 4-methoxysalicylate (<b>16</b>). The copper-catalyzed amination<a onclick="showRef(event, 'ref23 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref25">(23,25)</a> of <b>1a</b>–<b>d</b> with <i>m</i>-anisidine (<b>2</b>) and Buchwald–Hartwig cross-coupling<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> of triflate <b>17</b> with 3-(trifluoromethyl)-aniline (<b>18</b>) yielded the corresponding anthranilic acid/ester intermediates <b>3a</b>–<b>d</b> and <b>19</b>, respectively. Eaton’s acid-mediated cyclization of <b>3a</b>–<b>d</b> and <b>19</b> provided a mixture of corresponding methoxy-acridones <b>4a</b>–<b>d</b>, <b>5a</b>–<b>d</b>, and <b>20</b>, <b>21</b>, which were separated by recrystallization using a mixture of dimethylformamide (DMF) and MeOH in 4:1 ratio for <b>4a</b>–<b>d</b> and <b>5a</b>–<b>d</b> and EtOAc and MeOH in 6:3 ratio for <b>20</b> and <b>21</b>. The compounds <b>5a</b>–<b>d</b> and <b>21</b> were then demethylated with either hydriodic acid (HI)/phenol or boron tribromide (BBr<sub>3</sub>) to obtain the hydroxy-acridones <b>6a</b>–<b>d</b> and <b>22</b>, respectively, which when further treated with various 2-(dialkylamino)alkyl chlorides and K<sub>2</sub>CO<sub>3</sub> in dry acetone provided the desired acridones <b>7</b>–<b>15</b>, <b>23</b>, and <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Acridones <b>29</b> and <b>30</b>, in which ring-A is substituted with Cl at the 2 position and ring-B is substituted with the (dialkylamino)ethoxy moiety at the 6 position, were synthesized from triflate <b>17</b> and <i>p</i>-chloroaniline (<b>25</b>), via the similar chemistry. The acridone <b>32</b> with the (<i>tert</i>-butylamino)propyloxy moiety at the 6 position of ring-B was obtained from hydroxyacridone <b>28</b> via a two-step reaction sequence, in which <b>28</b> was first converted to chloropropyloxy acridone <b>31</b> prior to amination with <i>tert</i>-butylamine in the presence of NaI (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, bottom panel).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acridones <b>7</b>–<b>15</b>, <b>23</b>, <b>24</b>, and <b>29</b>–<b>32</b> with a Substitution at the 2/3 Position of Ring-A and the (Dialkylamino)alkoxy/chloroalkoxy Moiety at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Cu powder, K<sub>2</sub>CO<sub>3</sub>, pentanol, reflux, 5 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sup>1</sup>/R<sup>2</sup>. HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 5–12 h; (v) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature (rt), 5 h; (vi) Pd(dba)<sub>2</sub>, 1,1′-bis(diphenylphosphino)ferrocene (DPPF), KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (vii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 12 h; (viii) Br-(CH<sub>2</sub>)<sub>3</sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (ix) <i>tert</i>-butylamine, NaI, dimethyl sulfoxide (DMSO), 145 °C, 2 h.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Blood-Stage Antimalarial Activity and Cytotoxicity of Acridones (T3.5, <b>7</b>–<b>15</b>, <b>23</b>, <b>24</b>, and <b>29</b>–<b>32</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0020.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0019.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%). D6: CQ-sensitive; Dd2: MDR strain with Old World genetic background; 7G8: MDR strain with New World genetic background; Tm90-C2B: atovaquone-resistant clinical isolate; ATV: atovaquone; CQ: chloroquine.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) = IC<sub>50</sub> (cytotoxicity)/IC<sub>50</sub> (D6).</p></div></div><div></div></div><div class="NLM_p">To investigate the effect of disubstituent pattern at 1 and 3 positions of ring-A on potency, a large number of acridones <b>38</b>–<b>55</b>, <b>62</b>, and <b>63</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were prepared. These have ring-A substituted with either Cl/F atoms or a combination of Cl and OMe groups and ring-B substituted with a variety of (dialkylamino)alkyl/chloroalkyl ethers at the 6 position. Acridones <b>38</b>–<b>55</b> were synthesized from triflate <b>17</b> and 3,5-dichloroaniline (<b>33</b>)/3,5-difluoroaniline (<b>34</b>) via the same chemistry as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Conversely, a different reaction strategy was designed and executed for the synthesis of acridones <b>62</b> and <b>63</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, bottom panel), in which the (dipropylamino)ethoxy group was installed at the 6 position of ring-B before the Buchwald–Hartwig cross-coupling. Synthesis of <b>62</b> and <b>63</b> began with the coupling of methyl 2,4-dihydroxybenzoate (<b>56</b>) with 1,2-dibromoethane in the presence of potassium iodide (KI) and K<sub>2</sub>CO<sub>3</sub> to provide <i>O</i>-alkyl bromide <b>57</b>, which was further converted into the dipropylamino-ethoxy intermediate <b>58</b>, by coupling with dipropylamine in the presence of KI and K<sub>2</sub>CO<sub>3</sub>. The intermediate <b>58</b> was treated with triflic anhydride (Tf<sub>2</sub>O) in the presence of pyridine to give the triflate <b>59</b>, which was further subjected to Buchwald–Hartwig cross-coupling with 3-chloro-5-methoxyaniline (<b>60</b>) to give the anthranilate intermediate <b>61</b>. Eaton’s acid-mediated cyclization of <b>61</b> provided a mixture of two acridones <b>62</b> and <b>63</b>, which were separated by column chromatography using a mixture of dichloromethane (DCM) and MeOH as a mobile phase. It is noteworthy that our new strategy (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, bottom panel) is feasible to generate acridones that contain the OMe group on ring-A and the (dialkylamino)alkyl ethers on ring-B.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acridones <b>38</b>–<b>55</b>, <b>62</b>, and <b>63</b> with Disubstitutions at the 1 and 3 Positions of Ring-A and the Alkoxy/(dialkylamino)alkoxy/chloroalkoxy Moiety at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Br-(CH<sub>2</sub>)<i><sub>n</sub></i>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (v) alkylamine, NaI, DMSO, 145 °C, 2 h; (vi) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sup>3</sup>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 3–12 h; (vii) Br-(CH<sub>2</sub>)<sub>2</sub>-Br, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (viii) dipropylamine, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 18 h; (ix) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Blood-Stage Antimalarial Activity and Cytotoxicity of Acridones (<b>38</b>–<b>55</b>, <b>61</b>, and <b>63</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0001.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0002.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%). D6: CQ-sensitive; Dd2: MDR strain with Old World genetic background; 7G8: MDR strain with New World genetic background; Tm90-C2B: atovaquone-resistant clinical isolate; ATV: atovaquone; CQ: chloroquine.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) = IC<sub>50</sub> (cytotoxicity)/IC<sub>50</sub> (D6).</p></div></div><div></div></div><div class="NLM_p">To investigate the effect of the 1, 2- or the 2, 3-disubstitution pattern of ring-A on potency, a large number of acridones <b>70</b>–<b>86</b>, <b>92</b>, <b>93</b>, <b>98</b>, and <b>99</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were generated. These acridones have ring-A substituted with either Cl/F atoms or a combination of halogen and alkoxy groups at the 1 and 2 or 2 and 3 positions and ring-B substituted with a variety of (dialkylamino)alkoxy/chloroalkoxy moieties at the 6 position. Acridones <b>70</b>–<b>86</b>, <b>92</b>, and <b>93</b> were synthesized from the triflate <b>17</b> and 3,4-dichloroaniline (<b>64</b>)/3,4-difluoroaniline (<b>87</b>)/4-fluoro-3-methoxyaniline (<b>88</b>), via the same chemistry as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The key acridone intermediates <b>66</b> and <b>67</b>, obtained in 3:1 ratio, respectively, from <b>65</b>, were separated by recrystallization using a mixture of DMF and MeOH (3:7). The acridones <b>98</b> and <b>99</b>, which contain a F atom at the 2 position and an OMe group at the 3 position of ring-A and (diethylamino)ethoxy and (diethylamino)ethyl-amino groups at the 6 position of ring-B, were synthesized from methyl 2,4-dihydroxybenzoate (<b>56</b>) and methyl 4-iodosalicylate (<b>94</b>), respectively. Coupling of <b>56</b> with 2-bromo-<i>N</i>,<i>N</i>-diethylethylamine in the presence of tetrabutylammonium chloride (TBAC)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and K<sub>2</sub>CO<sub>3</sub> provided compound <b>95a</b>. Coupling of <b>94</b> with 2-diethylaminoethylamine in the presence of CuI/Cs<sub>2</sub>CO<sub>3</sub><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and 2-acetylcyclohexanone provided <b>95b</b>. By treating with triflic anhydride, <b>95a</b> and <b>95b</b> were then transformed into the corresponding triflates <b>96a</b> and <b>96b</b>, which when further subjected to Buchwald–Hartwig cross-coupling<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with <b>88</b>, followed by Eaton’s acid-mediated cyclization, gave acridones <b>98</b> and <b>99</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, bottom panel).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0017.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acridones <b>70</b>–<b>86</b>, <b>92</b>, <b>93</b>, <b>98</b>, and <b>99</b> with Disubstitutions at the 1 and 2 or the 2 and 3 Positions of Ring-A and (Diethylamino)ethoxy/ethyl-amino/chloroalkoxy at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Br-(CH<sub>2</sub>)<i><sub>n</sub></i>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (v) alkylamine, NaI, DMSO, 145 °C, 2 h; (vi) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sub>1</sub>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10–24 h; (vii) Cl-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (viii) Br-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>·HBr, TBAC, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4 h; (ix) NH<sub>2</sub>-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>, 2-acetylcyclohexanone, Cs<sub>2</sub>CO<sub>3</sub>, CuI, DMF, 100 °C, 4 h; (x) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h; (xi) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 5–8 h.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Blood-Stage Antimalarial Activity and Cytotoxicity of Acridones (<b>70</b>–<b>81</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0013.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0003.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%). D6: CQ-sensitive; Dd2: MDR strain with Old World genetic background; 7G8: MDR strain with New World genetic background; Tm90-C2B: atovaquone-resistant clinical isolate; ATV: atovaquone; CQ: chloroquine.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) = IC<sub>50</sub> (cytotoxicity)/IC<sub>50</sub> (D6).</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Blood-Stage Antimalarial Activity and Cytotoxicity of Acridones (<b>82</b>–<b>86</b>, <b>92</b>, <b>93</b>, and <b>98</b>–<b>102</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0009.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0004.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%). D6: CQ-sensitive; Dd2: MDR strain with Old World genetic background; 7G8: MDR strain with New World genetic background; Tm90-C2B: atovaquone-resistant clinical isolate; ATV: atovaquone; CQ: chloroquine.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) = IC<sub>50</sub> (cytotoxicity)/IC<sub>50</sub> (D6).</p></div></div><div></div></div><div class="NLM_p">To investigate the isomeric effect on potency, three dichloro-acridones <b>100</b>–<b>102</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which are isomeric to <b>45</b>, <b>73</b>, and <b>83</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), were prepared from triflate <b>17</b> and the corresponding dichloroanilines, via the similar chemistry as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 1,4/2,4/3,4-dichloro-acridones <b>100</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, our attention was turned toward the synthesis of acridones that contain (dialkylamino)alkyl ethers at the 7 position of ring-B. A series of acridones <b>109</b>–<b>113</b>, <b>119</b>, <b>120</b>, <b>123</b>, and <b>128</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), in which ring-A is substituted with either halogens or a combination of halogen and alkoxy groups and ring-B is substituted with the (alkylamino)alkyl ethers at the 7 position, were synthesized starting with commercially available precursors <b>103</b>, <b>114</b>, and <b>1d</b>, via the same synthetic methods that were employed in the previous schemes.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acridones <b>109</b>–<b>113</b>, <b>119</b>, <b>120</b>, <b>123</b>, and <b>128</b> with Mono-/Disubstitutions on Ring-A and the (Dialkylamino)alkoxy Moiety at the 7 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br-(CH<sub>2</sub>)<sub>2</sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (ii) dipropylamine, NaI, DMSO, 145 °C, 3 h; (iii) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h; (iv) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 5–8 h; (v) Eaton’s acid, 90 °C, 5–24 h; (vi) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 12 h; (vii) Cl-(CH<sub>2</sub>)<sub>2</sub>-<i>N</i>(Et)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (viii) Cl-(CH<sub>2</sub>)<sub>2</sub>-<i>N</i>(Pr)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (ix) Cu powder, K<sub>2</sub>CO<sub>3</sub>, pentanol, reflux, 5 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biological Activity</h3><div class="NLM_p last">In this work, the structure–activity relationship (SAR) studies were conducted with the focus on various substitutions at different positions on ring-A and ring-B of the acridones. We have synthesized a large library of acridones and evaluated these for antimalarial blood-stage and liver-stage efficacy, safety, mode of action, and metabolic/pharmacokinetic properties. The in vitro antimalarial blood-stage activity of acridone derivatives was tested against a panel of <i>P. falciparum</i> with different geographic and genetic backgrounds using a SYBR green-based assay.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Chloroquine (CQ) and atovaquone (ATV) were used as reference drugs in all experiments. These acridones exhibit potent activity against CQ-sensitive and multidrug-resistant (MDR) parasites, and cross-resistance patterns against ATV-resistant parasites vary significantly between positional isomers. The in vivo antimalarial blood-stage efficacy was determined using a well-established modified Thompson 4 day suppression rodent model against <i>Plasmodium yoelii</i>.<a onclick="showRef(event, 'ref23 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref23 ref31 ref32">(23,31,32)</a> The acridone derivatives (via oral administrations) exhibited excellent blood-stage efficacy. The in vitro liver-stage activity of acridone derivatives was assessed utilizing luciferase-expressing <i>Plasmodium berghei</i> sporozoite-infected human hepatocyte HepG2 cells.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> A number of acridone analogues exhibit potent activity (some superior to ATV) against the liver-stage parasite, without toxic effects on the host liver cells. The in vivo liver-stage antimalarial efficacy in a rodent malaria model was determined with a real-time in vivo imaging system (IVIS), utilizing transgenic bioluminescent parasites.<a onclick="showRef(event, 'ref33 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref35 ref36">(33,35,36)</a> Several lead compounds exhibited true causal prophylactic efficacy, providing full protection and cure in this animal model. The cytotoxicity test against human hepatic HepG2 cells indicates a favorable therapeutic index (>1000 for most compounds). In vitro cardiotoxicity and mutagenicity were assessed as well, with lead acridone compounds demonstrating feasible safety profiles. No overt clinical toxicity or behavior change was observed in mice treated with acridones. The in vitro metabolic stability studies using mouse and human liver microsomes and in vivo pharmacokinetic (PK) studies on mice were also conducted for lead compounds. Observations from preliminary drug resistance selection studies suggest a complex mode of action of broad-spectrum acridones, including but not limited to inhibition of the parasite electron transport chain.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Blood-Stage Activity and SAR of Acridones with Monosubstitution on Ring-A and Ring-B</h3><div class="NLM_p">In our previous work,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> acridone <b>7</b>, which is an intermediate of dual-function novel antimalarial acridone T3.5, demonstrated excellent potency against a panel of CQ-sensitive and multidrug-resistant (MDR) <i>P. falciparum</i> parasites (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Our initial lead optimizations focused on exploring substituents with the halogen and/or trifluoromethyl moieties on the 2 and 3 positions of ring-A and hydrophilic moieties such as (dialkylamino)alkyl ethers on the 6 position of ring-B. To probe the effect of a chlorine atom on potency, we initially synthesized three acridones <b>8</b>–<b>10</b>, in which the Cl atom at the 3 position of acridone <b>7</b> is replaced with bromine (Br), fluorine (F), and hydrogen (H) atoms, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), followed by examination of in vitro antimalarial activity.</div><div class="NLM_p">It appears that acridone <b>8</b> with the Br atom at the 3 position of ring-A retained the potency against all tested <i>P. falciparum</i> strains with great selectivity and was slightly more potent than acridone <b>7</b>. Replacing the Cl atom by a F atom as in <b>9</b> and by a H atom as in <b>10</b> led to a substantial decrease in the antimalarial activity (<b>9</b> IC<sub>50</sub> = 377 nM and <b>10</b> IC<sub>50</sub> = 1347 nM vs <b>7</b> IC<sub>50</sub> = 32 nM against D6) against all <i>P. falciparum</i> strains (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), suggesting that halogen at the 3 position of ring-A is required for potent antimalarial activity and the size of the halogen also has impact on potency (potency order of substituents: Br ≥ Cl > F ≫ H). We then investigated the effect of various substituents at the 6 position of ring-B on antimalarial activities. A series of acridones, <b>11</b>–<b>15</b>, where the (diethylamino)ethoxy group at the 6 position of acridone <b>7</b> is replaced with various (dialkylamino)alkoxy moieties, were generated and tested for their in vitro antimalarial activity. Acridone <b>11</b> with the (dimethylamino)ethoxy moiety at the 6 position on ring-B showed a roughly 2-fold decrease in activity as compared with <b>7</b> (<b>11</b> IC<sub>50</sub> = 56 nM vs <b>7</b> IC<sub>50</sub> = 32 nM against D6). In contrast, acridone <b>12</b> with the (dipropylamino)ethoxy moiety at the 6 position on ring-B showed increased potency over <b>7</b> (<b>12</b> IC<sub>50</sub> = 2.5 nM vs <b>7</b> IC<sub>50</sub> = 32 nM against D6). A significant loss of potency was observed for acridones <b>13</b>, <b>14</b>, and <b>15</b> containing ethoxypyrrolidin, (diethylamino)propoxy, and (diethylamino)pentyloxy moieties, respectively. These results demonstrate that the length and nature of the alkyl chain of (dialkylamino)alkoxy moieties at the 6 position play a crucial role in antimalarial potency. Replacing the chlorine atom of acridones <b>7</b> and <b>12</b> with the trifluoromethyl (CF<sub>3</sub>) moiety as in <b>23</b> and <b>24</b> dramatically decreased the antimalarial activity (<b>23</b> IC<sub>50</sub> = 816 nM vs <b>7</b> IC<sub>50</sub> = 32 nM and <b>24</b> IC<sub>50</sub> = 26 nM vs <b>12</b> IC<sub>50</sub> = 2.5 nM against D6). This work suggested that the bulky moiety (CF<sub>3</sub>) at the 3 position on ring-A had an adverse effect on the antimalarial activity.</div><div class="NLM_p last">Investigations on the 2 position of ring-A produced acridones <b>29</b>–<b>32</b>, in which the chlorine atom is shifted from the 3 position to the 2 position on ring-A. Interestingly, the effect of varying the substituent on ring-A depended to a degree on the ring-B substituent. Thus, shifting of the Cl atom from the 3 position to the 2 position as in <b>29</b>, a positional isomer of <b>7</b>, led to reduced potency (<b>29</b> IC<sub>50</sub> = 212 nM vs <b>7</b> IC<sub>50</sub> = 32 nM against D6), whereas acridone <b>30</b>, which is a positional isomer of <b>12</b>, retained potency (<b>30</b> IC<sub>50</sub> = 3.6 nM vs <b>12</b> IC<sub>50</sub> = 2.5 nM against D6). It is noteworthy that the activity was retained even after replacing the (dialkylamino)alkoxy moieties at the 6 position of ring-B with the chloropropoxy moiety as in <b>31</b> (IC<sub>50</sub> = 24 nM against D6). A significant loss of antimalarial potency was observed when the Cl atom at the terminal carbon of acridone <b>31</b> was replaced with <i>tert</i>-butylamine as in <b>32</b> (IC<sub>50</sub> = 674 nM against D6). SAR analyses of these acridones demonstrate that the nature of substituents on ring-A and the (dialkylamino)alkoxy moieties on ring-B play a pivotal role for antimalarial potency.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Blood-Stage Activity and SAR of Acridones with 1,3-Disubstitutions on Ring-A and a 6-Substitution on Ring-B</h3><div class="NLM_p">Having determined the impact of substituents on the antimalarial activity of acridones that contain a halogen at either the 2 or the 3 position of ring-A and an (alkylamino)alkyl ether at the 6 position of ring-B, we subsequently tested a hypothesis that two halogens on ring-A might represent an opportunity to make more potent and selective antimalarials. Therefore, we have generated a large number of acridones <b>38</b>–<b>55</b>, <b>62</b>, and <b>63</b> with ring-A substituted with either two chlorine/fluorine atoms or a combination of halogen and methoxy moieties at the 1 and 3 positions and ring-B substituted with a variety of hydrophilic and/or hydrophobic moieties at the 6 position and subsequently tested their antimalarial potentials against a panel of <i>P. falciparum</i> strains (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Dihalogenated acridones <b>38</b>–<b>42</b> with various chloroalkyl ethers at the 6 position of ring-B exhibited excellent potency against all <i>P. falciparum</i> strains (IC<sub>50</sub> = 0.12–14 nM against D6) with a high selectivity index (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). 1,3-Difluoro-acridones <b>43</b> and <b>44</b>, in which ring-B is substituted with trifluorobutoxy and hexyloxy moieties at the 6 position, respectively, showed substantially higher potency (>10-fold) than that of the chloroalkyl ether containing acridones <b>38</b>–<b>42</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These results demonstrated that elongation of the chloroalkyl/alkyl ether chain at the 6 position of ring-B (from chloroethyl ether; <b>38</b> IC<sub>50</sub> = 14 nM to hexyloxy ether; <b>44</b> IC<sub>50</sub> = 0.026 nM against D6) led to an increase in the antimalarial activity, regardless of the dichloro and/or difluoro substitutions on ring-A.</div><div class="NLM_p last">After establishing the optimal dihalogen substituent patterns at the 1 and 3 positions on ring-A and chloroalkyl/alkyl ethers at the 6 position of ring-B, we focused further on exploring hydrophilic moieties at the 6 position of ring-B. A set of dihalogenated acridones <b>45</b>–<b>49</b>, in which ring-B is substituted with various (dialkylamino)ethoxy moieties at the 6 position, were generated and screened for their antimalarial activity. Notably, dihalogenated acridones <b>45</b>–<b>49</b> were highly potent (IC<sub>50</sub> values as low as 0.00030 nM against D6, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) compared with monohalogenated acridones <b>7</b>, <b>8</b>, and <b>12</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and dihalogenated acridones <b>38</b>–<b>42</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Specifically, acridones <b>47</b>–<b>49</b> with (dipropylamino)ethoxy and (di-trifluoropropylamino)ethoxy moieties showed the highest potencies with picomolar IC<sub>50</sub> values. These results demonstrate that dipropylamine as part of the hydrophilic moiety at the 6 position of ring-B plays a vital role in enhancing antimalarial potency. We also sought to explore the elongation of the alkyl chain between oxygen and dialkylamine as a part of the hydrophilic moiety at the 6 position preparing three dihalogenated acridones <b>50</b>–<b>52</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Although acridones <b>50</b>–<b>52</b> maintained relatively good activity against all <i>P. falciparum</i> strains (IC<sub>50</sub> < 32 nM against D6), analogues <b>50</b>–<b>52</b> showed a significant decline in activity (<b>50</b> IC<sub>50</sub> = 19 nM vs <b>45</b> IC<sub>50</sub> = 8.2 nM; <b>51</b> IC<sub>50</sub> = 32 nM vs <b>46</b> IC<sub>50</sub> = 7.8 nM; <b>52</b> IC<sub>50</sub> = 0.35 nM vs <b>48</b> IC<sub>50</sub> = 0.00030 nM against D6) compared to that of their homologous acridones <b>45</b>, <b>46</b>, and <b>48</b>. Together these results again demonstrate that the length of the alkyl chain between oxygen and dialkylamine as in a part of a hydrophilic moiety at the 6 position plays an important role and it appears that two-carbon chain length is optimal for antimalarial potency. We next investigated the effect of (monoalkylamino)alkoxy moieties at the 6 position. Replacement of (dialkylamino)alkoxy moieties with the (monoalkylamino)alkoxy moieties as in <b>53</b>–<b>55</b> led to reduced potency in general (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The biggest potency loss occurred when we introduced a methoxy (OMe) group at either the 1 or the 3 position on ring-A as in <b>62</b> and <b>63</b>. It appears that the OMe group on ring-A has an adverse effect, specifically at the 1 position (<b>62</b> IC<sub>50</sub> = 0.65 nM vs <b>47</b> IC<sub>50</sub> = 0.0050 nM; and <b>63</b> IC<sub>50</sub> = 251 nM vs <b>47</b> IC<sub>50</sub> = 0.0050 nM against D6). In general, SAR analyses demonstrate that dihalogen substitutions at the 1 and 3 positions of ring-A and (dialkylamino)ethoxy moieties at the 6 position of ring-B are well tolerated (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Blood-Stage Activity and SAR of Acridones with 1,2-Dichlorosubstitutions on Ring-A and 6-Substitution on Ring-B</h3><div class="NLM_p last">Exploration of the SARs on ring-A and ring-B of acridones indicated that halogens at the 1 and 3 positions on ring-A and (dialkylamino)ethoxy moieties at the 6 position of ring-B were greatly favored. We next investigated the effect of halogens at the 1 and 2 positions on ring-A. We synthesized a series of 1,2-dichloro-acridones <b>70</b>–<b>81</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) with various chloroalkyl/(dialkylamino)alkoxy moieties at the 6 position of ring-B. It is noteworthy that most of the 1,2-dichloro-acridones <b>70</b>–<b>81</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) have shown great potency with low IC<sub>50</sub> values against all <i>P. falciparum</i> strains. However, they were significantly less potent than the corresponding 1,3-dichloro/fluoro-acridones <b>38</b>–<b>55</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> vs <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). More interestingly, the acridones <b>70</b>–<b>81</b> followed the similar SAR trend as we observed for 1,3-dichloro/fluoro-acridones <b>38</b>–<b>55</b> and it was consistent across all of the acridone analogues (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> vs <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). These findings demonstrate that 1,2-dichlorosubstitutions on ring-A and chloroalkoxy/(dialkylamino)ethoxy moieties at the 6 position of ring-B are well tolerated.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro Blood-Stage Activity and SAR of Acridones with 2,3-Disubstitutions on Ring-A and 6-Substitution on Ring-B</h3><div class="NLM_p">Exploration of the SARs around ring-A of acridones indicated that disubstitutions at the 1,2 and 1,3 positions (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were greatly favored compared with the monosubstitutions at either the 2 or the 3 position of ring-A (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We next investigated the effect of disubstituents at both 2 and 3 positions. We generated a series of 2,3-disubstituted acridones <b>82</b>–<b>86</b>, <b>92</b>, <b>93</b>, <b>98</b>, and <b>99</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Of these acridones, <b>82</b>–<b>84</b> with 2,3-dichlorosubstitutions on ring-A and chloroalkoxy/(dialkylamino)alkoxy moieties at the 6 position on ring-B showed diminished activity compared to that of the corresponding 1,3-dichloro-acridones (<b>82</b> IC<sub>50</sub> = 179 nM vs <b>40</b> IC<sub>50</sub> = 2.2 nM; <b>83</b> IC<sub>50</sub> = 44 nM vs <b>45</b> IC<sub>50</sub> = 8.2 nM against D6) and 1,2-dichloro-acridones (<b>82</b> IC<sub>50</sub> = 179 nM vs <b>71</b> IC<sub>50</sub> = 3.2 nM; <b>83</b> IC<sub>50</sub> = 44 nM vs <b>73</b> IC<sub>50</sub> = 10 nM; <b>84</b> IC<sub>50</sub> = 3.4 nM vs <b>75</b> IC<sub>50</sub> = 0.022 nM against D6). 2,3-Dichloro-acridones <b>85</b> and <b>86</b> with (<i>tert-</i>butylamino)propyloxy and (<i>n-</i>butylamino)propyloxy moieties, respectively, showed slightly increased potencies (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) as compared to those of the corresponding 1,3-dichloro/difluoro-acridones (<b>85</b> IC<sub>50</sub> = 123 nM vs <b>53</b> IC<sub>50</sub> = 101 nM; <b>86</b> IC<sub>50</sub> = 36 nM vs <b>54</b> IC<sub>50</sub> = 115 nM against D6) and 1,2-dichloro-acridones (<b>85</b> IC<sub>50</sub> = 123 nM vs <b>79</b> IC<sub>50</sub> = 196 nM; and <b>86</b> IC<sub>50</sub> = 36 nM vs <b>80</b> IC<sub>50</sub> = 46 nM against D6). The greatest loss of potency was observed in 2,3-difluoro-acridone <b>92</b> when compared with the corresponding 1,3-difluoro/dichloro-acridones (<b>92</b> IC<sub>50</sub> = 146 nM vs <b>46</b> IC<sub>50</sub> = 7.8 nM and <b>45</b> IC<sub>50</sub> = 8.2 nM against D6), 1,2-dichloro-acridone (<b>92</b> IC<sub>50</sub> = 146 nM vs <b>73</b> IC<sub>50</sub> = 10 nM against D6), and 2,3-dichloro-acridone (<b>92</b> IC<sub>50</sub> = 146 nM vs <b>83</b> IC<sub>50</sub> = 44 nM against D6). The adverse effect of substitutions at both the 2 and 3 positions on ring-A was further confirmed by the introduction of (diethylamino)ethoxy and OMe moieties at the 3 position as with the analogues <b>93</b> and <b>98</b>, respectively, which have an IC<sub>50</sub> of >116 nM against all <i>P. falciparum</i> strains (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), suggesting that disubstitutions at the 2 and 3 positions are not preferred. Replacement of the (diethylamino)ethoxy moiety at the 6 position of ring-B of <b>98</b> with the (diethylamino)ethyl-amino group, as with acridone <b>99</b>, led to further reduced potency (<b>99</b> IC<sub>50</sub> = 526 nM vs <b>98</b> IC<sub>50</sub> = 156 nM against D6). These findings demonstrate that the alkoxy moieties are well tolerated at the 6 position of ring-B.</div><div class="NLM_p last">To probe the effect of all possible disubstitution patterns on potency, we have prepared three dichloro representative analogues <b>100</b>–<b>102</b>, in which chlorine atoms were substituted at 1,4/2,4/3,4 positions, respectively. It is noteworthy that the antimalarial potency significantly declined (>10-fold) after shifting chlorine substitutions on ring-A from the 1,2/1,3/2,3 to 1,4/2,4/3,4 positions as in acridones <b>100</b>–<b>102</b>, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). These findings suggested that substitution at the 4 position on ring-A had an adverse effect on potency. Together, SAR analyses of the acridones (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) demonstrated that dihalogen substitutions at the 1,2 and 1,3 positions on ring-A and (dialkylamino)ethoxy moieties at the 6 position on ring-B are best tolerated.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vitro Blood-Stage Activity and SAR of Acridones with the Substitutions at the 7 position on Ring-B</h3><div class="NLM_p">Having identified the key pharmacophores at the 6 position of ring-B for enhanced antimalarial potency, we explored the effect of these substituents on the 7 position of ring-B. A series of acridones <b>109</b>–<b>113</b>, <b>119</b>, <b>120</b>, <b>123</b>, and <b>128</b>, where ring-A is substituted with either halogens or a combination of halogen and alkoxy groups and ring-B is substituted with (dipropylamino)ethoxy and (diethylamino)ethoxy moieties at the 7 position, were generated and screened for their antimalarial activity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Of these 7-substituted acridones, analogues <b>109</b> and <b>110</b>, with the disubstitutions at the 1 and 3 positions on ring-A, exhibited the greatest potency (IC<sub>50</sub> < 1.0 nM against D6) (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). However, the potency of these compounds, <b>109</b> and <b>110</b>, significantly declined compared to that of the corresponding isomer <b>48</b> (<b>109</b> IC<sub>50</sub> = 0.40 nM, <b>110</b> IC<sub>50</sub> = 0.70 nM vs <b>48</b> IC<sub>50</sub> = 0.00030 nM against D6). Interestingly, interchange of fluorine and methoxy groups between the 1 and 3 positions on ring-A as in <b>111</b> resulted in a 50-fold decrease in potency (<b>111</b> IC<sub>50</sub> = 35 nM vs <b>110</b> IC<sub>50</sub> = 0.70 nM against D6). Again, this result demonstrates that the methoxy group has an adverse effect at the 1 position on ring-A. Replacement of fluorine at the 1 position of <b>110</b> with chlorine, as in <b>112</b>, showed a roughly 100-fold drop in activity (<b>112</b> IC<sub>50</sub> = 79 nM vs <b>110</b> IC<sub>50</sub> = 0.70 nM against D6). Compound <b>112</b> also exhibited diminished potency (>100-fold) compared to that of the corresponding isomer <b>62</b> (<b>112</b> IC<sub>50</sub> = 79 nM vs <b>62</b> IC<sub>50</sub> = 0.65 nM against D6). Conversely, acridone <b>113</b> showed better activity compared to that of the corresponding positional isomers <b>63</b> and <b>112</b> (<b>113</b> IC<sub>50</sub> = 30 nM vs <b>63</b> IC<sub>50</sub> = 251 nM and <b>112</b> IC<sub>50</sub> = 79 nM against D6). The greatest loss of potency (>100-fold) was observed in two 7-substituted acridones <b>119</b> and <b>120</b> as compared with the corresponding positional isomer <b>75</b> (<b>119</b> IC<sub>50</sub> = 99 nM, <b>120</b> IC<sub>50</sub> = 26 nM vs <b>75</b> IC<sub>50</sub> = 0.022 nM against D6). 7-(Diethylamino)ethoxy acridone <b>123</b>, where ring-A is substituted with one chlorine atom at the 2 position, showed a better activity than that of the corresponding isomer <b>29</b> (<b>123</b> IC<sub>50</sub> = 159 nM vs <b>29</b> IC<sub>50</sub> = 212 nM against D6), whereas acridone <b>128</b> showed ∼4-fold lesser potency than the corresponding isomer <b>7</b> (<b>128</b> IC<sub>50</sub> = 110 nM vs <b>7</b> IC<sub>50</sub> = 32 nM against D6). Cross-resistance patterns against ATV-resistant Tm90-C2B vary significantly between positional isomers, with acridones having substitutions at the 7 position on ring-B demonstrating similar or equal potency across the <i>P. falciparum</i> test panel (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Blood-Stage Antimalarial Activity and Cytotoxicity of Acridones (<b>109</b>–<b>113</b>, <b>119</b>, <b>120</b>, <b>123</b>, and <b>128</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0012.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0014.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%). D6: CQ-sensitive; Dd2: MDR strain with Old World genetic background; 7G8: MDR strain with New World genetic background; Tm90-C2B: atovaquone-resistant clinical isolate; ATV: atovaquone; CQ: chloroquine.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) = IC<sub>50</sub> (cytotoxicity)/IC<sub>50</sub> (D6).</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vitro Liver-Stage Antimalarial Activity</h3><div class="NLM_p">The in vitro liver-stage activity of acridone derivatives was assessed utilizing luciferase-expressing <i>P. berghei</i> sporozoite-infected human hepatocyte HepG2 cells,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. A number of acridone analogues exhibited potent activity (some superior to ATV) against the liver-stage parasite, without toxic effects on the host liver cells. Of these screened compounds, acridones <b>47</b>–<b>49</b>, <b>52</b>, <b>62</b>, <b>73</b>–<b>75</b>, <b>84</b>, <b>109</b>, and <b>110</b> showed the highest liver-stage antimalarial potencies (IC<sub>50</sub> range: 0.090–7.8 nM). Interestingly, acridone derivatives exhibited superb activities in this liver-stage in vitro assay regardless of the different cross-resistance patterns against blood-stage parasites Tm90-C2B.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Liver-Stage Antimalarial Activity of Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">liver-stage IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> vs <i>P. berghei</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">503</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">14.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">456</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">436</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">202</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">221</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">523</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">0.090</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">362</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">183</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>110</b></td><td class="colsep0 rowsep0" align="left">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>128</b></td><td class="colsep0 rowsep0" align="left">793</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATV</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">>31 262</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (±10%).</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo Blood-Stage Efficacy in Rodent Malaria Models</h3><div class="NLM_p">Given the remarkable antimalarial potencies of several acridones against various <i>P. falciparum</i> strains along with favorable toxicological properties against HepG2 cells, in vivo studies on a murine <i>P. yoelii</i> model<a onclick="showRef(event, 'ref23 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref23 ref31 ref32">(23,31,32)</a> were undertaken with the most potent and selective (selective index >1000) acridones <b>7</b>, <b>44</b>–<b>50</b>, <b>52</b>, and <b>73</b>–<b>75</b>, with CQ as a reference drug (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In these in vivo experiments, animals were randomly placed in groups of four and test drugs were administered by oral gavage on 4 sequential days following the day of inoculation. The in vivo data are expressed as ED<sub>50</sub> and ED<sub>90</sub> values and reflect the dose (estimated from dose–response curves) for suppression of parasitemia by 50 and 90%, respectively, relative to vehicle-only controls as assessed on day 5 of each study. A number of acridones showed very promising in vivo oral efficacy (ED<sub>50</sub> and ED<sub>90</sub> values are shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Significantly, the acridones <b>48</b> (T36), <b>74</b> (T35), and <b>75</b> (T31) were curative in this model after 80 mg/kg × 4 days dosing. No overt clinical toxicity and/or behavior change was observed in mice treated with these acridones (highest dose tested was 80 mg/(kg days) × 4).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vivo Antimalarial Efficacy in a Murine <i>P. yoelii</i></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">blood-stage efficacy vs <i>P. yoelii</i> (4 day)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">code name</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (mg/(kg days))</th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub> (mg/(kg days))</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">T2</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">T42</td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="left">12.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">T27</td><td class="colsep0 rowsep0" align="left">3.09</td><td class="colsep0 rowsep0" align="left">50.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">T26</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">9.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">T49</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">3.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">T36</td><td class="colsep0 rowsep0" align="left">1.12</td><td class="colsep0 rowsep0" align="left">8.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">T41</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">2.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">T50</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">24.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">T43</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">2.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">T13</td><td class="colsep0 rowsep0" align="left">1.80</td><td class="colsep0 rowsep0" align="left">8.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">T35</td><td class="colsep0 rowsep0" align="left">1.04</td><td class="colsep0 rowsep0" align="left">1.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">T31</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">1.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CQ</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.46</td><td class="colsep0 rowsep0" align="left">3.28</td></tr></tbody></table></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Liver-Stage Efficacy in a Rodent Malaria Model</h3><div class="NLM_p">The assessment of in vivo liver-stage efficacy was conducted with a real-time in vivo imaging system (IVIS), utilizing a transgenic bioluminescent parasite.<a onclick="showRef(event, 'ref33 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref35 ref36">(33,35,36)</a> Mice were inoculated with 50 000 luciferase-expressing <i>P. berghei</i> sporozoites intravenously (i.v.) through the tail vein on day 0, and oral doses of acridones were administered on day −1, day 0, and day 1. The animals underwent imaging for luciferase activity at 24 and 48 h after the inoculation for liver-stage development and at 72 h for blood-stage infection. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, strong bioluminescence signals were detected in untreated mice at both 24 and 48 h in the area overlying the liver, followed by an intense signal in the whole body of the mice, resulting from infection in the peripheral blood circulation. Acridones <b>7</b> (T2) and <b>73</b> (T13) provided full protection and cure at 160 and 40 mg/kg, respectively. Significantly, acridones <b>48</b> (T36), <b>52</b> (T43), <b>74</b> (T35) and, <b>75</b> (T31) provided full protection and cure at 10 mg/kg with no or negligible parasite visible in the liver of any of the tested mice at 24 and 48 h, indicating true causal prophylactic efficacy (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Notably, all treated mice were cured with no blood-stage parasites up to day 30. Indeed, the acridone <b>75</b> (T31) was able to provide full protection and blood-stage cure even at 4 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). These results are comparable or superior to those of primaquine (full protection/cure at 25 mg/kg).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acridone efficacy in the in vivo liver-stage model in C57BL/6 male Albino mice infected with 50 000 luciferase-expressing <i>P. berghei</i> sporozoites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> In Vitro Cardiotoxicity and Mutagenicity</h3><div class="NLM_p">The in vitro effect of lead acridones on the human-ether-a-go-go-related gene (hERG) potassium channel current expressed in mammalian cells was evaluated using an automatic parallel patch clamp system (Eurofins Inc.), and the results are listed in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. Some of the lead compounds demonstrated the hERG inhibition level lower than that of CQ with IC<sub>50</sub> values higher than 10 μm, which is highly encouraging. Mutagenicity assessment of several lead acridones was conducted using the Ames assay (EPBI Inc.) at concentrations up to 10 μm, with and without S9 activation, against <i>Salmonella typhimurium</i> TA100 and TA98. Results were negative; there was no increase over the background reversion rate with any of the tested acridones.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. hERG Activity of Lead Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">hERG activity (% inhibition at 10 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr></tbody></table></div></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Metabolic Stability and Pharmacokinetic (PK) Studies</h3><div class="NLM_p">The metabolic stability of the lead acridones was assessed using mouse and human liver microsomes.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> Most of the lead acridones appear to be stable for up to 60 min in both human and mouse microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). The in vivo pharmacokinetic (PK) study of lead acridones <b>7</b> (T2), <b>48</b> (T36), <b>52</b> (T43), <b>74</b> (T35), and <b>75</b> (T31) was also conducted following a single intragastric (IG) (per os (p.o.)) administration in ICR male mice at 80 mg/kg, with blood and liver samples taken at the following time points: 0, 0.5, 1, 2, 4, 7, 24, 48, and 72 h.<a onclick="showRef(event, 'ref33 ref39'); return false;" href="javascript:void(0);" class="ref ref33 ref39">(33,39)</a> The key PK parameters of the lead acridones are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>. The PK data is supportive of the observed liver-stage efficacy, as it is evident that acridones demonstrating strong prophylactic efficacy concentrate in the liver, with high liver/plasma ratio.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro Metabolic Stability of Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability vs microsomes <i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>42</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>70</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>73</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>74</b></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>75</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>84</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>128</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">34</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. PK Parameters of Lead Acridones in Plasma and Liver Following a Single Oral Dose of 80 mg/kg Administrations in Mice<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">plasma/liver</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL/F (mL/(h kg))</th><th class="colsep0 rowsep0" align="center" char=".">Vz/F (mL/kg)</th><th class="colsep0 rowsep0" align="center" char=".">MRT b (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>7</b> (T2)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">1355</td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char=".">5309</td><td class="colsep0 rowsep0" align="char" char=".">5807</td><td class="colsep0 rowsep0" align="char" char=".">1.90</td><td class="colsep0 rowsep0" align="char" char=".">13 774</td><td class="colsep0 rowsep0" align="char" char=".">37 689</td><td class="colsep0 rowsep0" align="char" char=".">3.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">193 452</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">1 457 315</td><td class="colsep0 rowsep0" align="char" char=".">1 457 562</td><td class="colsep0 rowsep0" align="char" char=".">6.70</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>48</b> (T36)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">7.00</td><td class="colsep0 rowsep0" align="char" char=".">7558</td><td class="colsep0 rowsep0" align="char" char=".">56 485</td><td class="colsep0 rowsep0" align="char" char=".">54.24</td><td class="colsep0 rowsep0" align="char" char=".">24 466</td><td class="colsep0 rowsep0" align="char" char=".">657 604</td><td class="colsep0 rowsep0" align="char" char=".">10.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">3927</td><td class="colsep0 rowsep0" align="char" char=".">7.00</td><td class="colsep0 rowsep0" align="char" char=".">63 900</td><td class="colsep0 rowsep0" align="char" char=".">101 502</td><td class="colsep0 rowsep0" align="char" char=".">13.80</td><td class="colsep0 rowsep0" align="char" char=".">932</td><td class="colsep0 rowsep0" align="char" char=".">13 970</td><td class="colsep0 rowsep0" align="char" char=".">8.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>52</b> (T43)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">526</td><td class="colsep0 rowsep0" align="char" char=".">7.78</td><td class="colsep0 rowsep0" align="char" char=".">3434</td><td class="colsep0 rowsep0" align="char" char=".">5075</td><td class="colsep0 rowsep0" align="char" char=".">7.78</td><td class="colsep0 rowsep0" align="char" char=".">15 914</td><td class="colsep0 rowsep0" align="char" char=".">175 302</td><td class="colsep0 rowsep0" align="char" char=".">11.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">19 711</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">236 372</td><td class="colsep0 rowsep0" align="char" char=".">237 386</td><td class="colsep0 rowsep0" align="char" char=".">6.59</td><td class="colsep0 rowsep0" align="char" char=".">348</td><td class="colsep0 rowsep0" align="char" char=".">3478</td><td class="colsep0 rowsep0" align="char" char=".">13.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>74</b> (T35)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">631</td><td class="colsep0 rowsep0" align="char" char=".">5.50</td><td class="colsep0 rowsep0" align="char" char=".">3841</td><td class="colsep0 rowsep0" align="char" char=".">4516</td><td class="colsep0 rowsep0" align="char" char=".">2.29</td><td class="colsep0 rowsep0" align="char" char=".">17 714</td><td class="colsep0 rowsep0" align="char" char=".">58 684</td><td class="colsep0 rowsep0" align="char" char=".">4.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">42 344</td><td class="colsep0 rowsep0" align="char" char=".">7.00</td><td class="colsep0 rowsep0" align="char" char=".">546 818</td><td class="colsep0 rowsep0" align="char" char=".">546 889</td><td class="colsep0 rowsep0" align="char" char=".">1.84</td><td class="colsep0 rowsep0" align="char" char=".">147</td><td class="colsep0 rowsep0" align="char" char=".">392</td><td class="colsep0 rowsep0" align="char" char=".">6.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>75</b> (T31)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="char" char=".">2.75</td><td class="colsep0 rowsep0" align="char" char=".">3049</td><td class="colsep0 rowsep0" align="char" char=".">3239</td><td class="colsep0 rowsep0" align="char" char=".">6.00</td><td class="colsep0 rowsep0" align="char" char=".">25 879</td><td class="colsep0 rowsep0" align="char" char=".">223 865</td><td class="colsep0 rowsep0" align="char" char=".">6.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">21 269</td><td class="colsep0 rowsep0" align="char" char=".">2.75</td><td class="colsep0 rowsep0" align="char" char=".">167 981</td><td class="colsep0 rowsep0" align="char" char=".">169 389</td><td class="colsep0 rowsep0" align="char" char=".">4.63</td><td class="colsep0 rowsep0" align="char" char=".">537</td><td class="colsep0 rowsep0" align="char" char=".">3605</td><td class="colsep0 rowsep0" align="char" char=".">10.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">primaquine</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">531</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">1256</td><td class="colsep0 rowsep0" align="char" char=".">1314</td><td class="colsep0 rowsep0" align="char" char=".">1.84</td><td class="colsep0 rowsep0" align="char" char=".">16 415</td><td class="colsep0 rowsep0" align="char" char=".">43 801</td><td class="colsep0 rowsep0" align="char" char=".">2.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char=".">8148</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">27 450</td><td class="colsep0 rowsep0" align="char" char=".">27 665</td><td class="colsep0 rowsep0" align="char" char=".">4.27</td><td class="colsep0 rowsep0" align="char" char=".">724</td><td class="colsep0 rowsep0" align="char" char=".">4418</td><td class="colsep0 rowsep0" align="char" char=".">4.50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last"><i>C</i><sub>max</sub>: maximum plasma or hepatic concentration; <i>T</i><sub>max</sub>: time to <i>C</i><sub>max</sub>; AUC<sub>last</sub>: area under the concentration–time curve from 0 up to the last sampling time at which a quantifiable concentration is found; AUC<sub>inf</sub>: area under the concentration–time curve from 0 up to infinity; <i>t</i><sub>1/2</sub>: apparent elimination half-life; CL/F: apparent oral clearance; Vz/F: apparent volume of distribution after oral dose; MRT b: mean residence time, body.</p></div></div></div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In Vitro Resistance Selection with <b>73</b> and Acridone Target Validation</h3><div class="NLM_p">To identify a potential target(s) of acridone inhibition in <i>P. falciparum</i>, we used in vitro resistance selection with acridone <b>73</b> followed by whole genome sequencing, an approach that has been used successfully on multiple occasions for putative target identification in malaria parasites.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Several independent clonal lines of Dd2 and 3D7 were pressured for ∼180 days with gradually increasing concentrations of <b>73</b> up to 900 nM. Selections resulted in three resistant lines derived from Dd2 and one from 3D7. Whole genome sequencing of the parental Dd2 line and two independent clones from the first <b>73</b> selection experiment on Dd2 showed a G → T nucleotide change in <i>pfcytb</i> (mal_mito_3; position 4266) corresponding to a V259L polymorphism (Dd2<sup>V259L</sup>), which has been reported elsewhere in parasites selected for resistance to quinolones.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> Relative to the Dd2 parental line and the 3D7 reference line, only three other single nucleotide polymorphisms (SNPs) were detected from genes encoding proteins not involved in antigenic variation (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information). These included a conserved <i>Plasmodium</i> membrane protein of unknown function (A → G, position 629354, PF3D7_0615300), a putative RNA helicase (A → G position PF3D7_0615300), and an ApiAP2 transcription factor (C → T, position 330499, PF3D7_1107800). Given hypotheses that first-generation liver-stage active acridones may target cytochrome <i>b</i> and selection of V259L with quinolones, these latter genes were not explored further. We therefore Sanger-sequenced <i>pfcytb</i> from all other <b>73</b>-resistant lines. Alignment of sequences with parental lines revealed <i>pfcytb</i> nonsynonymous SNPs in each case, resulting in three additional mutant alleles: two derived from Dd2 (Dd2<sup>M133I</sup> and Dd2<sup>M133I-A138T</sup>; <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>) and one from 3D7 (3D7<sup>A82T+V259L</sup>; <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). The M133I polymorphism has been previously selected in both <i>P. falciparum</i> and <i>P. berghei</i><i>cytb</i> genes using ATV or other quinolones.<a onclick="showRef(event, 'ref41 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref43 ref44">(41,43,44)</a> Continued <b>73</b> selection on the Dd2<sup>M133</sup> line resulted in the acquisition of the second <i>pfcytb</i> mutation, yielding the Dd2<sup>M133I-A138T</sup> line, whereas the 3D7<sup>A82T-V259L</sup> line was discovered on our initial sampling of the <b>73</b> pressured 3D7 culture. To our knowledge, the A138T and A82T polymorphisms have not been previously reported. The Dd2<sup>V259L</sup> clone had an IC<sub>50</sub> value of 1439 nM or 36-fold greater that of the parental Dd2 line (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). The Dd2<sup>M133I</sup> line showed modest <b>73</b> resistance at a 242 nM IC<sub>50</sub> or 6-fold increase. The acquisition of an additional A138T mutation increased resistance to an IC<sub>50</sub> of 1678 nM, a 42-fold increase. Given that both M133I and A138T are predicted to occur in the Q<sub>o</sub> binding site of <i>PfCytB</i>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the high IC<sub>50</sub> value for the double mutant is not surprising. Our results showed strikingly similar decreased sensitivity changes to ATV in response to single mutations of V259L or M133I to those reported by Lane et al.,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> further supporting the role of PfCYTB in our reported drug response changes. The 3D7 double mutant, 3D7<sup>A82T-V259L</sup>, had a <b>73</b> IC<sub>50</sub> of 1518 nM or 54-fold higher than that of the parental line. A82T is located in the second transmembrane domain but not in the Q<sub>o</sub> site. Thus, the dominant effects on acridone decreased susceptibility are likely imparted by V259L, further supported by the comparable IC<sub>50</sub> results from the single mutant Dd2<sup>V259L</sup> (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). The <b>73</b>-resistant parasites grown for up to 3 months without drug pressure had stable phenotypes when retested for susceptibility against a panel of acridones (data not shown). Additionally, no changes in susceptibilities were observed among the resistant clones to control antimalarial drugs chloroquine, mefloquine, lumefantrine, and piperaquine relative to parental control lines (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). None of these drugs are known to act against the <i>P. falciparum</i> cytochrome <i>b</i>.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. IC<sub>50</sub> Values of Standard Antimalarials and Acridones Against Selected <i>P. falciparum</i> Parasites</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0008.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0015.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values ± standard error of the mean; <i>N</i> = 3.</p></div><div class="footnote" id="t11fn2"><sup><sup>b</sup></sup><p class="last">nt: not tested; CQ: chloroquine; ATV: atovaquone; endochin-like quinolone-300: currently MMV preclinical candidate, cytochrome <i>b</i> Q<sub>i</sub> site inhibitor.</p></div></div><div></div></div><div class="NLM_p last">Although these observations from preliminary mechanistic studies do not identify the site(s) of action, they suggest a complex mode of action of broad-spectrum acridones, including but not limited to inhibition of the parasite electron transport chain. The <i>cyt bc1</i> of the mitochondrial electron transport chain is a validated target and is considered as a “double-edge sword” for multistage antimalarial therapy, particularly given the recent discovery of the inability of malaria parasites to spread atovaquone resistance in the mosquito phase.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We report here the synthesis and antimalarial activities of various series of acridones against both blood-stage and liver-stage malaria. Acridone derivatives were synthesized via simple and inexpensive chemical procedures using easily available building blocks to respond to the demand for low-cost novel antimalarials. Several key findings emerged from these studies, specifically, a number of acridones were (i) effective at low nanomolar concentrations against blood-stage and liver-stage parasites, (ii) curative in the erythrocytic murine malaria model after oral administration, and (iii) able to provide full protection and cure in sporozoite-induced infection in mice. In addition, lead acridones exhibited favorable toxicological, metabolic, and pharmacokinetic profiles. Our detailed SAR profiling of different substituents on ring-A and ring-B of acridones demonstrated that dihalogens at either the 1,2 or 1,3 positions on ring-A and (dialkylamino)alkoxy moieties at the 6 position on ring-B are required for the optimal antimalarial potency. Acridones <b>48</b> (T36), <b>74</b> (T35), and <b>75</b> (T31) have shown very promising in vivo efficacy against both blood-stage and liver-stage malaria at low oral doses. The preliminary drug resistance selection studies demonstrated a complex mode of action of broad-spectrum acridones. Our future optimization studies will focus on producing the second generation of the novel acridone antimalarial chemotype that maintains efficacy against both blood-stage and liver-stage <i>Plasmodia</i>, with the ability to circumvent clinical atovaquone resistance and improved safety profiles.</div><div class="NLM_p last">The novel acridone chemotype described herein emphasizes a multistage targeting approach, highlighting compounds with efficacy against liver-stage malaria to kill <i>Plasmodium</i> parasites before they reach the bloodstream where they can weaken and kill the host.<a onclick="showRef(event, 'ref18 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref21 ref22">(18,20−22)</a> It is noteworthy that a recent open-source screening of over 500 000 compounds identified several acridone scaffolds as chemoprotective “hits”.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The novel acridones described here are structurally distinct, but it will be interesting to see whether there is a convergent path toward an optimized antimalarial acridone entity in the future. The ability to combat multiple stages (both exoerythrocytic and erythrocytic) of the infection represents a powerful tool and the one ideally suited to achieve the broadest possible benefit as a renewed malaria eradication effort proceeds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General</h3><div class="NLM_p last">NMR spectra were recorded on Bruker AMX-400 and AMX-600 spectrometers at 400 and 600 MHz, respectively. Experiments were recorded in CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> at 25 °C. Chemical shifts are given in parts per million (ppm) downfield from internal standard Me<sub>4</sub>Si. High-resolution mass spectrometry (HRMS) (electrospray ionization (ESI)) were recorded on a high-resolution (30 000) Thermo Scientific LTQ-Orbitrap Discovery hybrid mass spectrometer (San Jose, CA). Unless otherwise stated, all reagents and solvents were purchased from commercial suppliers and used without further purification. Reactions that required the use of anhydrous, inert atmosphere techniques were carried out under an atmosphere of argon/nitrogen. Chromatography was executed on Biotage-Isolera and/or CombiFlash instruments, using silica gel (230–400 mesh) and/or neutral alumina as the stationary phase and mixtures of ethyl acetate (EtOAc) and hexane or dichloromethane (DCM) and methanol as eluents. Analytical high-performance liquid chromatography (HPLC) analyses were performed on a Supelco Discovery HS C18 column (4.6 mm × 250 mm) with a linear elution gradient of water/methanol (containing 10 mM ammonium acetate) ranging from 80:20 to 0:100 for 50 min at a flow rate of 1 mL/min, at 254 nm. A purity of >95% has been established for all tested compounds.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Representative Procedure for the Synthesis of 4-Chloro-2-((3-methoxyphenyl)amino)-benzoic Acid (<b>3a</b>)</h3><div class="NLM_p last">To a stirred suspension of <i>m</i>-anisidine (<b>2</b>) (18.5 g, 150.0 mmol), K<sub>2</sub>CO<sub>3</sub> (27.6 g, 200.0 mmol), and Cu powder (0.12 g, 1.8 mmol) in pentanol (150 mL) at room temperature was added 2,4-dichlorobenzoic acid (<b>1a</b>) (19.1 g, 100.0 mmol), and the reaction mixture was refluxed for 5 h. Water was then added, and the mixture was extracted with ethyl acetate (3 × 200 mL). The combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure, and the product was recrystallized in methanol to yield the title compound <b>3a</b> (24.4 g, 88%) as a pale green solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 13.31 (br s, 1H), 9.70 (s, 1H), 7.90 (d, <i>J</i> = 8.5 Hz, 1H), 7.32 (t, <i>J</i> = 8.1 Hz, 1H), 7.13 (s, 1H), 6.88 (d, <i>J</i> = 8.0 Hz, 1H), 6.85–6.69 (m, 2H), 6.74 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 3.77 (s, 3H); HRMS (ESI) calcd for C<sub>14</sub>H<sub>13</sub>Cl<sub>1</sub>N<sub>1</sub>O<sub>3</sub> (M + H)<sup>+</sup> 278.0578, found 278.0564. Compounds <b>3b</b> and <b>3c</b> were synthesized (65–85%) by the same procedure as described for <b>3a</b>, and their identity was confirmed by NMR and gas chromatography–mass spectrometry (GC–MS) analyses.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Representative Procedure for the Synthesis of 3-Chloro-6-methoxyacridin-9(10<i>H</i>)-one (<b>5a</b>)</h3><div class="NLM_p last">Eaton’s acid (120 mL) was added to a flask containing <b>3a</b> (15.0 g, 54.2 mmol). The reaction mixture was then stirred at 90 °C for 5 h. After cooling to room temperature, water was added slowly to the flask and allowed to stir for 15 min and the solid material was filtered by a sintered funnel and washed with water (500 mL). The pure compound <b>5a</b> (7.8 g, 55%) was obtained by recrystallization in DMF/CH<sub>3</sub>OH (4:1). It is noteworthy that the minor isomer <b>4a</b> was also observed in the crude material; however, our focus was on the major isomer <b>5a</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 11.68 (br s, 1H), 8.18 (d, <i>J</i> = 8.6 Hz, 1H), 8.14–8.08 (m, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.24 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.90–6.86 (m, 2H), 3.91 (s, 3H). Methoxy-acridones <b>5</b> and <b>5c</b> were synthesized in good yields (42–50%) by the same procedure as described for <b>5a</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Representative Procedure for the Synthesis of 3-Chloro-6-hydroxyacridin-9(10<i>H</i>)-one (<b>6a</b>)</h3><div class="NLM_p last">To a stirred solution of <b>5a</b> (5.0 g, 17.98 mmol) in 100 mL of 57% hydriodic acid (HI) at room temperature was added phenol (27.2 g, 289.3 mmol), and the reaction mixture was stirred at reflux for 3 h. After cooling to room temperature, water was added slowly to the flask and the mixture was extracted with ethyl acetate (3 × 200 mL). The combined organic phases were washed with saturated NaHSO<sub>3</sub> solution (200 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure to yield the title compound <b>6a</b> (4.38 g, 93%) as a pale yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.51 (br s, 1H), 10.56 (s, 1H), 8.15 (d, <i>J</i> = 8.6 Hz, 1H), 8.07 (d, <i>J</i> = 8.7 Hz, 1H), 7.45 (d, <i>J</i> = 2.0 Hz, 1H), 7.22 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.90–6.86 (m, 2H); HRMS (ESI) calcd for C<sub>13</sub>H<sub>8</sub>Cl<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 246.0316, found 246.0323. Hydroxy-acridones <b>6b</b> and <b>6c</b> were synthesized in excellent yields (85–90%) by the same procedure as described for <b>6a</b>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Representative Procedure for the Synthesis of 3-Chloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>7</b>)</h3><div class="NLM_p last">To a stirred solution of <b>6a</b> (1.0 g, 4.08 mmol) in anhydrous acetone (50 mL) at room temperature were added K<sub>2</sub>CO<sub>3</sub> (5.63 g, 40.08 mmol) and 2-(diethylamino)ethyl chloride hydrochloride (772 mg, 4.48 mmol), and the reaction mixture was stirred at reflux for 5 h. The mixture was then filtered, and the solvent was removed by rotary evaporation. The crude product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent to afford the desired acridone <b>7</b> as a pale yellow solid (1.07 g, 76%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 11.64 (s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.11 (d, <i>J</i> = 9.1 Hz, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.24 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.89–6.86 (m, 2H), 4.15 (t, <i>J</i> = 6.1 Hz, 2H), 2.84 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 345.1364, found 345.1366. Note: Most of the (dialkylamino)alkyl chlorides were obtained from commercial sources except the following (dialkylamino)alkyl chlorides that were prepared by adopting literature procedures.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Synthesis of <i>N</i>-(2-Chloroethyl)-<i>N</i>-propylpropan-1-amine Hydrochloride</h3><div class="NLM_p last">A solution of 2-chloroethanol (5.00 g, 62.1 mmol) and dipropylamine (6.27 g, 62.1 mmol) in 25 mL of anhydrous toluene was refluxed for 3.5 h. Then, the reaction mixture was brought to 0 °C, SOCl<sub>2</sub> (11.08 g, 93.2 mmol) was added dropwise, and the temperature of the mixture was then gradually raised to 90 °C over 1 h period. Consumption of the 2-(dipropylamino)ethan-1-ol intermediate was confirmed by GC–MS analysis. Concentration of all solvents in vacuo gave the desired <i>N</i>-(2-chloroethyl)-<i>N</i>-propylpropan-1-amine hydrochloride in good yield (10.2 g, 82%). The product was used in subsequent reactions without further purification. 3-Chloro-<i>N</i>,<i>N</i>-dipropylpropan-1-amine hydrochloride was also prepared using the same procedure. These compounds were stored at −20 °C until further use.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of 3-Chloro-<i>N</i>,<i>N</i>-diethylpropan-1-amine</h3><div class="NLM_p last">To a stirred solution of SOCl<sub>2</sub> (30.8 mL, 422 mmol) in anhydrous chloroform (250 mL) at 0 °C was added gradually a solution of 3-(diethylamino)propan-1-ol (22.1 g, 168 mmol) in 35 mL chloroform. Then, the reaction mixture was heated to reflux for 2 h. The solvent and excess SOCl<sub>2</sub> were removed in vacuo, and the residue was cautiously treated with 20% NaOH solution (50 mL), extracted with diethyl ether (3 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The product 3-chloro-<i>N</i>,<i>N</i>-diethylpropan-1-amine was obtained as a light yellow oil (22.9 g, 72%) and stored at −20 °C until further use.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Synthesis of Acridones <b>8</b>–<b>15</b></h3><div class="NLM_p last">The final compounds <b>8</b>–<b>15</b> were synthesized in good yields (50–65%) by the same procedure as described for <b>7</b>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-Bromo-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.32 (br s, 1H), 8.16 (d, <i>J</i> = 9.0 Hz, 1H), 8.10 (d, <i>J</i> = 8.6 Hz, 1H), 7.77 (d, <i>J</i> = 1.8 Hz, 1H), 7.38 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.00 (d, <i>J</i> = 2.3 Hz, 1H), 6.95 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 4.51 (t, <i>J</i> = 4.6 Hz, 2H), 3.60 (t, <i>J</i> = 4.5 Hz, 2H), 3.28–3.20 (m, 4H), 1.27 (t, <i>J</i> = 7.2 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>Br<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 389.0859, found 389.0856.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Fluoro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.65 (s, 1H), 8.24 (dd, <i>J</i> = 8.9, 6.5 Hz, 1H), 8.11 (d, <i>J</i> = 9.5 Hz, 1H), 7.20 (dd, <i>J</i> = 10.4, 2.3 Hz, 1H), 7.08 (m, 1H), 6.88–6.85 (m, 2H), 4.15 (t, <i>J</i> = 6.0 Hz, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>F<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 329.1660, found 329.1661.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-(2-(Diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.57 (s, 1H), 8.19 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 8.12 (d, <i>J</i> = 8.9 Hz, 1H), 7.69 (m, 1H), 7.48 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (m, 1H), 6.89 (d, <i>J</i> = 2.3 Hz, 1H), 6.84 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 4.14 (t, <i>J</i> = 6.2 Hz, 2H), 2.84 (t, <i>J</i> = 6.1 Hz, 2H), 2.58 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 311.1754, found 311.1771.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-Chloro-6-(2-(dimethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.68 (d, <i>J</i> = 0.3 Hz, 1H), 8.18 (d, <i>J</i> = 8.6 Hz, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 1H), 7.51 (d, <i>J</i> = 1.9 Hz, 1H), 7.25 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.90–6.86 (m, 2H), 4.20 (t, <i>J</i> = 5.8 Hz, 2H), 2.69 (t, <i>J</i> = 5.8 Hz, 2H), 2.25 (s, 6H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>18</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 317.1051, found 317.1062.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-Chloro-6-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.65 (s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.11 (d, <i>J</i> = 9.6 Hz, 1H), 7.49 (d, <i>J</i> = 1.9 Hz, 1H), 7.24 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.87–6.85 (m, 2H), 4.13 (t, <i>J</i> = 6.0 Hz, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.42 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 373.1677, found 373.1687.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-Chloro-6-(2-(pyrrolidin-1-yl)ethoxy)acridin-9(10<i>H</i>)-one (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.67 (br s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 1.8 Hz, 1H), 7.24 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 6.90–6.86 (m, 2H), 4.21 (t, <i>J</i> = 5.8 Hz, 2H), 2.85 (t, <i>J</i> = 5.8 Hz, 2H), 2.54 (m, 4H), 1.69 (m, 4H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 343.1208, found 343.1212.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-Chloro-6-(3-(diethylamino)propoxy)acridin-9(10<i>H</i>)-one (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.69 (br s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.10 (d, <i>J</i> = 9.2 Hz, 1H), 7.49 (s, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 6.89–6.85 (m, 2H), 4.13 (t, <i>J</i> = 5.9 Hz, 2H), 2.55 (t, <i>J</i> = 6.5 Hz, 2H), 2.46 (q, <i>J</i> = 7.0 Hz, 4H), 1.91–1.85 (m, 2H), 0.95 (t, <i>J</i> = 6.9 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>24</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 359.1521, found 359.1529.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-Chloro-6-((5-(diethylamino)pentyl)oxy)acridin-9(10<i>H</i>)-one (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ11.67 (br s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (s, 1H), 7.24 (d, <i>J</i> = 8.6 Hz, 1H), 6.88–6.86 (m, 2H), 4.11 (t, <i>J</i> = 5.7 Hz, 2H), 2.62 (q, <i>J</i> = 6.8 Hz, 4H), 1.91–1.79 (m, 4H), 1.51–1.45 (m, 4H), 1.00 (t, <i>J</i> = 6.6 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 387.1834, found 387.1835.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Representative Procedure for the Synthesis of Methyl 4-Methoxy-2-(((trifluoromethyl)-sulfonyl)oxy)benzoate (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of methyl 4-methoxysalicylate (<b>16</b>) (85 g, 467 mmol) and pyridine (50 mL) in anhydrous dichloromethane (100 mL) at 0 °C was added dropwise triflic anhydride (Tf<sub>2</sub>O) (158 g, 560 mmol). Then, the reaction mixture was stirred for 5 h while it was allowed to warm to room temperature. The mixture was poured into ice-cold water (500 mL) and extracted with diethyl ether (3 × 200 mL). The combined organic layers were washed with 2 N HCl (3 × 50 mL) and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated under reduced pressure to afford the desired product <b>17</b> (143.7 g, 98%) as a thick syrup. The product <b>17</b> was carried forward into the next reaction without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.98 (d, <i>J</i> = 8.9 Hz, 1H), 6.88 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.70 (d, <i>J</i> = 2.3 Hz, 1H), 3.85 (s, 3H), 3.80 (s, 3H); HRMS (ESI) calcd for C<sub>10</sub>H<sub>10</sub>F<sub>3</sub>O<sub>6</sub>S<sub>1</sub> (M + H)<sup>+</sup> 315.01447, found 315.01569.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Representative Procedure for the Synthesis of Methyl 4-Methoxy-2-((3-(trifluoromethyl)phenyl)amino)benzoate (<b>19</b>)</h3><div class="NLM_p last">To a degassed solution of <b>17</b> (1.00 g, 3.18 mmol) and 3-(trifluoromethyl)aniline (<b>18</b>) (615 mg, 3.82 mmol) in anhydrous toluene (20 mL) at room temperature were added Pd(dba)<sub>2</sub> (183 mg, 0.31 mmol), DPPF (353 mg, 0.63 mmol), and KO<i>t</i>Bu (392 mg, 3.50 mmol), and the reaction mixture was heated at 100 °C for 8 h. After cooling to room temperature, the mixture was filtered through a pad of celite and washed with dichloromethane (100 mL). The combined filtrates were concentrated under reduced pressure, and the crude product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent, to afford the title compound <b>19</b> in good yield (765 mg, 74%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.66 (br s, 1H), 7.82 (d, <i>J</i> = 8.9 Hz, 1H), 7.42 (s, 1H), 7.32–7.31 (m, 1H), 7.20 (d, <i>J</i> = 6.1 Hz, 1H), 6.63 (d, <i>J</i> = 2.2 Hz, 1H), 6.26 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 3.76 (s, 3H), 3.64 (s, 3H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Synthesis of 3-Methoxy-6-(trifluoromethyl)acridin-9(10<i>H</i>)-one (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was synthesized along with compound <b>20</b> by the same procedure as described for <b>5a</b>. The pure compound <b>21</b> (69%) was obtained by recrystallization from a mixture of methanol and ethyl acetate (3:6). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.88 (br s, 1H), 8.37 (d, <i>J</i> = 8.3 Hz, 1H), 8.15 (d, <i>J</i> = 8.9 Hz, 1H), 7.79 (s, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 6.91 (dd, <i>J</i> = 9.0, 2.2 Hz, 1H), 6.86 (d, <i>J</i> = 2.1 Hz, 1H), 3.92 (s, 3H).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Synthesis of 3-Hydroxy-6-(trifluoromethyl)acridin-9(10<i>H</i>)-one (<b>22</b>)</h3><div class="NLM_p last">To a stirred solution of <b>21</b> (2.26 g, 7.71 mmol) in anhydrous dichloromethane (25 mL) maintained under an argon atmosphere was added dropwise BBr<sub>3</sub> (9.63 g, 38.5 mmol) at −78 °C. Then, the reaction mixture was stirred for 12 h while it was allowed to warm to room temperature. The reaction mixture was quenched with water (50 mL), and the organic layer was evaporated under reduced pressure. The resultant solid material was filtered by a sintered funnel and washed with water (100 mL) to afford the title compound <b>22</b> (2.01 g, 93%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.78 (br s, 1H), 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.8 Hz, 1H), 7.80 (s, 1H), 7.47 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 6.82 (d, <i>J</i> = 2.1 Hz, 1H), 6.78 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Synthesis of Acridones <b>23</b> and <b>24</b></h3><div class="NLM_p last">Compounds <b>23</b> and <b>24</b> were synthesized (70–75%) by the same procedure as described for <b>7</b>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-Trifluoromethyl-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.87 (br s, 1H), 8.38 (d, <i>J</i> = 8.3 Hz, 1H), 8.15 (d, <i>J</i> = 8.9 Hz, 1H), 7.81 (s, 1H), 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 6.93–6.88 (m, 2H), 4.17 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.58 (q, <i>J</i> = 7.1 Hz, 4H), 1.00 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.1628, found 379.1632.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-Trifluoromethyl-6-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.87 (s, 1H), 8.37 (d, <i>J</i> = 8.6 Hz, 1H), 8.15 (d, <i>J</i> = 8.9 Hz, 1H), 7.80 (s, 1H), 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 6.92–6.88 (m, 2H), 4.16 (t, <i>J</i> = 5.9 Hz, 2H), 2.85 (t, <i>J</i> = 5.9 Hz, 2H), 2.46 (t, <i>J</i> = 7.2 Hz, 4H), 1.46–1.40 (m, 4H), 0.86 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.1941, found 407.1943.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Synthesis of 2-Chloro-6-hydroxyacridin-9(10<i>H</i>)-one (<b>28</b>)</h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>19</b> (Buchwald–Hartwig cross-coupling (Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu)), <b>5a</b> (Eaton’s acid-mediated cyclization) and <b>6a</b> (demethylation (HI/phenol)), the title compound <b>28</b> was synthesized in a good yield via the appropriate intermediates <b>26</b> and <b>27</b> from the triflate <b>17</b> and <i>p</i>-chloroaniline (<b>25</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.61 (s, 1H), 10.56 (s, 1H), 8.04–8.12 (m, 2H), 7.69 (dd, <i>J</i> = 8.8, 2.7 Hz, 1H), 7.49 (d, <i>J</i> = 8.9 Hz, 1H), 6.80 (d, <i>J</i> = 2.3 Hz, 1H), 6.75 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H); HRMS (ESI) calcd for C<sub>13</sub>H<sub>9</sub>Cl<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 246.0316, found 246.0317.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Synthesis of Acridones <b>29</b> and <b>30</b></h3><div class="NLM_p last">Acridones <b>29</b> (36%) and <b>30</b> (49%) were generated by the same procedure as described for <b>7</b> from <b>28</b>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Chloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.11–8.09 (m, 2H), 7.69 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.52 (d, <i>J</i> = 8.9 Hz 1H), 6.89 (d, <i>J</i> = 2.34 Hz, 1H), 6.86 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 4.15 (t, <i>J</i> = 6.1 Hz, 2H), 2.84 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 345.1364, found 345.1370.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Chloro-6-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>30</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.74 (br s 1H), 8.11 (m, 2H), 7.71 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.52 (d, <i>J</i> = 9.0 Hz, 1H), 6.88–6.85 (m, 2H), 4.13 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.46 (t, <i>J</i> = 7.2 Hz, 4H), 1.45–1.40 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>26</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 373.1677, found 373.1680.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Representative Procedure for the Synthesis of 2-Chloro-6-(3-chloropropoxy)acridin-9(10<i>H</i>)-one (<b>31</b>)</h3><div class="NLM_p last">To a stirred solution of <b>28</b> (500 mg, 2.04 mmol) in anhydrous acetone (50 mL) at room temperature were added K<sub>2</sub>CO<sub>3</sub> (1.40 g, 10.20 mmol) and 1-bromo-3-chloropropane (640 mg, 4.08 mmol), and the reaction mixture was stirred at reflux for 24 h. The mixture was then filtered, and the solvent was removed by rotary evaporation. The obtained product was purified by recrystallization from a mixture of acetone and methanol (1:1), to afford the title compound <b>31</b> (498 mg, 76%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.78 (br s, 1 H), 8.16–8.10 (m, 2H), 7.72 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.53 (d, <i>J</i> = 8.9 Hz, 1H), 6.90–6.88 (m, 2H), 4.23 (t, <i>J</i> = 6.1 Hz, 2H), 3.84 (t, <i>J</i> = 6.4 Hz, 2H), 2.27–2.24 (m, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 322.0396, found 322.0394.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Representative Procedure for the Synthesis of 6-(3-(<i>tert</i>-Butylamino)propoxy)-2-chloroacridin-9(10<i>H</i>)-one (<b>32</b>)</h3><div class="NLM_p last">To a stirred solution of <b>31</b> (400 mg, 1.24 mmol) in DMSO (25 mL) at room temperature were added NaI (747 mg, 4.98 mmol) and <i>tert</i>-butylamine (910 mg, 12.46 mmol), and the reaction mixture was stirred at 145 °C for 2 h. The excess <i>tert</i>-butylamine was removed under reduced pressure, and the mixture was poured into 50 mL of water. The precipitate that fell out was filtered and recrystallized from a mixture of methanol, ethyl acetate, and triethylamine (1:1:1), to afford the title compound <b>32</b> (240 mg, 54%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.76 (br s, 1H), 8.10 (m, 2H), 7.72 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.53 (d, <i>J</i> = 8.9 Hz, 1H), 6.88 (m, 2H), 4.18 (t, <i>J</i> = 6.5 Hz, 2H), 2.65 (t, <i>J</i> = 6.8 Hz, 2H), 1.89–1.83 (m, 2H), 1.03 (s, 9H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>24</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 359.1521, found 359.1523.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Synthesis of Acridones <b>38</b>–<b>55</b></h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>19</b> (Buchwald–Hartwig cross-coupling (Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu)), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>6a</b> (demethylation (HI/phenol)), <b>7</b> (O-alkylation by (alkylamino)-alkyl chlorides), <b>31</b> (O-alkylation by bromo–chloro alkanes), and <b>32</b> (amination by alkyl amines), the acridones <b>38</b>–<b>55</b> were synthesized in good yields (40–65%) via the appropriate intermediates <b>35</b>–<b>37</b> from the triflate <b>17</b> and 3,5-dichloroaniline (<b>33</b>)/3,5-difluoroaniline (<b>34</b>). The compounds <b>38</b>–<b>44</b> were purified by recrystallization from a mixture of acetone and methanol (1:1), and <b>45</b>–<b>55</b> were purified by recrystallization from a mixture of methanol, ethyl acetate, and triethylamine (1:1:1).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1,3-Dichloro-6-(2-chloroethoxy)acridin-9(10<i>H</i>)-one (<b>38</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.71 (s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.43 (d, <i>J</i> = 2.0 Hz, 1H), 7.26 (d, <i>J</i> = 2.0 Hz, 1H), 6.91 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 6.79 (d, <i>J</i> = 2.4 Hz, 1H), 4.39 (t, <i>J</i> = 5.1 Hz, 2H), 4.03 (t, <i>J</i> = 5.1 Hz, 2H); HRMS (ESI) calcd for C<sub>15</sub>H<sub>10</sub>Cl<sub>3</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 363.9669, found 363.9666.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 6-(2-Chloroethoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>39</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.78 (s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.03–6.90 (m, 3H), 6.83 (d, <i>J</i> = 2.2 Hz, 1H), 4.39 (t, <i>J</i> = 5.0 Hz, 2H), 4.02 (t, <i>J</i> = 5.0 Hz, 2H); HRMS (ESI) calcd for C<sub>15</sub>H<sub>10</sub>Cl<sub>1</sub>F<sub>2</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 332.0260, found 332.0259.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1,3-Dichloro-6-(3-chloropropoxy)acridin-9(10<i>H</i>)-one (<b>40</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.72 (s, 1H), 8.07 (d, <i>J</i> = 9.1 Hz, 1H), 7.44 (d, <i>J</i> = 1.7 Hz, 1H), 7.28 (d, <i>J</i> = 1.3 Hz, 1H), 6.90 (dd, <i>J</i> = 8.9, 1.7 Hz, 1H), 6.82 (d, <i>J</i> = 1.8 Hz, 1H), 4.23 (t, <i>J</i> = 5.9 Hz, 2H), 3.84 (t, <i>J</i> = 6.3 Hz, 2H), 2.25 (m, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>12</sub>Cl<sub>3</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 377.9826, found 377.9821.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 6-(3-Chloropropoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>41</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.77 (s, 1H), 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.02–7.00 (m, 1H), 6.95 (m, 1H), 6.88 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.84 (d, <i>J</i> = 2.3 Hz, 1H), 4.22 (t, <i>J</i> = 6.1 Hz, 2H), 3.83 (t, <i>J</i> = 6.4 Hz, 2H), 2.24 (m, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>12</sub>Cl<sub>1</sub>F<sub>2</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 346.0417, found 346.0416.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-(4-Chlorobutoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>42</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.75 (br s, 1H), 8.05 (d, <i>J</i> = 9.0 Hz, 1H), 7.02–6.92 (m, 2H), 6.87 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.81 (d, <i>J</i> = 2.3 Hz, 1H), 4.14 (t, <i>J</i> = 5.7 Hz, 2H), 3.74 (t, <i>J</i> = 6.1 Hz, 2H), 1.94–1.88 (m, 4H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>14</sub>Cl<sub>1</sub>F<sub>2</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 360.0573, found 360.0572.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1,3-Difluoro-6-(4,4,4-trifluorobutoxy)acridin-9(10<i>H</i>)-one (<b>43</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.77 (br s, 1H), 8.06 (d, <i>J</i> = 9.0 Hz, 1H), 7.02–6.93 (m, 2H), 6.89 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 6.82 (d, <i>J</i> = 2.3 Hz, 1H), 4.17 (t, <i>J</i> = 6.2 Hz, 2H), 2.47–2.44 (m, 2H), 2.05–1.98 (m, 2H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>12</sub>F<sub>5</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 380.0680, found 380.0679.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1,3-Difluoro-6-(hexyloxy)acridin-9(10<i>H</i>)-one (<b>44</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.72 (br s, 1H), 8.04 (d, <i>J</i> = 8.9 Hz, 1H), 7.02–6.95 (m, 2H), 6.86 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.81 (d, <i>J</i> = 2.3 Hz, 1H), 4.09 (t, <i>J</i> = 6.5 Hz, 2H), 1.81–1.74 (m, 2H), 1.46–1.43 (m, 2H), 1.35–1.31 (m, 4H), 0.89 (t, <i>J</i> = 7.0 Hz, 3H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 354.1276, found 354.1275.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1,3-Dichloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>45</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.73 (br s, 1H), 8.06 (d, <i>J</i> = 9.0 Hz, 1H), 7.45 (d, <i>J</i> = 1.8 Hz, 1H), 7.28 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 6.81 (d, <i>J</i> = 1.9 Hz, 1H), 4.15 (t, <i>J</i> = 5.8 Hz, 2H), 2.85 (t, <i>J</i> = 5.9 Hz, 2H), 2.59 (q, <i>J</i> = 6.9 Hz, 4H), 1.00 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0974.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 6-(2-(Diethylamino)ethoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>46</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.02–6.92 (m, 2H), 6.86 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 6.83 (d, <i>J</i> = 2.2 Hz, 1H), 4.14 (t, <i>J</i> = 6.1 Hz, 2H), 2.83 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 347.1566, found 347.1565.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1,3-Dichloro-6-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>47</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.68 (br s, 1H), 8.05 (d, <i>J</i> = 9.0 Hz, 1H), 7.42 (d, <i>J</i> = 1.9 Hz, 1H), 7.26 (d, <i>J</i> = 1.9 Hz, 1H), 6.86 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 6.78 (d, <i>J</i> = 2.1 Hz, 1H), 4.12 (t, <i>J</i> = 5.9 Hz, 2H), 2.83 (t, <i>J</i> = 5.6 Hz, 2H), 2.46 (t, <i>J</i> = 7.1 Hz, 4H), 1.46–1.37 (m, 4H), 0.865 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.1288, found 407.1289.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 6-(2-(Dipropylamino)ethoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>48</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.75 (br s, 1H), 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.02–6.92 (m, 2H), 6.85 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 6.82 (d, <i>J</i> = 2.0 Hz, 1H), 4.12 (t, <i>J</i> = 6.0 Hz, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.44 (t, <i>J</i> = 7.2 Hz, 4H), 1.46–1.37 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 375.1879, found 375.1878.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 6-(2-(Bis(3,3,3-trifluoropropyl)amino)ethoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>49</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.75 (br s, 1H), 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.01–6.92 (m, 2H), 6.84 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 6.80 (d, <i>J</i> = 2.1 Hz, 1H), 4.15 (t, <i>J</i> = 5.5 Hz, 2H), 2.95 (t, <i>J</i> = 5.6 Hz, 2H), 2.83–2.79 (m, 4H), 2.48–2.42 (m, 4H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>19</sub>F<sub>8</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 483.1313, found 483.1306.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1,3-Dichloro-6-(3-(diethylamino)propoxy)acridin-9(10<i>H</i>)-one (<b>50</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.68 (br s, 1H), 8.04 (d, <i>J</i> = 8.9 Hz, 1H), 7.42 (d, <i>J</i> = 1.5 Hz, 1H), 7.26 (d, <i>J</i> = 1.5 Hz, 1H), 6.86 (dd, <i>J</i> = 9.0, 1.9 Hz, 1H), 6.78 (d, <i>J</i> = 1.8 Hz, 1H), 4.12 (t, <i>J</i> = 6.0 Hz, 2H), 2.55 (t, <i>J</i> = 6.4 Hz, 2H), 2.46 (q, <i>J</i> = 6.9 Hz, 4H), 1.92–1.84 (m, 2H), 0.95 (t, <i>J</i> = 7.0 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1132.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 6-(3-(Diethylamino)propoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>51</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.04 (d, <i>J</i> = 9.0 Hz, 1H), 7.00–6.87 (m, 2H), 6.76 (dd, <i>J</i> = 8.7, 9.6 Hz, 2H), 4.12 (t, <i>J</i> = 5.5 Hz, 2H), 2.53 (t, <i>J</i> = 7.3 Hz, 2H), 2.45 (q, <i>J</i> = 7.1 Hz, 4H), 1.87 (m, 2H), 0.95 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 361.1722, found 361.1727.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 6-(3-(Dipropylamino)propoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>52</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.74 (br s, 1H), 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.02–6.94 (m, 2H), 6.86 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 6.81 (d, <i>J</i> = 2.1 Hz, 1H), 4.14 (t, <i>J</i> = 6.3 Hz, 2H), 2.54 (t, <i>J</i> = 7.1 Hz, 2H), 2.33 (t, <i>J</i> = 7.2 Hz, 4H), 1.92–1.85 (m, 2H), 1.44–1.34 (m, 4H), 0.83 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 389.2035, found 389.2032.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 6-(3-(Butylamino)propoxy)-1,3-dichloroacridin-9(10<i>H</i>)-one (<b>53</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.44 (d, <i>J</i> = 1.5 Hz, 1H), 7.27 (d, <i>J</i> = 1.4 Hz, 1H), 6.87 (dd, <i>J</i> = 9.2, 1.6 Hz, 1H), 6.80 (d, <i>J</i> = 1.4 Hz, 1H), 4.17 (t, <i>J</i> = 6.0 Hz, 2H), 2.70 (t, <i>J</i> = 6.2 Hz, 2H), 2.55–2.50 (m, 2H), 1.94–1.91 (m, 2H), 1.42–1.28 (m, 4H), 0.87 (t, <i>J</i> = 7.1 Hz, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1134.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 6-(3-(<i>tert</i>-Butylamino)propoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>54</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.07–8.05 (m, 1H), 7.06 (d, <i>J</i> = 9.8 Hz, 1H), 6.98–6.92 (m, 1H), 6.85–6.79 (m, 2H), 4.20 (t, <i>J</i> = 6.1 Hz, 2H), 2.88 (t, <i>J</i> = 7.2 Hz, 2H), 2.07–2.00 (m, 2H), 1.19 (s, 9H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 361.1722, found 361.1729.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 6-(4-(<i>tert-</i>Butylamino)butoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>55</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.04–6.93 (m, 2H), 6.87 (dd, <i>J</i> = 9.0, 1.9 Hz, 1H), 6.83 (d, <i>J</i> = 1.5 Hz, 1H), 4.11 (t, <i>J</i> = 6.3 Hz, 2H), 2.62 (t, <i>J</i> = 6.4 Hz, 2H), 1.87–1.80 (m, 2H), 1.62–1.55 (m, 2H), 1.08 (s, 9H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 375.1879, found 375.1881.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Synthesis of Methyl 4-(2-Bromoethoxy)-2-hydroxybenzoate (<b>57</b>)</h3><div class="NLM_p last">A suspension of methyl 2,4-dihydroxybenzoate (<b>56</b>) (5.0 g, 29.76 mmol) and K<sub>2</sub>CO<sub>3</sub> (20.53 g, 148.8 mmol) in anhydrous acetone (100 mL) was stirred at reflux for 2 h. Then, the reaction mixture was brought to room temperature, potassium iodide (KI) (1.48 g, 8.92 mmol) and 1,2-dibromoethane (11.13 g, 59.52 mmol) were added dropwise, and the reaction mixture was heated at reflux for overnight. The mixture was diluted with acetone (100 mL) and filtered through a pad of celite. The solvent was removed by rotary evaporation, and the product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent, to afford the title compound <b>57</b> as a white solid (3.85 g, 47%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 10.98 (s, 1H), 7.76 (d, <i>J</i> = 8.7 Hz, 1H), 6.48 (d, <i>J</i> = 2.5 Hz, 1H), 6.46 (m, 1H), 4.32 (t, <i>J</i> = 6.2 Hz, 2H), 3.93 (s, 3H), 3.65 (t, <i>J</i> = 6.2 Hz, 2H).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Synthesis of Methyl 4-(2-(Dipropylamino)ethoxy)-2-hydroxybenzoate (<b>58</b>)</h3><div class="NLM_p last">A suspension of dipropylamine (2.76 g, 27.37 mmol) and K<sub>2</sub>CO<sub>3</sub> (6.3 g, 45.62 mmol) in anhydrous acetone (50 mL) was stirred at reflux for 2 h. Then, the reaction mixture was brought to room temperature, KI (454 mg, 2.73 mmol) and a solution of <b>57</b> (2.5 g, 9.15 mmol) in anhydrous acetone (20 mL) were added dropwise, and the mixture was heated at reflux for 16 h. The mixture was diluted with acetone (100 mL) and filtered through a pad of celite, and the solvent was removed by rotary evaporation to furnish the desired product <b>58</b> (2.21 g, 82%) as an orange syrup. The product <b>58</b> was carried forward into the next reaction without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 10.87 (s, 1H), 7.64 (d, <i>J</i> = 8.6 Hz, 1H), 6.36 (d, <i>J</i> = 2.6 Hz, 1H), 6.34 (m, 1H), 4.18 (t, <i>J</i> = 6.3 Hz, 2H), 3.94 (s, 3H), 2.78 (t, <i>J</i> = 6.3 Hz, 2H), 2.40 (t, <i>J</i> = 7.3 Hz, 4H), 1.41 (m, 4H), 0.89 (t, <i>J</i> = 7.1 Hz, 6H).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Synthesis of Methyl 4-(2-(Dipropylamino)ethoxy)-2-(((trifluoromethyl)sulfonyl)oxy)benzoate (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was synthesized by the same procedure as described for <b>17</b>, and the product was chromatographed on silica gel with ethyl acetate/hexanes as the eluent, to afford the pure product <b>59</b> (2.5 g, 86%) as a thick syrup. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.06 (d, <i>J</i> = 8.8 Hz, 1H), 6.97 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.79 (d, <i>J</i> = 2.4 Hz, 1H), 4.09 (t, <i>J</i> = 6.2 Hz, 2H), 3.94 (s, 3H), 2.89 (t, <i>J</i> = 6.2 Hz, 2H), 2.49 (t, <i>J</i> = 7.5 Hz, 4H), 1.49 (m, 4H), 0.90 (t, <i>J</i> = 7.3 Hz, 6H).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Synthesis of Methyl 2-((3-Chloro-5-methoxyphenyl)amino)-4-(2-(dipropylamino)-ethoxy)benzoate (<b>61</b>)</h3><div class="NLM_p last">Compound <b>61</b> (1.0 g, 76%) was synthesized by the same procedure as described for <b>19</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 9.62 (s, 1H), 7.92 (d, <i>J</i> = 8.9 Hz, 1H), 6.90 (d, <i>J</i> = 3.8 Hz, 1H), 6.79 (d, <i>J</i> = 2.4 Hz, 1H), 6.69 (d, <i>J</i> = 4.0 Hz, 1H), 6.63 (d, <i>J</i> = 4.0 Hz, 1H), 6.37 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 4.01 (t, <i>J</i> = 6.4 Hz, 2H), 3.09 (s, 3H), 3.89 (s, 3H), 2.85 (t, <i>J</i> = 6.4 Hz, 2H), 2.48 (t, <i>J</i> = 7.6 Hz, 4H), 1.49 (m, 4H), 0.89 (t, <i>J</i> = 7.3 Hz, 6H).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Synthesis of Acridones <b>62</b> and <b>63</b></h3><div class="NLM_p last">Compounds <b>62</b> and <b>63</b> were synthesized by the same procedure as described for <b>5a</b>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 1-Chloro-6-(2-(dipropylamino)ethoxy)-3-methoxyacridin-9(10<i>H</i>)-one (<b>62</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.68 (s, 1H), 8.29 (d, <i>J</i> = 8.9 Hz, 1H), 6.81–6.70 (m, 4H), 4.01 (t, <i>J</i> = 6.1 Hz, 2H), 3.79 (s, 3H), 2.89 (t, <i>J</i> = 6.1 Hz, 2H), 2.50 (t, <i>J</i> = 7.5 Hz, 4H), 1.49 (m, 4H), 0.88 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 403.1783, found 403.1781.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 3-Chloro-6-(2-(dipropylamino)ethoxy)-1-methoxyacridin-9(10<i>H</i>)-one (<b>63</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.76 (br s, 1H), 8.30 (d, <i>J</i> = 9.0 Hz, 1H), 7.24 (d, <i>J</i> = 1.9 Hz, 1H), 7.08 (d, <i>J</i> = 2.0 Hz, 1H), 6.88 (dd, <i>J</i> = 9.0, 1.9 Hz, 1H), 6.63 (d, <i>J</i> = 1.6 Hz, 1H), 4.10 (t, <i>J</i> = 6.2 Hz, 2H), 3.25 (s, 3H), 2.92 (t, <i>J</i> = 6.2 Hz, 2H), 2.52 (t, <i>J</i> = 7.6 Hz, 4H), 1.52 (m, 4H), 0.91 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 403.1783, found 403.1782.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Synthesis of Acridones <b>70</b>–<b>86</b>, <b>92</b>, and <b>93</b></h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>19</b> (Buchwald–Hartwig cross-coupling (Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu)), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>6a</b> (demethylation (HI/phenol)), <b>7</b> (O-alkylation by (alkylamino)alkyl chlorides), <b>31</b> (O-alkylation by bromo–chloro alkanes), and <b>32</b> (amination by alkyl amines), the acridones <b>70</b>–<b>86</b>, <b>92</b>, and <b>93</b> were prepared in good yields (40–75%) via the appropriate intermediates <b>65</b>–<b>69</b> and <b>89</b>–<b>91</b> from the triflate <b>17</b> and commercially available 3,4-dichloroaniline (<b>64</b>)/3,4-difluoroaniline (<b>87</b>)/4-fluoro-3-methoxyaniline (<b>88</b>). The compounds <b>70</b>, <b>71</b>, and <b>83</b> were purified by recrystallization from a mixture of acetone and methanol (1:1), and <b>72</b>–<b>82</b>, <b>84</b>–<b>86</b>, <b>92</b>, and <b>93</b> were purified by either recrystallization from a mixture of methanol, ethyl acetate, and triethylamine (1:1:1) or trituration from aqueous acetone.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 1,2-Dichloro-6-(2-chloroethoxy)acridin-9(10<i>H</i>)-one (<b>70</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.45 (d, <i>J</i> = 9.2 Hz, 1H), 6.90 (dd, <i>J</i> = 9.1, 1.7 Hz, 1H), 6.82 (d, <i>J</i> = 1.8 Hz, 1H), 4.39 (t, <i>J</i> = 4.4 Hz, 2H), 4.03 (t, <i>J</i> = 4.7 Hz, 2H); HRMS (ESI) calcd for C<sub>15</sub>H<sub>10</sub>Cl<sub>3</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 363.9669, found 363.9666.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 1,2-Dichloro-6-(3-chloropropoxy)acridin-9(10<i>H</i>)-one (<b>71</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.77 (br s, 1H), 8.08 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.45 (d, <i>J</i> = 9.1 Hz, 1H), 6.88 (d, <i>J</i> = 9.1 Hz, 1H), 6.83 (s, 1H), 4.22 (t, <i>J</i> = 6.3 Hz, 2H), 3.84 (t, <i>J</i> = 6.2 Hz, 2H), 2.25 (m, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>12</sub>Cl<sub>3</sub>Na<sub>1</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 377.9826, found 377.9822.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 1,2-Dichloro-6-(2-(dimethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>72</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.07 (d, <i>J</i> = 8.9 Hz, 1H), 7.81 (d, <i>J</i> = 9.0 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 6.90–6.83 (m, 2H), 4.17 (t, <i>J</i> = 5.5 Hz, 2H), 2.68 (t, <i>J</i> = 5.5 Hz, 2H), 2.23 (s, 6H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 351.0662, found 351.0659.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 1,2-Dichloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>73</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.08 (d, <i>J</i> = 8.8 Hz, 1H), 7.80 (d, <i>J</i> = 9.0 Hz, 1H), 7.45 (d, <i>J</i> = 9.1 Hz, 1H), 6.87–6.83 (m, 2H), 4.14 (t, <i>J</i> = 6.0 Hz, 2H), 2.83 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0974.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 1,2-Dichloro-6-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>74</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.08 (d, <i>J</i> = 8.9 Hz, 1H), 7.82 (d, <i>J</i> = 9.0 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 6.87–6.83 (m, 2H), 4.13 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.45–1.40 (m, 4H), 0.86 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.1283, found 407.1287.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 1,2-Dichloro-6-(3-(dibutylamino)propoxy)acridin-9(10<i>H</i>)-one (<b>75</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.77 (br s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.82 (d, <i>J</i> = 9.0 Hz, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 1H), 6.86 (dd, <i>J</i> = 9.0, 2.2 Hz, 1H), 6.81 (d, <i>J</i> = 2.0 Hz, 1H), 4.13 (t, <i>J</i> = 6.1 Hz, 2H), 2.54 (t, <i>J</i> = 7.2 Hz, 2H), 2.36 (t, <i>J</i> = 6.3 Hz, 4H), 1.89–1.85 (m, 2H), 1.37–1.23 (m, 8H), 0.82 (t, <i>J</i> = 7.2 Hz, 6H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 449.1757, found 449.1759.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 1,2-Dichloro-6-(2-(1-methylpyrrolidin-2-yl)ethoxy)acridin-9(10<i>H</i>)-one (<b>76</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 11.78 (br s, 1H), 8.06 (d, <i>J</i> = 9.0 Hz, 1H), 7.81 (d, <i>J</i> = 9.0 Hz, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 1H), 6.84 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 6.80 (d, <i>J</i> = 2.3 Hz, 1H), 4.72 (br s, 1H), 2.89–2.81 (m, 1H), 2.72 (t, <i>J</i> = 6.0 Hz 2H), 2.69–2.61 (m, 1H), 2.42 (s 3H), 2.34–1.90 (m, 6H), 1.77–1.74 (m, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 391.0975, found 391.0973.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 1,2-Dichloro-6-(2-morpholinoethoxy)acridin-9(10<i>H</i>)-one (<b>77</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.76 (s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.82 (d, <i>J</i> = 9.0 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 6.89 (dd, <i>J</i> = 9.0, 2.1 Hz, 1H), 6.83 (d, <i>J</i> = 2.2 Hz, 1H), 4.22 (t, <i>J</i> = 5.5 Hz, 2H), 3.59 (t, <i>J</i> = 4.4 Hz, 4H), 3.32 (t, <i>J</i> = 4.5 Hz, 4H), 2.76 (t, <i>J</i> = 5.5 Hz, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 393.0767, found 393.0764.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 6-(2-(<i>tert</i>-Butylamino)ethoxy)-1,2-dichloroacridin-9(10<i>H</i>)-one (<b>78</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.76 (br s, 1H), 8.07 (d, <i>J</i> = 9.3 Hz, 1H), 7.82 (d, <i>J</i> = 8.9 Hz, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 1H), 6.89–6.81 (m, 2H), 4.10 (t, <i>J</i> = 5.8 Hz, 2H), 2.91 (t, <i>J</i> = 6.5 Hz, 2H), 1.07 (s, 9H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0977.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 6-(3-(<i>tert</i>-Butylamino)propoxy)-1,2-dichloroacridin-9(10<i>H</i>)-one (<b>79</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.07 (d, <i>J</i> = 8.5 Hz, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 6.87–6.82 (m, 2H), 4.17 (t, <i>J</i> = 6.3 Hz, 2H), 2.65 (t, <i>J</i> = 6.7 Hz, 2H), 1.89–1.85 (m, 2H), 1.03 (s, 9H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1135.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 6-(3-(Butylamino)propoxy)-1,2-dichloroacridin-9(10<i>H</i>)-one (<b>80</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.83 (d, <i>J</i> = 9.1 Hz, 1H), 7.46 (d, <i>J</i> = 9.2 Hz, 1H), 6.89–6.83 (m, 2H), 4.17 (t, <i>J</i> = 6.9 Hz, 2H), 2.70 (t, <i>J</i> = 6.8 Hz, 2H), 1.86 (t, <i>J</i> = 6.4 Hz, 2H), 1.45–1.27 (m, 6H), 0.89 (t, <i>J</i> = 6.4 Hz, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1135.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 6-(2-((Adamantan-1-yl)amino)ethoxy)-1,2-dichloroacridin-9(10<i>H</i>)-one (<b>81</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.82 (d, <i>J</i> = 9.0 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 6.88 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 6.81 (d, <i>J</i> = 2.1 Hz, 1H), 4.08 (t, <i>J</i> = 5.6 Hz, 2H), 3.17 (d, <i>J</i> = 4.8 Hz, 3H), 2.93 (t, <i>J</i> = 5.3 Hz, 2H), 2.08–2.00 (m, 2H), 1.64–1.54 (m, 10H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 457.1444, found 457.1443.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 2,3-Dichloro-6-(3-chloropropoxy)acridin-9(10<i>H</i>)-one (<b>82</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.78 (s, 1H), 8.25 (s, 1H), 8.11 (d, <i>J</i> = 8.9 Hz, 1H), 7.69 (s, 1H), 6.92 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.88 (d, <i>J</i> = 2.3 Hz, 1H), 4.24 (t, <i>J</i> = 6.0 Hz, 2H), 3.84 (t, <i>J</i> = 6.4 Hz, 2H), 2.28–2.22 (m, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>13</sub>Cl<sub>3</sub>N<sub>1</sub>O<sub>2</sub> (M + H)<sup>+</sup> 356.0006, found 356.0007.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 2,3-Dichloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>83</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.68 (s, 1H), 6.88 (d, <i>J</i> = 2.3 Hz, 1H), 6.78 (dd, <i>J</i> = 9.0, 2.1 Hz, 1H), 4.13 (t, <i>J</i> = 6.1 Hz, 2H), 2.83 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0980.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 2,3-Dichloro-6-(3-(dibutylamino)propoxy)acridin-9(10<i>H</i>)-one (<b>84</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.78 (br s, 1H), 8.25 (s, 1H), 8.10 (d, <i>J</i> = 8.9 Hz, 1H), 7.69 (s, 1H), 6.89 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 6.85 (d, <i>J</i> = 2.4 Hz, 1H), 4.15 (t, <i>J</i> = 6.0 Hz, 2H), 2.55 (t, <i>J</i> = 6.7 Hz, 2H), 2.41–2.35 (m, 4H), 1.92–1.87 (m, 2H), 1.38–1.22 (m, 8H), 0.83 (t, <i>J</i> = 7.2 Hz, 6H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 449.1757, found 449.1755.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 6-(3-(<i>tert</i>-Butylamino)propoxy)-2,3-dichloroacridin-9(10<i>H</i>)-one (<b>85</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.24 (s, 1H), 8.10 (d, <i>J</i> = 8.9 Hz 1H), 7.69 (s, 1H), 6.90 (dd, <i>J</i> = 9.2, 2.9 Hz 1H), 6.86 (d, <i>J</i> = 3.1 Hz, 1H), 4.19 (t, <i>J</i> = 6.4 Hz, 2H), 2.73 (t, <i>J</i> = 6.7 Hz, 2H), 1.93–1.82 (m, 2H), 1.07 (s, 9H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1130.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 6-(3-(Butylamino)propoxy)-2,3-dichloroacridin-9(10<i>H</i>)-one (<b>86</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.24 (s, 1H), 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.68 (s, 1H), 6.89–6.81 (m, 2H), 4.16 (t, <i>J</i> = 5.7 Hz, 2H), 2.67 (t, <i>J</i> = 6.6 Hz, 2H), 1.93–1.87 (m, 2H), 1.41–1.27 (m, 6H), 0.87 (t, <i>J</i> = 7.0 Hz, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 393.1131, found 393.1130.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 6-(2-(Diethylamino)ethoxy)-2,3-difluoroacridin-9(10<i>H</i>)-one (<b>92</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 8.01 (dd, <i>J</i> = 11.1, 9.2 Hz, 1H), 7.44 (dd, <i>J</i> = 11.9, 6.9 Hz, 1H), 6.89 (d, <i>J</i> = 2.3 Hz, 1H), 6.82 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 4.13 (t, <i>J</i> = 6.1 Hz, 2H), 2.83 (t, <i>J</i> = 6.1 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 347.1566, found 347.1570.</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 3,6-Bis(2-(diethylamino)ethoxy)-2-fluoroacridin-9(10<i>H</i>)-one (<b>93</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.54 (br s, 1H), 8.07 (d, <i>J</i> = 9.2 Hz, 1H), 7.80 (d, <i>J</i> = 11.6 Hz, 1H), 7.03 (d, <i>J</i> = 7.1 Hz, 1H), 6.85–6.82 (m, 2H), 4.20 (t, <i>J</i> = 5.9 Hz, 2H), 4.15 (t, <i>J</i> = 6.0 Hz, 2H), 2.88 (t, <i>J</i> = 5.9 Hz, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.62–2.55 (m, 8H), 0.99 (t, <i>J</i> = 7.0 Hz, 12H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>35</sub>F<sub>1</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 444.2657, found 444.2651.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Synthesis of Methyl 4-(2-(Diethylamino)ethoxy)-2-hydroxybenzoate (<b>95a</b>)</h3><div class="NLM_p last">A suspension of <b>56</b> (1.0 g, 5.95 mmol), K<sub>2</sub>CO<sub>3</sub> (4.10 g, 29.76 mmol), and tetrabutylammonium chloride (TBAC) (574 mg, 1.78 mmol) in anhydrous acetone (50 mL) was stirred at room temperature. After 30 min, a solution of 2-bromo-<i>N</i>,<i>N</i>-diethylethanamine hydrobromide (1.86 g, 7.14 mmol) in acetone (5 mL) was added dropwise and the mixture was then heated at reflux for 4 h. The mixture was diluted with acetone (100 mL) and filtered through a pad of celite. The solvent was removed by rotary evaporation, and the product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent, to afford the pure product <b>95a</b> as a clear oil (1.35 g, 85%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 10.96 (s, 1H), 7.73 (d, <i>J</i> = 9.5 Hz, 1H), 6.45 (m, 2H), 4.07 (t, <i>J</i> = 6.2 Hz, 2H), 3.92 (s, 3H), 2.88 (t, <i>J</i> = 6.2 Hz, 2H), 2.64 (q, <i>J</i> = 7.2 Hz, 4H), 1.07 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) calcd for C<sub>14</sub>H<sub>22</sub>N<sub>1</sub>O<sub>4</sub> (M + H)<sup>+</sup> 268.1543, found 268.1552.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Synthesis of Methyl 4-((2-(Diethylamino)ethyl)amino)-2-hydroxybenzoate (<b>95b</b>)</h3><div class="NLM_p last">To a stirred solution of methyl 4-iodosalicylate (<b>94</b>, 5.0 g, 17.98 mmol) in 50 mL of dry DMF at room temperature were added 2-diethylaminoethylamine (2.5 g, 21.58 mmol), Cs<sub>2</sub>CO<sub>3</sub> (11.69 g, 35.97 mmol), 2-acetylcyclohexanone (200 mg, 1.43 mmol), and CuI (170 mg, 0.89 mmol). The reaction mixture was stirred at 100 °C for 4 h. The mixture was filtered through a pad of celite, and the filtrate was diluted with ethyl acetate (250 mL). The organic layer was washed with saturated NH<sub>4</sub>Cl, water, and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed by rotary evaporation, and the product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent, to afford the pure <b>95b</b> as a thick syrup (3.97 g, 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 11.01 (s, 1H), 7.60 (d, <i>J</i> = 8.7 Hz, 1H), 6.12 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.07 (d, <i>J</i> = 2.4 Hz, 1H), 4.97 (br s, 1H), 3.88 (s, 3H), 3.15 (m, 2 H), 2.69 (t, <i>J</i> = 6.2 Hz, 2H), 2.57 (q, <i>J</i> = 7.2 Hz, 4H), 1.04 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) calcd for C<sub>14</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 267.1703, found 267.1711.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Synthesis of Methyl 4-(2-(Diethylamino)ethoxy)-2-(((trifluoromethyl)sulfonyl)oxy)-benzoate (<b>96a</b>) and Methyl 4-((2-(Diethylamino)ethyl)amino)-2-(((trifluoromethyl)-sulfonyl)oxy)benzoate (<b>96b</b>)</h3><div class="NLM_p">Compounds <b>96a</b> (1.47 g, 99%) and <b>96b</b> (3.3 g, 74%) were synthesized by the same procedure as described for <b>17</b>.</div><div class="NLM_p last"><b>96a</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.05 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.85 (d, <i>J</i> = 2.4 Hz, 1H), 4.50 (t, <i>J</i> = 4.7 Hz, 2H), 3.91 (s, 3H), 3.59 (t, <i>J</i> = 4.7 Hz, 2H), 3.32 (q, <i>J</i> = 7.3 Hz, 4H), 1.41 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>15</sub>H<sub>21</sub>F<sub>3</sub>N<sub>1</sub>O<sub>6</sub>S<sub>1</sub> (M + H)<sup>+</sup> 400.1036, found 400.1044. <b>96b</b>: <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.88 (d, <i>J</i> = 8.7 Hz, 1H), 7.07 (br s, 1H), 6.73 (dd, <i>J</i> = 8.7 2.2 Hz, 1H), 6.43 (d, <i>J</i> = 2.2 Hz, 1H), 3.88 (s, 3H), 3.58 (m, 2H), 3.23 (t, <i>J</i> = 5.6 Hz, 2H), 3.14 (q, <i>J</i> = 7.3 Hz, 4H), 1.36 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>15</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S<sub>1</sub> (M + H)<sup>+</sup> 399.1196, found 399.1195.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Representative Procedure for the Synthesis of Methyl 4-(2-(Diethylamino)ethoxy)-2-((4-fluoro-3-methoxyphenyl)amino)-benzoate (<b>97a</b>)</h3><div class="NLM_p last">To a degassed solution of <b>96a</b> (1.00 g, 2.50 mmol) and 4-fluoro-3-methoxyaniline (<b>88</b>) (389 mg, 2.75 mmol) in toluene (50 mL) at room temperature were added palladium acetate (34 mg, 0.15 mmol), XPhos (143 mg, 0.30 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.62 g, 50.12 mmol). The mixture was again degassed and heated at reflux for 5 h. After cooling to room temperature, the mixture was filtered through a pad of celite and washed with dichloromethane (100 mL). The filtrate was concentrated under reduced pressure, and the crude product was chromatographed on silica gel, with ethyl acetate/hexanes as the eluent, to afford the desired product <b>97a</b> as a brown syrup (811 mg, 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.52 (s, 1H), 7.93 (d, <i>J</i> = 8.9 Hz, 1H), 7.08 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 6.84 (m, 2H), 6.51 (d, <i>J</i> = 2.5 Hz, 1H), 6.30 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 4.20 (t, <i>J</i> = 5.2 Hz, 2H), 3.89 (s, 3H), 3.88 (s, 3H), 3.20 (t, <i>J</i> = 5.2 Hz, 2H), 3.00 (q, <i>J</i> = 7.2 Hz, 4H), 1.25 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) calcd for C<sub>21</sub>H<sub>28</sub>F<sub>1</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 391.2028, found 391.2034.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Synthesis of Methyl 4-((2-(Diethylamino)ethyl)amino)-2-((4-fluoro-3-methoxyphenyl)-amino)benzoate (<b>97b</b>)</h3><div class="NLM_p last">Compound <b>97b</b> (693 mg, 71%) was synthesized by the same procedure as described for <b>97a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.54 (s, 1H), 7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.06 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.89 (dd, <i>J</i> = 7.6, 2.4 Hz, 1H), 6.82 (m, 1H), 6.20 (d, <i>J</i> = 2.2 Hz, 1H), 6.04 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 4.90 (br s, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.15 (t, <i>J</i> = 5.9 Hz, 2H), 2.74 (t, <i>J</i> = 5.9 Hz, 2H), 2.66 (q, <i>J</i> = 7.2 Hz, 4H), 1.07 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) calcd for C<sub>21</sub>H<sub>29</sub>F<sub>1</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 390.2187, found 390.2191.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Synthesis of Acridones <b>98</b> and <b>99</b></h3><div class="NLM_p last">Compounds <b>98</b> (298 mg, 65%) and <b>99</b> (238 mg, 52%) were synthesized by the same procedure as described for <b>5a</b> and purified by recrystallization from a mixture of acetone and methanol (1:1).</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> 6-(2-(Diethylamino)ethoxy)-2-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>98</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.76 (d, <i>J</i> = 12.2 Hz, 1H), 7.15 (d, <i>J</i> = 7.6 Hz, 1H), 6.91 (d, <i>J</i> = 2.4 Hz, 1H), 6.72 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 4.09 (t, <i>J</i> = 6.2 Hz, 2H), 3.93 (s, 3H), 2.81 (t, <i>J</i> = 6.2 Hz, 2H), 2.56 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H). HRMS (ESI) calcd for C<sub>20</sub>H<sub>24</sub>F<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 359.1765, found 359.1766.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> 6-((2-(Diethylamino)ethyl)amino)-2-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>99</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.42 (s, 1H), 7.87 (d, <i>J</i> = 8.9 Hz, 1H), 7.73 (d, <i>J</i> = 11.9 Hz, 1H), 7.03 (d, <i>J</i> = 7.3 Hz, 1H), 6.65 (br s, 1H), 6.60 (dd, <i>J</i> = 6.9, 2.0 Hz, 1H), 6.37 (d, <i>J</i> = 1.7 Hz, 1H), 3.94 (s, 3H), 3.34 (2H are merged), 2.84–2.75 (m, 6H), 1.07 (t, <i>J</i> = 7.0 Hz, 6H). HRMS (ESI) calcd for C<sub>20</sub>H<sub>25</sub>F<sub>1</sub>N<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup> 358.1925, found 358.1923.</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> Synthesis of Acridones <b>100</b>–<b>102</b></h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>19</b> (Buchwald–Hartwig cross-coupling (Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu)), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>6a</b> (demethylation (HI/phenol)), <b>7</b> (O-alkylation by (alkylamino)-alkyl chlorides), the acridones <b>100</b>–<b>102</b> were synthesized in good yields (67–79%) from <b>17</b> and commercially available 2,5-dichloroaniline, 2,4-dichloroaniline, and 2,3-dichloroaniline, respectively.</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> 1,4-Dichloro-6-(3-(diethylamino)propoxy)acridin-9(10<i>H</i>)-one (<b>100</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.68 (s, 1H), 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 4.13 (t, <i>J</i> = 5.5 Hz, 2H), 2.85 (t, <i>J</i> = 5.8 Hz, 2H), 2.60 (q, <i>J</i> = 6.7 Hz, 4H), 0.99 (t, <i>J</i> = 6.8 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0979.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> 2,4-Dichloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>101</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.94 (br s, 1H), 8.11–8.08 (m, 2H), 8.03 (d, <i>J</i> = 2.5 Hz, 1H), 7.52 (d, <i>J</i> = 2.2 Hz, 1H), 6.91 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 4.13 (t, <i>J</i> = 6.2 Hz, 2H), 2.86 (t, <i>J</i> = 6.0 Hz, 2H), 2.59 (q, <i>J</i> = 7.1 Hz, 4H), 1.00 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0980.</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> 3,4-Dichloro-6-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>102</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.91 (br s, 1H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 8.10 (d, <i>J</i> = 8.9 Hz, 1H), 7.55 (s, 1H), 7.46 (d, <i>J</i> = 8.6 Hz, 1H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 4.13 (t, <i>J</i> = 5.4 Hz, 2H), 2.86 (t, <i>J</i> = 5.5 Hz, 2H), 2.58 (q, <i>J</i> = 6.8 Hz, 4H), 1.00 (t, <i>J</i> = 6.9 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 379.0975, found 379.0979.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Synthesis of Acridones <b>109</b>–<b>113</b></h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>31</b> (O-alkylation by bromo–chloro alkanes), <b>32</b> (amination by alkyl amines), <b>17</b> (Tf<sub>2</sub>O/pyridine), <b>97a</b> (Buchwald–Hartwig cross-coupling: Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>), and <b>5a</b> (Eaton’s acid-mediated cyclization), the acridones <b>109</b>–<b>113</b> were synthesized in good yields (40–75%) via the appropriate intermediates <b>104</b>–<b>106</b> and <b>108</b> from commercially available methyl 2,5-dihydroxybenzoate (<b>103</b>) and anilines <b>107</b>, <b>34</b>, and <b>60</b>.</div></div><div id="sec4_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> 7-(2-(Dipropylamino)ethoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>109</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.90 (s, 1H), 7.57 (d, <i>J</i> = 2.7 Hz, 1H), 7.47 (d, <i>J</i> = 9.0 Hz, 1H), 7.39 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.04 (dd, <i>J</i> = 10.4, 2.4 Hz, 1H), 6.96 (ddd, <i>J</i> = 11.9, 9.6, 2.3 Hz, 1H), 4.09 (t, <i>J</i> = 5.6 Hz, 2H), 2.82 (t, <i>J</i> = 7.1 Hz, 2H), 2.46 (t, <i>J</i> = 6.7 Hz, 4H), 1.45–1.40 (m, 4H), 0.86 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 375.1879, found 375.1883.</div></div><div id="sec4_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> 7-(2-(Dipropylamino)ethoxy)-1-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>110</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.62 (s, 1H), 7.54 (d, <i>J</i> = 2.6 Hz, 1H), 7.41 (d, <i>J</i> = 9.0 Hz, 1H), 7.33 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 6.68 (d, <i>J</i> = 1.7 Hz, 1H), 6.57 (dd, <i>J</i> = 13.5, 2.0 Hz, 1H), 4.07 (t, <i>J</i> = 5.9 Hz, 2H), 3.88 (s, 3H), 2.81 (t, <i>J</i> = 5.8 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.43–1.41 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>F<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 387.2078, found 387.2079.</div></div><div id="sec4_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> 7-(2-(Dipropylamino)ethoxy)-3-fluoro-1-methoxyacridin-9(10<i>H</i>)-one (<b>111</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.49 (s, 1H), 7.54 (d, <i>J</i> = 2.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.9 Hz, 1H), 7.31 (dd, <i>J</i> = 8.9, 2.8 Hz, 1H), 6.70 (dd, <i>J</i> = 10.3, 2.3 Hz, 1H), 6.56 (dd, <i>J</i> = 11.9, 2.3 Hz, 1H), 4.06 (t, <i>J</i> = 6.0 Hz, 2H), 3.86 (s, 3H), 2.81 (t, <i>J</i> = 5.9 Hz, 2H), 2.45 (t, <i>J</i> = 7.1 Hz, 4H), 1.45–1.39 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>F<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 387.2078, found 387.2083.</div></div><div id="sec4_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> 1-Chloro-7-(2-(dipropylamino)ethoxy)-3-methoxyacridin-9(10<i>H</i>)-one (<b>112</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.52 (s, 1H), 7.53 (d, <i>J</i> = 2.7 Hz, 1H), 7.40 (d, <i>J</i> = 8.9 Hz, 1H), 7.33 (dd, <i>J</i> = 8.9, 2.8 Hz, 1H), 7.03 (d, <i>J</i> = 1.6 Hz, 1H), 6.67 (d, <i>J</i> = 1.6 Hz, 1H), 4.07 (t, <i>J</i> = 5.8 Hz, 2H), 3.87 (s, 3H), 2.83 (t, <i>J</i> = 5.6 Hz, 2H), 2.46 (t, <i>J</i> = 7.0 Hz, 4H), 1.47–1.38 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 403.1783, found 403.1784.</div></div><div id="sec4_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> 3-Chloro-7-(2-(dipropylamino)ethoxy)-1-methoxyacridin-9(10<i>H</i>)-one (<b>113</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.61 (s, 1H), 7.55 (d, <i>J</i> = 2.9 Hz, 1H), 7.40 (d, <i>J</i> = 8.9 Hz, 1H), 7.33 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 6.83–6.82 (m, 2H), 4.07 (t, <i>J</i> = 6.0 Hz, 2H), 3.88 (s, 3H), 2.82 (t, <i>J</i> = 6.0 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.47–1.37 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 403.1783, found 403.1782.</div></div><div id="sec4_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> Synthesis of Acridones <b>119</b> and <b>120</b></h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>97a</b> (Buchwald–Hartwig cross-coupling: Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>22</b> (demethylation: BBr<sub>3</sub>), and <b>7</b> (O-alkylation by (alkylamino)alkyl chloride), the acridones <b>119</b> and <b>120</b> were synthesized in good yields (60–65%) via the appropriate intermediates <b>115</b>–<b>118</b> from commercially available methyl 2-bromo-5-methoxybenzoate (<b>114</b>) and 3,4-dichloroaniline (<b>64</b>).</div></div><div id="sec4_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> 1,2-Dichloro-7-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>119</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.80 (d, <i>J</i> = 9.1 Hz, 1H), 7.58 (d, <i>J</i> = 2.7 Hz, 1H), 7.52–7.47 (m, 2H), 7.38 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 4.08 (t, <i>J</i> = 6.0 Hz, 2H), 2.82 (t, <i>J</i> = 6.0 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.47–1.37 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.1288, found 407.1286.</div></div><div id="sec4_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> 2,3-Dichloro-7-(2-(dipropylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>120</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 11.92 (s, 1H), 8.28 (s, 1H), 7.73 (s, 1H), 7.58 (d, <i>J</i> = 2.3 Hz, 1H), 7.51 (d, <i>J</i> = 9.0 Hz, 1H), 7.42 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 4.09 (t, <i>J</i> = 5.7 Hz, 2H), 2.82 (t, <i>J</i> = 5.7 Hz, 2H), 2.45 (t, <i>J</i> = 7.2 Hz, 4H), 1.45–1.38 (m, 4H), 0.85 (t, <i>J</i> = 7.3 Hz, 6H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.1288, found 407.1287.</div></div><div id="sec4_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> Synthesis of 2-Chloro-7-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>123</b>)</h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>97a</b> (Buchwald–Hartwig cross-coupling: Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>22</b> (demethylation: BBr<sub>3</sub>), and <b>7</b> (O-alkylation by (alkylamino)alkyl chloride), the acridone <b>123</b> was synthesized in a good yield (71%) via the appropriate intermediates <b>121</b> and <b>122</b> from commercially available methyl 2-bromo-5-methoxybenzoate (<b>114</b>) and 4-chloroaniline (<b>25</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) 8.14 (d, <i>J</i> = 2.5 Hz, 1H), 7.71 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.61 (d, <i>J</i> = 2.9 Hz, 1H), 7.57 (d, <i>J</i> = 8.9 Hz, 1H), 7.53 (d, <i>J</i> = 9.0 Hz, 1H), 7.42 (dd, <i>J</i> = 9.0, 2.9 Hz, 1H), 4.10 (t, <i>J</i> = 6.1 Hz, 2H), 2.82 (t, <i>J</i> = 6.0 Hz, 2H), 2.57 (q, <i>J</i> = 7.1 Hz, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 345.1364, found 345.1370.</div></div><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> Synthesis of 6-Chloro-2-(2-(diethylamino)ethoxy)acridin-9(10<i>H</i>)-one (<b>128</b>)</h3><div class="NLM_p last">By using our standardized procedures, as described above for <b>3a</b> (copper-catalyzed amination reaction), <b>5a</b> (Eaton’s acid-mediated cyclization), <b>22</b> (demethylation (BBr<sub>3</sub>)), and <b>7</b> (O-alkylation by (alkylamino)alkyl chloride), the acridone <b>128</b> was synthesized in a good yield (77%) via the appropriate intermediates <b>125</b>–<b>127</b> from commercially available <b>1d</b> and 4-methoxyaniline (<b>124</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) 12.15 (s, 1H), 9.98 (s, 1H), 8.22 (d, <i>J</i> = 8.7 Hz, 1H), 7.70 (d, <i>J</i> = 2.4 Hz, 1H), 7.62–7.59 (m, 2H), 7.49 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 4.46 (t, <i>J</i> = 4.7 Hz, 2H), 3.56 (q, <i>J</i> = 4.5 Hz, 2H), 3.29–3.21 (m, 4H), 1.26 (t, <i>J</i> = 7.2 Hz, 6H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>Cl<sub>1</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 345.1364, found 345.1369.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i132">Biological Experiments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> Culture Conditions</h3><div class="NLM_p last"><i>P. falciparum</i> strains D6, Dd2, 7G8, and TM90-C2B were cultured in human erythrocytes at 2% hematocrit in Roswell Park Memorial Institute (RPMI) 1640 containing 0.5% Albumax, 45 μg/L hypoxanthine, and 50 μg/L gentamicin, as previously described.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> In Vitro Blood-Stage Antimalarial Activity</h3><div class="NLM_p last">In vitro antimalarial activity was determined by the malaria SYBR green I-based fluorescence (MSF) assay described previously with minor modifications, as previously described, and expressed as the compound concentration inhibiting growth by 50% (IC<sub>50</sub>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> In Vitro Liver-Stage Antimalarial Activity</h3><div class="NLM_p last">In vitro liver-stage activity of each new acridone was assessed utilizing luciferase-expressing <i>P. berghei</i> sporozoite-infected HepG2 hepatocyte cells (a hepatoma cell line that allows higher rates of sporozoite invasion and full development of <i>P. berghei</i>).<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Briefly, luciferase-expressing <i>P. berghei</i> (ANKA-676m1cl1) sporozoites were extracted from salivary glands of infected <i>Anopheles stephensi</i> mosquitoes. HepG2-A16 cells were cultivated and seeded in 96-well plates and grown for 24 h. Then, 10 000 sporozoites were incubated with the HepG2 cells for 3 h, after which, the wells were washed with media to remove noninvaded sporozoites. Drug solutions then were added and plates were placed in a 37 °C and 5% CO<sub>2</sub> incubator for 45 h. Luciferin was added, and the plates were incubated for 30 min; afterward, luciferase activity was determined in a luminometer.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> In Vivo Blood-Stage Efficacy against Murine Malaria</h3><div class="NLM_p last">The in vivo activity of selected acridones was assessed against the blood stages using a modified 4 day test.<a onclick="showRef(event, 'ref23 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref23 ref31 ref32">(23,31,32)</a> Four to five week old female CF1 mice (Charles River Laboratories) were infected intravenously with 2.5 × 10<sup>5</sup><i>P. yoelii</i> (Kenya strain, MR4 MRA-428)-parasitized erythrocytes from a donor animal. Drug administration commenced the day after the animals were inoculated (day 1). The test compounds were dissolved in poly(ethylene glycol) (PEG) 400 and administered by oral gavage once daily for four successive days; chloroquine phosphate was used as a positive control. Blood for blood film analysis and body weights were obtained on the day following the last dose and then at weekly intervals through day 28. Blood films were Giemsa-stained and examined microscopically to determine the levels of parasitemia. These blood samples were collected from the tail vein with the aid of a syringe needle. All mice were observed daily to assess their clinical signs, which were recorded. Animals with observable parasitemia following the experiment were euthanized; animals cleared of parasites from their bloodstream were observed daily with assessment of parasitemia performed weekly until day 28, at which point we score the animal(s) as cured of infection, and the animals were euthanized. All treated mice with a negative smear on day 28 were considered cured (100% protection). ED<sub>50</sub> and ED<sub>90</sub> values (mg/(kg days)) were derived graphically from the dose required to reduce parasite burden by 50 and 90%, respectively, relative to drug-free controls.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> Animals and Ethic Statement at Portland VA Medical Center (PVAMC)</h3><div class="NLM_p last">In vivo blood-stage testing was carried out at PVAMC, and the procedures were conducted under protocols approved by the PVAMC Institutional Animal Care and Use Committee (protocol number 3072). Research was conducted in an AAALACi accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011 edition.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> In Vivo Liver-Stage Efficacy against Murine Malaria</h3><div class="NLM_p">A real-time in vivo imaging system (IVIS) was used to determine the in vivo liver-stage antimalarial efficacy of selected acridone candidates.<a onclick="showRef(event, 'ref33 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref35 ref36">(33,35,36)</a> Luciferase-expressing <i>P. berghei</i> sporozoites were extracted from salivary glands of <i>A. stephensii</i> mosquitoes. C57BL/6 male albino mice were infected i.v. in the tail vein with 50 000 sporozoites on day 0. Drugs were administered orally on days −1, 0, and +1. All drug solutions were prepared fresh before drug administration by dissolving the needed quantity of drug in cold (4 °C) 0.5% (w/v) hydroxyethyl cellulose and 0.2% (v/v) Tween-80 (0.5% HECT) or PEG 400. If needed, drugs were ground using a ProScientific 300D homogenizer, and the particle size was measured using a Horiba LA-950V2 particle size analyzer. Formulations of acridones were prepared in PEG 400 and administered orally (p.o.) at 10 and/or 40 mg/kg on days −1, 0, and 1. A vehicle control (PEG 400) group was included as a negative control in all of the studies. The positive control consisted of three doses of 4-methyl primaquine, which was dissolved in 0.5% HECT and was given at 5 mg/kg on days −1, 0, and 1 post infections. All dosing solutions were given based on mice body weight measured on the day before infections took place.</div><div class="NLM_p last"><i>P. berghei</i> parasite load in the liver and blood (approximately at 24, 48, and 72 h post animal infections) was assessed using an IVIS Spectrum instrument. Mice were injected intraperitoneally with 150 μL of <span class="smallcaps smallerCapital">d</span>-luciferin solution (Gold Biotechnology, St. Louis, MO) at a concentration of 200 mg/kg body weight. Three minutes after luciferin injection, the mice were placed in the induction chamber and anesthetized. As soon as the mice were asleep, they were transferred in the IVIS chamber and positioned ventral side down on the heated platform with their noises positioned inside the nose cones. The IVIS camera exposure times were 1 and 5 min for the 24, 48, and 72 h time points with a large binning setting and an f-stop = 1. The IVIS Living Image software (version 4.0) was used to quantitate the bioluminescence in photons per second observed from the liver region or whole animal surface area, respectively, for the liver and blood-stage efficacy studies. Starting at 6 days after infection, all mice were assessed for blood-stage parasitemia, which was quantitated using flow cytometry conducted using a FC500 MPL flow cytometer (Beckman Coulter, Fullerton, CA). The green photomultiplier tube (PMT) and filter setting were used in these studies (520–555 nm filter settings for the green PMT and greater than 580 nm settings for the red PMT). Infected erythrocytes, uninfected erythrocytes, and leukocytes were gated on logarithmic forward/side dot plots. The method of FCM sample preparation has been described previously. In brief, a small 3 μL sample of blood was obtained from the tails of all mice. The blood was transferred into 0.3 mL of 1% heparinized isotonic buffer (phosphate-buffered saline (PBS) saline). Glutaraldehyde (1 mM of 0.04%) was added to fix each sample, and samples were incubated for 60 min at 4 °C followed by centrifugation at 450<i>g</i> for 5 min. The supernatant was removed by aspiration, and the cells were resuspended in 0.5 mL of PBS buffer supplemented with 0.25% (v/v) Triton X-100 for 10 min incubation at room temperature. After centrifugation, the permeabilized cells were resuspended in 0.5 mL of RNAase at 1 mg/mL concentrations and incubated for at least 2 h at 37 °C to ensure complete digestion of reticulocytes, which are at high concentrations due to anemia associated with <i>P. berghei</i> infection. The YOYO-1 dye (20 μL) at a concentration of 2500 ng/mL was added to the 0.5 mL sample volume to create a final dye concentration of 100 ng/mL of YOYO-1. Parasitemia was monitored for up to 31 days post infections. Blood samples for parasitemia determination were taken every week or prior to euthanizing the animals sick with malaria that were being removed from the study. Mice that tested negative for parasitemia on day 31 post infection were considered cured. The minimum curative dose (ED<sub>100</sub>) in 100% of animals dosed was defined as the lowest dose that cured all animals for the entire 31 day follow-up period.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> Animals and Ethic Statement at Walter Reed Army Institute of Research (WRAIR)</h3><div class="NLM_p">Male C57BL/6 Albino mice aged 6 weeks (Charles River) were used in this study. The mice were left to acclimatize for 7 days prior to the beginning of research studies. All mice were assigned a study number with an individual ear tag. Cards attached to each mouse cage were also used to identify the study groups. All animals were quarantined for stabilization for 7 days prior to infection. Mice were housed in a designated room with food and water supplied ad libitum and a 12:12 light–dark cycle.</div><div class="NLM_p last">The animal protocol for this study was approved by the Walter Reed Army Institute of Research, Institutional Animal Care and Use Committee (protocol number 18-ET-12), in accordance with national and Department of Defence guidelines. Research was conducted in an AAALACi accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011 edition.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> HepG2 Cytotoxicity Assay</h3><div class="NLM_p last">To identify toxicity to mammalian cells, an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using hepatic HepG2 cells was employed.<a onclick="showRef(event, 'ref39 ref49'); return false;" href="javascript:void(0);" class="ref ref39 ref49">(39,49)</a> Drugs were dissolved in DMSO to make 10 mM stock solutions. Human hepatocarcinoma cells (HepG2) were maintained on RPMI 1640 medium supplemented with 10% fetal bovine serum at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. Cells were seeded at a density of 2 × 10<sup>4</sup> per well in 96-well flat-bottom tissue culture plates containing complete medium in a total volume of 160 μL/well. The cells were allowed to attach at 37 °C overnight. On the following day, drug solutions (40 μL/well) were serially diluted with complete culture medium across the plate. The plates were then incubated at 37 °C and 5% CO<sub>2</sub> for another 24–36 h. Afterward, the medium was aspirated and replaced with complete RPMI medium (200 μL/well), and the plates were incubated for an additional 24 h at 37 °C and 5% CO<sub>2</sub>. An aliquot of a stock solution of resazurin (Alamar Blue, prepared in 1× PBS) was then added at 20 μL per well (final concentration 10 μm), and the plates were returned to the incubator for 3 h. After this period, fluorescence in each well, indicative of the cellular redox activity, was measured in a Gemini EM plate reader with excitation wavelength of 560 nm and emission wavelength of 590 nm. IC<sub>50</sub> values were determined by nonlinear regression analysis of logistic concentration–fluorescence intensity curves (GraphPad Prism software).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> In Vitro Metabolic Profile</h3><div class="NLM_p last">The half-lives of lead acridones in mouse and human liver microsomes were determined as described previously.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> All samples were tested in human and mouse liver microsomal preparations. Sample stocks at 10 or 20 μm (depending on solubility) in DMSO were diluted to a final concentration of 1 μm with a mixture containing 0.5 mg/mL prewarmed pooled human or mouse liver microsomes (BD Gentest), 1.3 μm nicotinamide adenine dinucleotide phosphate (Sigma), 3.3 μm MgCl<sub>2</sub> (Sigma), and 0.1 M, pH 7.4, PBS using a TECAN Genesis robotic liquid handler. The reaction was started with the addition of 1 U/mL glucose-6-phosphate dehydrogenase. The mixture was incubated in a shaking platform at 37 °C, and aliquots were taken and quenched with the addition of an equal volume of cold acetonitrile at 0, 10, 20, 30, and 60 min. Samples were centrifuged at 3700 rpm for 10 min at 20 °C to remove debris. Sample quantification was carried out by LC/MS, metabolic half-life was calculated by fitting the data to a first-order decay model, and intrinsic clearance (<i>C</i><sub>Lint</sub>) is dependent on the half-life and concentration of protein, calculated as follows: <i>C</i><sub>Lint</sub> = ln<sub>2</sub>/(<i>T</i><sub>1/2</sub>[microsomal protein]).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> In Vivo Pharmacokinetic (PK) Studies</h3><div class="NLM_p last">PK studies were conducted using the previously established methods.<a onclick="showRef(event, 'ref33 ref39'); return false;" href="javascript:void(0);" class="ref ref33 ref39">(33,39)</a> Male 7 week old ICR mice weighing from 23 to 28 g (Charles River Laboratories, Inc., Raleigh, NC) were used for the PK evaluations. On arrival, the animals were acclimated for 7 days in quarantine. The animals were housed in a cage maintained in a room with a temperature range of 64–79 °F, 34–68% relative humidity, and a 12 h light–dark cycle. Food and water were provided ad libitum during quarantine and throughout the study. The animals were fed a standard rodent maintenance diet. All animal studies were performed under IACUC-approved protocols. These protocols detail the experimental procedures and designs as well as the number of animals that were used. All animal use, care, and handling were performed in accordance with the current “Guide for the Care and Use of Laboratory Animals” (8th edition, 2011). PK studies were performed using intragastric (IG) administration. For each time point to be acquired, three male ICR mice per time point were dosed at single p.o. dosing of 80 mg/kg. The drug vehicle was double distilled water, administered at 100 μL/20 g. At each time point, blood and plasma samples were collected. Whole blood was collected by cardiac puncture. Blood samples were collected in lithium heparin tubes. Following the separation of appropriate aliquots, plasma was obtained from the whole blood via centrifugation. Liver tissues were isolated. All liquid and tissue samples were immediately preserved on dry ice and later stored at −80 °C until analytical work was performed. Drug concentrations were generated for each sample taken from animals dosed with test compounds. A measured plasma or liver drug concentration versus time curve was produced, in graphic and tabular forms, for each subject on both linear/linear and log/linear scales, for the parent compound. Mean plasma drug concentration versus time curves were also prepared separately. Maximum plasma concentration (<i>C</i><sub>max</sub>), and time to maximum concentration (<i>t</i><sub>max</sub>) were obtained from the plasma drug concentration–time curves. The elimination half-life (<i>t</i><sub>1/2</sub>) was calculated from (ln 2)/<i>kel</i>, which is the elimination rate constant calculated from the log concentration–time plot. The area under the curve (AUC) was determined by the linear trapezoidal rule with extrapolation to infinity based on the concentration of the last time point divided by the terminal rate constant. Mean residence time (MRT) was determined by dividing the area under the first moment curve (AUMC) by AUC. The volume of the central compartment (Vz) and volume of the tissue compartment (Vz/F) were calculated as the product of CL and MRT.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> In Vitro Cardiotoxicity</h3><div class="NLM_p last">The measurement of hERG channel inhibitory activity of the test compounds was performed by Essen BioScience Inc., Ann Arbor, MI. Basic principles and operation of the IonWorks platform have been described by Schroeder et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> In Vitro Mutagenicity</h3><div class="NLM_p last">Mutagenicity evaluation was assessed using the Ames assay<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> (EBPI, Ontario, Canada) against <i>S. typhimurium</i> TA100 and TA98, with and without S9 activation. Tester strain <i>S. typhimurium</i> (TA100 or TA98) cultures were inoculated from the lyophilized pellets and grown in nutrient broth provided by EBPI. Each inoculated flask (125 or 150 mL volume) was placed overnight in the incubator at 37 °C. The positive controls for the assay were 5 μg/mL 2-aminoanthracene for incubations with an S9 mix and a mixture of 1 μg/mL 4-nitroquinoline <i>N</i>-oxide and 2 μg/mL 2-nitrofluorene for incubations without the S9 mix. The tester strains (2.5 mL) were mixed with exposure medium and, where appropriate, 2.0 mL of S9 to give a final volume of 18 mL. An aliquot (0.2 mL) of the mixture was then added to each well of a 96-well plate. The test chemical (10 μL/well) was then added to each well. The 96-well plates were covered and sealed in zip-lock bags and incubated for 96 h at 37°C. Plates were scored visually, and the positive wells against background mutations were recorded.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> Culture of <i>P. falciparum</i> for Drug Selection Studies</h3><div class="NLM_p last">Malaria parasites were maintained in human O + erythrocytes (Interstate Blood Bank) at 5% hematocrit in RPMI 1640 (Invitrogen) medium supplemented with 0.5% AlbuMAX I (Life Technologies), 30 mM sodium bicarbonate, 25 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid, 0.37 mM hypoxanthine, and 10 μg/mL gentamicin and maintained at 37 °C under an atmosphere of 90% nitrogen, 5% carbon dioxide, and 5% oxygen. Cultures were monitored by Giemsa-stained blood smears and maintained at a parasitemia of 1–5%. <i>P. falciparum</i> strains were obtained from the Malaria Research and Reference Reagent Resource Center.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> In Vitro Selection of <i>P. falciparum</i> with Reduced Susceptibility to Acridone <b>73</b></h3><div class="NLM_p last">Cloned lines of Dd2 and 3D7 were used for drug selections, with reference stocks cryopreserved for whole genome sequencing. Independent clones of parasites in 50 mL cultures were exposed to gradually increasing <b>73</b> concentrations for several months, beginning at 10 nM and ending at up to 900 nM. After cultures persisted at 300 nM <b>73</b>, or ∼10-fold the IC<sub>50</sub> of the control lines (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>), the parasites were assessed for acridone susceptibility by 72 h growth inhibition assays. <b>73</b>-resistant parasites that emerged from drug pressure were expanded, cryopreserved, and cloned by limiting dilution for genomic DNA isolation and further phenotypic characterizations.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i147" class="anchor-spacer"></div><h3 class="article-section__title" id="_i147"> In Vitro Blood-Stage Antimalarial Activity of Acridone-Resistant Parasites</h3><div class="NLM_p last">3D7 and Dd2 lines of <i>P. falciparum</i> were obtained from the Malaria Research and Reference Reagent Resource Center (BEI Resources). Acridone stocks were dissolved in DMSO at 10 mM and maintained at −20 °C. Drug susceptibility was assessed using a 72 h SYBR green I fluorescence microplate as described elsewhere in this article, except that parasites were stage-synchronized using sorbitol and introduced into the assays at a ring stage. IC<sub>50</sub> values were derived from fitting of data using a variable Hill slope function with the aid of GraphPad Prism 6.0 (GraphPad Software, San Diego, CA). IC<sub>50</sub> values represent means of two or three biological replicates, run at 48 h intervals to preserve ring-stage specificity of the assay.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i148" class="anchor-spacer"></div><h3 class="article-section__title" id="_i148"> Whole Genome Sequencing</h3><div class="NLM_p last">Genomic <i>P. falciparum</i> DNA was isolated with either a QIAamp DNA extraction kit (QIAGEN; Redwood City, CA) or a ZYMO Quick gDNA Miniprep kit (ZYMO Research; Irvine, CA) according to manufacturer’s instructions. Whole genome sequencing of the Dd2 control and <b>73</b>-resistant parasite DNA was performed using 1 μg of gDNA to generate libraries with the Illumina TruSeq DNA library prep kit following manufacturer’s instructions. DNA libraries were sequenced on an Illumina MiSeq using 250 base pair paired-end reads with a 2% PhiX spike-in. The PhiX spike-in served as a sequencing control and to maintain sequence diversity. Reads were trimmed to remove adapter sequences using Cutadapt v1.2.1 prior to read mapping. Reads were aligned to the <i>P. falciparum</i> PlasmoDB v9.3 3D7 reference genome using the bwa-mem algorithm of bwa v0.7.5a-r405. varScan v2.3.2 was used to identify candidate SNP loci with ≥8× read coverage with ≥87.5% of the reads supporting the SNP genotype.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i149" class="anchor-spacer"></div><h3 class="article-section__title" id="_i149"> <i>P. falciparum</i> Cytochrome <i>b</i> Gene (<i>pfcytb</i>) Sequencing</h3><div class="NLM_p last">Genomic DNA was used for direct Sanger sequencing of <i>pfcytb</i> (mal_mito_3). Initial PCR was performed using the <i>pfcytb</i> flanking forward and reverse primers 5′-TTCCTGATTATCCAGACGCT-3′ and 5′-TGTTCCGCTCAATACTCAGA-3′. Sanger sequencing (performed by Genewiz, South Plainfield, NJ) utilized the aforementioned primers and two additional internal primers, 5′-CACTCACAGTATATCCTCCACA-3′ and 5′-GAGTTATTGGGGTGCAA CTG-3′, for complete gene coverage. Sequences were assembled and aligned using MacVector Software 9.5 (MacVector Inc., Apex, NC). All chromatograms were inspected visually to confirm SNPs.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i150"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01961" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01961" class="ext-link">10.1021/acs.jmedchem.8b01961</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Summary of single nucleotide polymorphisms (SNPs) in <b>73</b>-resistant clones of Dd2-V259L relative to the Dd2 parental line and reference line 3D7; spectra (NMR and HRMS) of all final compounds; HPLC chromatograms of key target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and in vitro data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_001.pdf">jm8b01961_si_001.pdf (8.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_002.csv">jm8b01961_si_002.csv (6.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01961" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane X. Kelly</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8871-0207" title="Orcid link">http://orcid.org/0000-0001-8871-0207</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#96fdf3fafaeffcf7d6f9fee5e3b8f3f2e3"><span class="__cf_email__" data-cfemail="e388868f8f9a8982a38c8b9096cd868796">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rozalia
A. Dodean</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5002-4607" title="Orcid link">http://orcid.org/0000-0001-5002-4607</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Papireddy Kancharla</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6381-1236" title="Orcid link">http://orcid.org/0000-0002-6381-1236</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuexin Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor Melendez</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Read</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Bane</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Vesely</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mara Kreishman-Deitrick</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad Black</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qigui Li</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Sciotti</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raul Olmeda</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thu-Lan Luong</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Gaona</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brittney Potter</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Sousa</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Marcsisin</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Caridha</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Xie</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chau Vuong</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Zeng</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhang</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Zhang</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsiuling Lin</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirk Butler</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norma Roncal</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lacy Gaynor-Ohnstad</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan E. Leed</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Nolan</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie J. Huezo</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie A. Rasmussen</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa T. Stephens</span> - <span class="hlFld-Affiliation affiliation">Genomics Core Facility and , University of Notre Dame, Notre
Dame, Indiana 46556, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Tan</span> - <span class="hlFld-Affiliation affiliation">Genomics Core Facility, 
    Eck Institute for Global
Health, 
     and , University of Notre Dame, Notre
Dame, Indiana 46556, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland A. Cooper</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin J. Smilkstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sovitj Pou</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rolf W. Winter</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Riscoe</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.A.D. and P.K. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">The intellectual property rights disclosed in this document is secured in a U.S. Patent filed by Portland VA Medical Center and Oregon Health & Science University.</p></div></li></ul></div><div class="ack" id="ACK-d7e10630-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i153">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This project was supported by NIH/NIAID (award 1R01AI093784) and DOD/PRMRP (award PR160693/W81XWH-17-2-0041). Material has been reviewed by the Walter Reed Army Institute of Research (WRAIR). There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting true views of the Department of the Army or the Department of Defense. Research was conducted in AAALACi accredited facilities in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">ATV</td><td class="NLM_def"><p class="first last">atovaquone</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug-resistant</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective concentrations</p></td></tr><tr><td class="NLM_term">EC<sub>90</sub></td><td class="NLM_def"><p class="first last">90% effective concentrations</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">TBAC</td><td class="NLM_def"><p class="first last">tetrabutylammonium chloride</p></td></tr><tr><td class="NLM_term">IVIS</td><td class="NLM_def"><p class="first last">in vivo imaging system</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenously</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral route</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human-ether-a-go-go-related gene</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i155">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26pub%3DWHO%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antony, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parija, S. C.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: an overview</span>. <i>Trop. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.4103/2229-5070.175081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4103%2F2229-5070.175081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26998432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC28fitlWmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30-41&author=H.+A.+Antonyauthor=S.+C.+Parija&title=Antimalarial+drug+resistance%3A+an+overview&doi=10.4103%2F2229-5070.175081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: An overview</span></div><div class="casAuthors">Antony Hiasindh Ashmi; Parija Subhash Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Tropical parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-41</span>
        ISSN:<span class="NLM_cas:issn">2229-5070</span>.
    </div><div class="casAbstract">Malaria is a major public health burden throughout the world.  Resistance to the antimalarial drugs has increased the mortality and morbidity rate that is achieved so far through the malaria control program.  Monitoring the drug resistance to the available antimalarial drugs helps to implement effective drug policy, through the in vivo efficacy studies, in vitro drug susceptibility tests and detection of molecular markers.  It is important to understand the mechanism of the antimalarial drugs, as it is one of the key factors in the emergence and spread of drug resistance.  This review summarizes the commonly used antimalarial drugs, their mechanism of action and the genetic markers validated so far for the detection of drug-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU1tKNafHz7OR_TJajKxJDfW6udTcc2eaJ0ynfCCY-fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fitlWmug%253D%253D&md5=0df7bac72c7267d5dbd8808c6eea4125</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4103%2F2229-5070.175081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2229-5070.175081%26sid%3Dliteratum%253Aachs%26aulast%3DAntony%26aufirst%3DH.%2BA.%26aulast%3DParija%26aufirst%3DS.%2BC.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520an%2520overview%26jtitle%3DTrop.%2520Parasitol.%26date%3D2016%26volume%3D6%26spage%3D30%26epage%3D41%26doi%3D10.4103%2F2229-5070.175081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, R.</span></span> <span> </span><span class="NLM_article-title">Challenges of drug-resistant malaria</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1051/parasite/2014059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1051%2Fparasite%2F2014059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=25402734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmvVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=61&author=S.+Sinhaauthor=B.+Medhiauthor=R.+Sehgal&title=Challenges+of+drug-resistant+malaria&doi=10.1051%2Fparasite%2F2014059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges of drug-resistant malaria</span></div><div class="casAuthors">Sinha Shweta; Sehgal Rakesh; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Parasite (Paris, France)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past six decades, the drug resistance of Plasmodium falciparum has become an issue of utmost concern.  Despite the remarkable progress that has been made in recent years in reducing the mortality rate to about 30% with the scaling-up of vector control, introduction of artemisinin-based combination therapies and other malaria control strategies, the confirmation of artemisinin resistance on the Cambodia-Thailand border threatened all the previous success.  This review addresses the global scenario of antimalarial resistance and factors associated with it, with the main emphasis on futuristic approaches like nanotechnology and stem cell therapy that may impede resistant malaria, along with novel medications which are preparing to enter the global antimalarial market.  These novel studies are likely to escalate over the coming years and will hopefully help to reduce the burden of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHDI3EqIaZ_y86Js-BCLiifW6udTcc2eaJ0ynfCCY-fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmvVKmtA%253D%253D&md5=377ddbcb4c00babc048ad4eb189d3c0a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2014059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2014059%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DMedhi%26aufirst%3DB.%26aulast%3DSehgal%26aufirst%3DR.%26atitle%3DChallenges%2520of%2520drug-resistant%2520malaria%26jtitle%3DParasite%26date%3D2014%26volume%3D21%26spage%3D61%26doi%3D10.1051%2Fparasite%2F2014059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F. H.</span></span> <span> </span><span class="NLM_article-title">Combating multi-drug resistant <i>Plasmodium falciparum</i> malaria</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">2569</span>– <span class="NLM_lpage">2578</span>, <span class="refDoi"> DOI: 10.1111/febs.14127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Ffebs.14127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=2569-2578&author=A.+M.+Thuauthor=A.+P.+Phyoauthor=J.+Landierauthor=D.+M.+Parkerauthor=F.+H.+Nosten&title=Combating+multi-drug+resistant+Plasmodium+falciparum+malaria&doi=10.1111%2Ffebs.14127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14127%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DA.%2BM.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DLandier%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DD.%2BM.%26aulast%3DNosten%26aufirst%3DF.%2BH.%26atitle%3DCombating%2520multi-drug%2520resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D2569%26epage%3D2578%26doi%3D10.1111%2Ffebs.14127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(13)60024-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS0140-6736%2813%2960024-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23953767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgs1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=723-735&author=N.+J.+Whiteauthor=S.+Pukrittayakameeauthor=T.+T.+Hienauthor=M.+A.+Faizauthor=O.+A.+Mokuoluauthor=A.+M.+Dondorp&title=Malaria&doi=10.1016%2FS0140-6736%2813%2960024-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">White Nicholas J; Pukrittayakamee Sasithon; Hien Tran Tinh; Faiz M Abul; Mokuolu Olugbenga A; Dondorp Arjen M</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">9918</span>),
    <span class="NLM_cas:pages">723-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although global morbidity and mortality have decreased substantially, malaria, a parasite infection of red blood cells, still kills roughly 2000 people per day, most of whom are children in Africa.  Two factors largely account for these decreases; increased deployment of insecticide-treated bednets and increased availability of highly effective artemisinin combination treatments.  In large trials, parenteral artesunate (an artemisinin derivative) reduced severe malaria mortality by 22·5% in Africa and 34·7% in Asia compared with quinine, whereas adjunctive interventions have been uniformly unsuccessful.  Rapid tests have been an important addition to microscopy for malaria diagnosis.  Chemopreventive strategies have been increasingly deployed in Africa, notably intermittent sulfadoxine-pyrimethamine treatment in pregnancy, and monthly amodiaquine-sulfadoxine-pyrimethamine during the rainy season months in children aged between 3 months and 5 years across the sub-Sahel.  Enthusiasm for malaria elimination has resurfaced.  This ambitious but laudable goal faces many challenges, including the worldwide economic downturn, difficulties in elimination of vivax malaria, development of pyrethroid resistance in some anopheline mosquitoes, and the emergence of artemisinin resistance in Plasmodium falciparum in southeast Asia.  We review the epidemiology, clinical features, pathology, prevention, and treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUNJZs6BRXR-kdrW1FkXG-fW6udTcc2ebBaxuv2sebk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgs1Grug%253D%253D&md5=bd84954e5e034997111401f4dcdc69fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2960024-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252960024-0%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26atitle%3DMalaria%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D723%26epage%3D735%26doi%3D10.1016%2FS0140-6736%2813%2960024-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poespoprodjo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium vivax</i>: clinical spectrum, risk factors and pathogenesis</span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-397900-1.00003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FB978-0-12-397900-1.00003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23199488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=151-201&author=N.+M.+Ansteyauthor=N.+M.+Douglasauthor=J.+R.+Poespoprodjoauthor=R.+N.+Price&title=Plasmodium+vivax%3A+clinical+spectrum%2C+risk+factors+and+pathogenesis&doi=10.1016%2FB978-0-12-397900-1.00003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium vivax: clinical spectrum, risk factors and pathogenesis</span></div><div class="casAuthors">Anstey Nicholas M; Douglas Nicholas M; Poespoprodjo Jeanne R; Price Ric N</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vivax malaria was historically described as 'benign tertian malaria' because individual clinical episodes were less likely to cause severe illness than Plasmodium falciparum.  Despite this, Plasmodium vivax was, and remains, responsible for major morbidity and significant mortality in vivax-endemic areas.  Single infections causing febrile illness in otherwise healthy individuals rarely progress to severe disease.  Nevertheless, in the presence of co-morbidities, P. vivax can cause severe illness and fatal outcomes.  Recurrent or chronic infections in endemic areas can cause severe anaemia and malnutrition, particularly in early childhood.  Other severe manifestations include acute lung injury, acute kidney injury and uncommonly, coma.  Multiorgan failure and shock are described but further studies are needed to investigate the role of bacterial and other co-infections in these syndromes.  In pregnancy, P. vivax infection can cause maternal anaemia, miscarriage, low birth weight and congenital malaria.  Compared to P. falciparum, P. vivax has a greater capacity to elicit an inflammatory response, resulting in a lower pyrogenic threshold.  Conversely, cytoadherence of P. vivax to endothelial cells is less frequent and parasite sequestration is not thought to be a significant cause of severe illness in vivax malaria.  With a predilection for young red cells, P. vivax does not result in the high parasite biomass associated with severe disease in P. falciparum, but a four to fivefold greater removal of uninfected red cells from the circulation relative to P. falciparum is associated with a similar risk of severe anaemia.  Mechanisms underlying the pathogenesis of severe vivax syndromes remain incompletely understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0v8nZQMi1iLt7lRqEFUJVfW6udTcc2ebBaxuv2sebk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtQ%253D%253D&md5=c93c9389270b7507d13d0c18591f19be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397900-1.00003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-397900-1.00003-7%26sid%3Dliteratum%253Aachs%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26aulast%3DDouglas%26aufirst%3DN.%2BM.%26aulast%3DPoespoprodjo%26aufirst%3DJ.%2BR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26atitle%3DPlasmodium%2520vivax%253A%2520clinical%2520spectrum%252C%2520risk%2520factors%2520and%2520pathogenesis%26jtitle%3DAdv.%2520Parasitol.%26date%3D2012%26volume%3D80%26spage%3D151%26epage%3D201%26doi%3D10.1016%2FB978-0-12-397900-1.00003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span> <span> </span><span class="NLM_article-title">Malaria caused by <i>Plasmodium vivax</i>: recurrent, difficult to treat, disabling, and threatening to life-the infectious bite preempts these hazards</span>. <i>Pathog. Global Health</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1179/2047772413Z.000000000179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1179%2F2047772413Z.000000000179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24428831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=475-479&author=J.+K.+Baird&title=Malaria+caused+by+Plasmodium+vivax%3A+recurrent%2C+difficult+to+treat%2C+disabling%2C+and+threatening+to+life-the+infectious+bite+preempts+these+hazards&doi=10.1179%2F2047772413Z.000000000179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1179%2F2047772413Z.000000000179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047772413Z.000000000179%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DMalaria%2520caused%2520by%2520Plasmodium%2520vivax%253A%2520recurrent%252C%2520difficult%2520to%2520treat%252C%2520disabling%252C%2520and%2520threatening%2520to%2520life-the%2520infectious%2520bite%2520preempts%2520these%2520hazards%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2013%26volume%3D107%26spage%3D475%26epage%3D479%26doi%3D10.1179%2F2047772413Z.000000000179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battle, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gething, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elyazar, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinka, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, S. I.</span></span> <span> </span><span class="NLM_article-title">The global public health significance of <i>Plasmodium vivax</i></span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-397900-1.00001-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fb978-0-12-397900-1.00001-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23199486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1-111&author=K.+E.+Battleauthor=P.+W.+Gethingauthor=I.+R.+Elyazarauthor=C.+L.+Moyesauthor=M.+E.+Sinkaauthor=R.+E.+Howesauthor=C.+A.+Guerraauthor=R.+N.+Priceauthor=K.+J.+Bairdauthor=S.+I.+Hay&title=The+global+public+health+significance+of+Plasmodium+vivax&doi=10.1016%2Fb978-0-12-397900-1.00001-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The global public health significance of Plasmodium vivax</span></div><div class="casAuthors">Battle Katherine E; Gething Peter W; Elyazar Iqbal R F; Moyes Catherine L; Sinka Marianne E; Howes Rosalind E; Guerra Carlos A; Price Ric N; Baird Kevin J; Hay Simon I</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-111</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium vivax occurs globally and thrives in both temperate and tropical climates.  Here, we review the evidence of the biological limits of its contemporary distribution and the global population at risk (PAR) of the disease within endemic countries.  We also review the most recent evidence for the endemic level of transmission within its range and discuss the implications for burden of disease assessments.  Finally, the evidence-base for defining the contemporary distribution and PAR of P. vivax are discussed alongside a description of the vectors of human malaria within the limits of risk.  This information along with recent data documenting the severe morbid and fatal consequences of P. vivax infection indicates that the public health significance of P. vivax is likely to have been seriously underestimated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0v8nZQMi1iJagfuraLLzSfW6udTcc2ebOln-HSLmwXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtw%253D%253D&md5=df8d5bc086839b20f0adb593193eeeac</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-397900-1.00001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-397900-1.00001-3%26sid%3Dliteratum%253Aachs%26aulast%3DBattle%26aufirst%3DK.%2BE.%26aulast%3DGething%26aufirst%3DP.%2BW.%26aulast%3DElyazar%26aufirst%3DI.%2BR.%26aulast%3DMoyes%26aufirst%3DC.%2BL.%26aulast%3DSinka%26aufirst%3DM.%2BE.%26aulast%3DHowes%26aufirst%3DR.%2BE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DBaird%26aufirst%3DK.%2BJ.%26aulast%3DHay%26aufirst%3DS.%2BI.%26atitle%3DThe%2520global%2520public%2520health%2520significance%2520of%2520Plasmodium%2520vivax%26jtitle%3DAdv.%2520Parasitol.%26date%3D2012%26volume%3D80%26spage%3D1%26epage%3D111%26doi%3D10.1016%2Fb978-0-12-397900-1.00001-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Portillo, H. A.</span></span> <span> </span><span class="NLM_article-title">Key gaps in the knowledge of <i>Plasmodium vivax</i>, a neglected human malaria parasite</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(09)70177-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS1473-3099%2809%2970177-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=19695492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=555-566&author=I.+Muellerauthor=M.+R.+Galinskiauthor=J.+K.+Bairdauthor=J.+M.+Carltonauthor=D.+K.+Kocharauthor=P.+L.+Alonsoauthor=H.+A.+del+Portillo&title=Key+gaps+in+the+knowledge+of+Plasmodium+vivax%2C+a+neglected+human+malaria+parasite&doi=10.1016%2FS1473-3099%2809%2970177-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite</span></div><div class="casAuthors">Mueller, Ivo; Galinski, Mary R.; Baird, J. Kevin; Carlton, Jane M.; Kochar, Dhanpat K.; Alonso, Pedro L.; del Portillo, Hernando A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasmodium vivax is geog. the most widely distributed cause of malaria in people, with up to 2.5 billion people at risk and an estd. 80 million to 300 million clin. cases every year-including severe disease and death.  Despite this large burden of disease, P vivax is overlooked and left in the shadow of the enormous problem caused by Plasmodium falciparum in sub-Saharan Africa.  The technol. advances enabling the sequencing of the P vivax genome and a recent call for worldwide malaria eradication have together placed new emphasis on the importance of addressing P vivax as a major public health problem.  However, because of this parasite's biol., it is esp. difficult to interrupt the transmission of P vivax, and experts agree that the available methods for preventing and treating infections with P vivax are inadequate.  It is thus imperative that the development of new methods and strategies become a priority.  Advancing the development of such methods needs renewed emphasis on understanding the biol., pathogenesis, and epidemiol. of P vivax.  This Review critically examines what is known about P vivax, focusing on identifying the crucial gaps that create obstacles to the elimination of this parasite in human populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIkotAgyOhy7Vg90H21EOLACvtfcHk0lgDkMdnzwhb6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vE&md5=f3a1621c7b69c8b9e838648a1bbbd3b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2809%2970177-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252809%252970177-X%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DI.%26aulast%3DGalinski%26aufirst%3DM.%2BR.%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DKochar%26aufirst%3DD.%2BK.%26aulast%3DAlonso%26aufirst%3DP.%2BL.%26aulast%3Ddel%2BPortillo%26aufirst%3DH.%2BA.%26atitle%3DKey%2520gaps%2520in%2520the%2520knowledge%2520of%2520Plasmodium%2520vivax%252C%2520a%2520neglected%2520human%2520malaria%2520parasite%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2009%26volume%3D9%26spage%3D555%26epage%3D566%26doi%3D10.1016%2FS1473-3099%2809%2970177-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjitra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span> <span> </span><span class="NLM_article-title">Vivax malaria: neglected and not benign</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2007.77.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4269%2Fajtmh.2007.77.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2007&pages=79-87&author=R.+N.+Priceauthor=E.+Tjitraauthor=C.+A.+Guerraauthor=S.+Yeungauthor=N.+J.+Whiteauthor=N.+M.+Anstey&title=Vivax+malaria%3A+neglected+and+not+benign&doi=10.4269%2Fajtmh.2007.77.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2007.77.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2007.77.79%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DTjitra%26aufirst%3DE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26atitle%3DVivax%2520malaria%253A%2520neglected%2520and%2520not%2520benign%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2007%26volume%3D77%26spage%3D79%26epage%3D87%26doi%3D10.4269%2Fajtmh.2007.77.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">WHO</span>. International Travel and Health, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO.+International+Travel+and+Health%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeching, N. J.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>J. R. Army Med. Corps</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1136/jramc-2013-000112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1136%2Fjramc-2013-000112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24109136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmsFWjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2013&pages=158-166&author=T.+E.+Fletcherauthor=N.+J.+Beeching&title=Malaria&doi=10.1136%2Fjramc-2013-000112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Fletcher Tom E; Beeching N J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Army Medical Corps</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-66</span>
        ISSN:<span class="NLM_cas:issn">0035-8665</span>.
    </div><div class="casAbstract">Malaria is a life-threatening disease, with its largest impact being due to Plasmodium falciparum infection in Africa.  Military populations continue to be at a high risk of malaria and reported case series have frequently revealed poor compliance with preventative measures.  The symptoms of malaria are non-specific and its management depends on awareness of the diagnosis and early recognition and treatment.  This is aided by new and simple rapid diagnostic tests, but these should not replace the examination of blood films if these are available.  Artemisinin combination therapy provides a more rapid and dependable cure of uncomplicated P falciparum infection, with artesunate now being the drug of choice in severe infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSD59E4HP_jcTEC-75aqa5AfW6udTcc2eZCPFFWM7IkQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmsFWjsA%253D%253D&md5=1f593fe2dcb3f114ef5fefb4ed91a78c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fjramc-2013-000112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjramc-2013-000112%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DT.%2BE.%26aulast%3DBeeching%26aufirst%3DN.%2BJ.%26atitle%3DMalaria%26jtitle%3DJ.%2520R.%2520Army%2520Med.%2520Corps%26date%3D2013%26volume%3D159%26spage%3D158%26epage%3D166%26doi%3D10.1136%2Fjramc-2013-000112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acremont, V.</span></span> <span> </span><span class="NLM_article-title">Malaria prevention in travelers</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.idc.2012.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=22963775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC38bls1Srug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=637-654&author=B.+Gentonauthor=V.+D%E2%80%99Acremont&title=Malaria+prevention+in+travelers&doi=10.1016%2Fj.idc.2012.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria prevention in travelers</span></div><div class="casAuthors">Genton Blaise; D'Acremont Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A common approach to malaria prevention is to follow the "A, B, C, D" rule: Awareness of risk, Bite avoidance, Compliance with chemoprophylaxis, and prompt Diagnosis in case of fever.  The risk of acquiring malaria depends on the length and intensity of exposure; the risk of developing severe disease is primarily determined by the health status of the traveler.  These parameters need to be assessed before recommending chemoprophylaxis and/or stand-by emergency treatment.  This review discusses the different strategies and drug options available for the prevention of malaria during and post travel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO_FeYyDg75ZHZzFRCXxVKfW6udTcc2eZCPFFWM7IkQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bls1Srug%253D%253D&md5=e7b19901ec7ae829eed95a2a1758e38e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Acremont%26aufirst%3DV.%26atitle%3DMalaria%2520prevention%2520in%2520travelers%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D637%26epage%3D654%26doi%3D10.1016%2Fj.idc.2012.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Touze, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debonne, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. P.</span></span> <span> </span><span class="NLM_article-title">Current situation and future perspectives for malaria prophylaxis among travellers and military personnel</span>. <i>Bull. Acad. Natl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1302</span>, discussion 1302–1303.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=18447051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BD1c3osFGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2007&pages=1293-1302&author=J.+E.+Touzeauthor=J.+M.+Debonneauthor=J.+P.+Boutin&title=Current+situation+and+future+perspectives+for+malaria+prophylaxis+among+travellers+and+military+personnel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Current situation and future perspectives for malaria prophylaxis among travellers and military personnel</span></div><div class="casAuthors">Touze Jean-Etienne; Debonne Jean-Marc; Boutin Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin de l'Academie nationale de medecine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1293-302; discussion 1302-3</span>
        ISSN:<span class="NLM_cas:issn">0001-4079</span>.
    </div><div class="casAbstract">Malaria remains a major public health problem, both for travellers and for the 40,000 French soldiers deployed each year to endemic areas.  Epidemiological data show that imported malaria (IM) is on the increase, and that migrants account for more than 60% of malaria cases notified each year in France.  The increase in IM among French military personnel is explained by prematurely terminated chemoprophylaxis on return, repeated short missions, and more cases of P. vivax and P. ovale infection.  The choice of chemoprophylaxis depends mainly on the level of chloroquine resistance in the country visited.  The atovaquone-proguanil combination is well tolerated and only requires 7 days of intake on return from the endemic area.  Doxycycline monohydrate is cheaper and better-tolerated than mefloquine, and is thus preferred for French military personnel.  However, its short half-life necessitates very good compliance.  Chemoprophylaxis should be combined with vector control measures and with personal protection (impregnated bednets, protective clothing, repellents, and indoor insecticide spraying).  The need for these measures should be clearly explained before departure, during the stay, and after return.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlC7lvJGoqKiSm0e6ZOaemfW6udTcc2eZCPFFWM7IkQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3osFGhuw%253D%253D&md5=740e8cf96bf44777802c7b885087fcc8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTouze%26aufirst%3DJ.%2BE.%26aulast%3DDebonne%26aufirst%3DJ.%2BM.%26aulast%3DBoutin%26aufirst%3DJ.%2BP.%26atitle%3DCurrent%2520situation%2520and%2520future%2520perspectives%2520for%2520malaria%2520prophylaxis%2520among%2520travellers%2520and%2520military%2520personnel%26jtitle%3DBull.%2520Acad.%2520Natl.%2520Med.%26date%3D2007%26volume%3D191%26spage%3D1293%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troye-Blomberg, M.</span></span> <span> </span><span class="NLM_article-title">The path of malaria vaccine development: challenges and perspectives</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1111/joim.12223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Fjoim.12223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24635625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2crkt12isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=456-466&author=C.+Aramaauthor=M.+Troye-Blomberg&title=The+path+of+malaria+vaccine+development%3A+challenges+and+perspectives&doi=10.1111%2Fjoim.12223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The path of malaria vaccine development: challenges and perspectives</span></div><div class="casAuthors">Arama C; Troye-Blomberg M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">456-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a life-threatening disease caused by parasites of the Plasmodium genus.  In many parts of the world, the parasites have developed resistance to a number of antimalarial agents.  Key interventions to control malaria include prompt and effective treatment with artemisinin-based combination therapies, use of insecticidal nets by individuals at risk and active research into malaria vaccines.  Protection against malaria through vaccination was demonstrated more than 30 years ago when individuals were vaccinated via repeated bites by Plasmodium falciparum-infected and irradiated but still metabolically active mosquitoes.  However, vaccination with high doses of irradiated sporozoites injected into humans has long been considered impractical.  Yet, following recent success using whole-organism vaccines, the approach has received renewed interest; it was recently reported that repeated injections of irradiated sporozoites increased protection in 80 vaccinated individuals.  Other approaches include subunit malaria vaccines, such as the current leading candidate RTS,S (consisting of fusion between a portion of the P. falciparum-derived circumsporozoite protein and the hepatitis B surface antigen), which has been demonstrated to induce reasonably good protection.  Although results have been encouraging, the level of protection is generally considered to be too low to achieve eradication of malaria.  There is great interest in developing new and better formulations and stable delivery systems to improve immunogenicity.  In this review, we will discuss recent strategies to develop efficient malaria vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7FGGGGW1blJZoeNcnHOQ9fW6udTcc2eYGRGRO8qDz17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crkt12isA%253D%253D&md5=e9aa43d3a3af5f0909f55a1ed5127e32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12223%26sid%3Dliteratum%253Aachs%26aulast%3DArama%26aufirst%3DC.%26aulast%3DTroye-Blomberg%26aufirst%3DM.%26atitle%3DThe%2520path%2520of%2520malaria%2520vaccine%2520development%253A%2520challenges%2520and%2520perspectives%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D456%26epage%3D466%26doi%3D10.1111%2Fjoim.12223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Malaria medicines: a glass half full?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1038/nrd4573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnrd4573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26000721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=424-442&author=T.+N.+Wellsauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhis&title=Malaria+medicines%3A+a+glass+half+full%3F&doi=10.1038%2Fnrd4573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria medicines: a glass half full?</span></div><div class="casAuthors">Wells, Timothy N. C.; Hooft van Huijsduijnen, Rob; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">424-442</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite substantial scientific progress over the past two decades, malaria remains a worldwide burden that causes hundreds of thousands of deaths every year.  New, affordable and safe drugs are required to overcome increasing resistance against artemisinin-based treatments, treat vulnerable populations, interrupt the parasite life cycle by blocking transmission to the vectors, prevent infection and target malaria species that transiently remain dormant in the liver.  In this Review, we discuss how the antimalarial drug discovery pipeline has changed over the past 10 years, grouped by the various target compd. or product profiles, to assess progress and gaps, and to recommend priorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJNZa5gyvg7Vg90H21EOLACvtfcHk0lgTSh_ch2c-6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM&md5=43f35590f86c240a4150b5cb4f5670ad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd4573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4573%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DMalaria%2520medicines%253A%2520a%2520glass%2520half%2520full%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D424%26epage%3D442%26doi%3D10.1038%2Fnrd4573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alano, P.</span></span> <span> </span><span class="NLM_article-title">Discovering new transmission-blocking antimalarial compounds: challenges and opportunities</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.pt.2016.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=27209388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1eiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=669-681&author=L.+M.+Birkholtzauthor=T.+L.+Coetzerauthor=D.+Mancamaauthor=D.+Leroyauthor=P.+Alano&title=Discovering+new+transmission-blocking+antimalarial+compounds%3A+challenges+and+opportunities&doi=10.1016%2Fj.pt.2016.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities</span></div><div class="casAuthors">Birkholtz, Lyn-Marie; Coetzer, Theresa L.; Mancama, Dalu; Leroy, Didier; Alano, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The ability to target human-mosquito parasite transmission challenges global malaria elimination.  However, it is not obvious what a transmission-blocking drug will look like; should it target only parasite transmission stages; be combined with a partner drug killing the pathogenic asexual stages; or kill both the sexual and asexual blood stages, preferably displaying polypharmacol.  The development of transmission-blocking antimalarials requires objective analyses of the current strategies.  Here, pertinent issues and questions regarding the target candidate profile of a transmission-blocking compd., and its role in malaria elimination strategies, are highlighted and novel perspectives proposed.  The essential role of a test cascade that integrates screening and validation strategies to identify next-generation transmission-blocking antimalarials is emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Fn14sWlrr7Vg90H21EOLACvtfcHk0lgTSh_ch2c-6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1eiu7g%253D&md5=e68c731ef23c285475bea63012aff641</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DAlano%26aufirst%3DP.%26atitle%3DDiscovering%2520new%2520transmission-blocking%2520antimalarial%2520compounds%253A%2520challenges%2520and%2520opportunities%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.pt.2016.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span> <span> </span><span class="NLM_article-title">Killing the hypnozoite-drug discovery approaches to prevent relapse in <i>Plasmodium vivax</i></span>. <i>Pathog. Global Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1179/2047773215Y.0000000013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1179%2F2047773215Y.0000000013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=25891812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2015&pages=107-122&author=B.+Campoauthor=O.+Vandalauthor=D.+L.+Wescheauthor=J.+N.+Burrows&title=Killing+the+hypnozoite-drug+discovery+approaches+to+prevent+relapse+in+Plasmodium+vivax&doi=10.1179%2F2047773215Y.0000000013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax</span></div><div class="casAuthors">Campo, Brice; Vandal, Omar; Wesche, David L.; Burrows, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Pathogens and Global Health</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-122</span>CODEN:
                <span class="NLM_cas:coden">PGHAB7</span>;
        ISSN:<span class="NLM_cas:issn">2047-7724</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients.  Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compds. has been hampered by the dearth of biol. tools and assays, which in turn has been limited by the immense scientific and logistical challenges assocd. with accessing relevant human tissue and sporozoites.  This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZobuvLqmY8rVg90H21EOLACvtfcHk0liFN4YYEnadSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D&md5=5b8e1091c3df8331cc6b72fb943fdbb6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1179%2F2047773215Y.0000000013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047773215Y.0000000013%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DVandal%26aufirst%3DO.%26aulast%3DWesche%26aufirst%3DD.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26atitle%3DKilling%2520the%2520hypnozoite-drug%2520discovery%2520approaches%2520to%2520prevent%2520relapse%2520in%2520Plasmodium%2520vivax%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2015%26volume%3D109%26spage%3D107%26epage%3D122%26doi%3D10.1179%2F2047773215Y.0000000013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">Supporting malaria elimination with 21st century antimalarial agent drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_fpage">1265</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.drudis.2015.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26103616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmtV2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1265&author=T.+T.+Diagana&title=Supporting+malaria+elimination+with+21st+century+antimalarial+agent+drug+discovery&doi=10.1016%2Fj.drudis.2015.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Supporting malaria elimination with 21st century antimalarial agent drug discovery</span></div><div class="casAuthors">Diagana Thierry T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The burden of malaria has been considerably reduced over recent years.  However, to achieve disease elimination, drug discovery for the next generation needs to focus on blocking disease transmission and on targeting the liver-stage forms of the parasite.  Properties of the 'ideal' new antimalarial drug and the key scientific and technological advances that have led to recent progress in antimalarial drug discovery are reviewed.  Using these advances, Novartis has built a robust pipeline of next-generation antimalarials.  The preclinical and clinical development of two candidate drugs: KAE609 and KAF156, provide a framework for the path to breakthrough treatments that could be taking us a step closer to the vision of malaria elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOKlg0cqm-HTDnmmyUf5qOfW6udTcc2eYYpIC-Q4MsI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmtV2itw%253D%253D&md5=071c685d9c873f3ebc58ac2b4db39f25</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSupporting%2520malaria%2520elimination%2520with%252021st%2520century%2520antimalarial%2520agent%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26spage%3D1265%26doi%3D10.1016%2Fj.drudis.2015.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2011.01734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Fj.1462-5822.2011.01734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=22151703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=316-324&author=S.+E.+Lindnerauthor=J.+L.+Millerauthor=S.+H.+Kappe&title=Malaria+parasite+pre-erythrocytic+infection%3A+preparation+meets+opportunity&doi=10.1111%2Fj.1462-5822.2011.01734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span></div><div class="casAuthors">Lindner, Scott E.; Miller, Jessica L.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  For those stricken with malaria, the classic clin. symptoms are caused by the parasite's cyclic infection of red blood cells.  However, this erythrocytic phase of the parasite's life cycle initiates from an asymptomatic pre-erythrocytic phase: the injection of sporozoites via the bite of a parasite-carrying Anopheline mosquito, and the ensuing infection of the liver.  With the increased capabilities of studying liver stages in mice, much progress was made elucidating the cellular and mol. basis of the parasite's progression through this bottleneck of its life cycle.  Here we review relevant findings on how sporozoites prep. for infection of the liver and factors crucial to liver stage development as well as key host/parasite interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0M19yfzes2bVg90H21EOLACvtfcHk0liFN4YYEnadSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D&md5=12008701e239bba5150a4792d215bf21</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01734.x%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DKappe%26aufirst%3DS.%2BH.%26atitle%3DMalaria%2520parasite%2520pre-erythrocytic%2520infection%253A%2520preparation%2520meets%2520opportunity%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D316%26epage%3D324%26doi%3D10.1111%2Fj.1462-5822.2011.01734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snounou, G.</span></span> <span> </span><span class="NLM_article-title">A pre-emptive strike against malaria’s stealthy hepatic forms</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1038/nrd2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnrd2960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=854-864&author=D.+Mazierauthor=L.+Reniaauthor=G.+Snounou&title=A+pre-emptive+strike+against+malaria%E2%80%99s+stealthy+hepatic+forms&doi=10.1038%2Fnrd2960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2960%26sid%3Dliteratum%253Aachs%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSnounou%26aufirst%3DG.%26atitle%3DA%2520pre-emptive%2520strike%2520against%2520malaria%25E2%2580%2599s%2520stealthy%2520hepatic%2520forms%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D854%26epage%3D864%26doi%3D10.1038%2Fnrd2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudencio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the liver stage of malaria parasites: a yet unmet goal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1012</span>, <span class="refDoi"> DOI: 10.1021/jm201095h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201095h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=995-1012&author=T.+Rodriguesauthor=M.+Prudencioauthor=R.+Moreiraauthor=M.+M.+Motaauthor=F.+Lopes&title=Targeting+the+liver+stage+of+malaria+parasites%3A+a+yet+unmet+goal&doi=10.1021%2Fjm201095h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal</span></div><div class="casAuthors">Rodrigues, Tiago; Prudencio, Miguel; Moreira, Rui; Mota, Maria M.; Lopes, Francisca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An overview of Plasmodium liver stages malaria (LS) and inhibitors targeting the LS; special emphasis is given to structure-activity relationships (SARs) and to recent developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3to30Pz23MLVg90H21EOLACvtfcHk0lis3IpeK82KDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE&md5=3a24c7c84968b0801fb56a4d90fb177f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201095h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201095h%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DPrudencio%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DLopes%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520liver%2520stage%2520of%2520malaria%2520parasites%253A%2520a%2520yet%2520unmet%2520goal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D995%26epage%3D1012%26doi%3D10.1021%2Fjm201095h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual function acridones as a new antimalarial chemotype</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature07937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnature07937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=19357645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=270-273&author=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Brunauthor=S.+Wittlinauthor=R.+A.+Cooperauthor=K.+D.+Laneauthor=A.+Janowskyauthor=R.+A.+Johnsonauthor=R.+A.+Dodeanauthor=R.+Winterauthor=D.+J.+Hinrichsauthor=M.+K.+Riscoe&title=Discovery+of+dual+function+acridones+as+a+new+antimalarial+chemotype&doi=10.1038%2Fnature07937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dual function acridones as a new antimalarial chemotype</span></div><div class="casAuthors">Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7244</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new antimalarial chemotype was described that combined the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs.  Beyond the essential intrinsic characteristics common to deserving candidate antimalarials (high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favorable physicochem. properties), the initial lead compd. I demonstrated unique synergistic properties.  In addn. to verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, I also resulted in an apparently mechanistically distinct synergism with quinine and with piperaquine.  This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, was demonstrated both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNhD1G8U2cbVg90H21EOLACvtfcHk0lgGC0IX_87eOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D&md5=436e58e6dab0365b88144f83e990b4d1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature07937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07937%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520of%2520dual%2520function%2520acridones%2520as%2520a%2520new%2520antimalarial%2520chemotype%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fnature07937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagby, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathbun, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Evaluation and lead optimization of anti-malarial acridones</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.exppara.2006.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=16828746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2gurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2006&pages=47-56&author=R.+W.+Winterauthor=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Dodeanauthor=G.+C.+Bagbyauthor=R.+K.+Rathbunauthor=J.+I.+Levinauthor=D.+Hinrichsauthor=M.+K.+Riscoe&title=Evaluation+and+lead+optimization+of+anti-malarial+acridones&doi=10.1016%2Fj.exppara.2006.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and lead optimization of antimalarial acridones</span></div><div class="casAuthors">Winter, Rolf W.; Kelly, Jane X.; Smilkstein, Martin J.; Dodean, Rozalia; Bagby, Grover C.; Rathbun, R. Keaney; Levin, Joshua I.; Hinrichs, David; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-56</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">With 2-methoxy-6-chloroacridone as a lead compd., the authors synthesized and tested acridone derivs. to develop a better understanding of the antimalarial structure-activity relationships.  Over 30 acridone derivs. were synthesized.  The most potent compds. contained extended alkyl chains terminated by trifluoromethyl groups and located at the 3-position of the tricyclic system.  Acridones optimized in the length of the side chain and the nature of the terminal fluorinated moiety exhibited in vitro antimalarial IC50 values in the low nanomolar and picomolar range and were without cytotoxic effects on the proliferation and differentiation of human bone marrow progenitors or mitogen-activated murine lymphocytes at concns. up to 100,000-fold higher.  Based on a structural similarity to known antimalarial agents it is proposed that the haloalkoxyacridones exert their antimalarial effects through inhibition of the Plasmodium cytochrome bc1 complex.  Haloalkoxyacridones represent an extraordinarily potent novel class of chem. compds. with the potential for development as therapeutic agents to treat or prevent malaria in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU62H0aHnzELVg90H21EOLACvtfcHk0lgGC0IX_87eOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2gurw%253D&md5=301a5109dda84dbbaa4c8efec68c30ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DDodean%26aufirst%3DR.%26aulast%3DBagby%26aufirst%3DG.%2BC.%26aulast%3DRathbun%26aufirst%3DR.%2BK.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DHinrichs%26aufirst%3DD.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DEvaluation%2520and%2520lead%2520optimization%2520of%2520anti-malarial%2520acridones%26jtitle%3DExp.%2520Parasitol.%26date%3D2006%26volume%3D114%26spage%3D47%26epage%3D56%26doi%3D10.1016%2Fj.exppara.2006.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span> <span> </span><span class="NLM_article-title">Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1021/jo0518809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0518809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=142-149&author=X.+Meiauthor=A.+T.+Augustauthor=C.+Wolf&title=Regioselective+copper-catalyzed+amination+of+chlorobenzoic+acids%3A+synthesis+and+solid-state+structures+of+N-aryl+anthranilic+acid+derivatives&doi=10.1021%2Fjo0518809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Copper-Catalyzed Amination of Chlorobenzoic Acids: Synthesis and Solid-State Structures of N-Aryl Anthranilic Acid Derivatives</span></div><div class="casAuthors">Mei, Xuefeng; August, Adam T.; Wolf, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-149</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chemo- and regioselective copper-catalyzed cross-coupling reaction for effective amination of 2-chlorobenzoic acids with aniline derivs. was developed.  The method eliminates the need for acid protection and produces a wide range of N-aryl anthranilic acid derivs. in up to 99% yield.  The amination proceeds with both electron-rich and electron-deficient aryl chlorides and anilines and also uses sterically hindered anilines such as 2,6-dimethylaniline and 2-tert-butylaniline.  The conformational isomerism of appropriately substituted N-aryl anthranilic acids was studied in the solid state.  Crystallog. anal. of seven anthranilic acid derivs. showed formation of two distinct supramol. architectures exhibiting trans-anti and unprecedented trans-syn dimeric structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrjZmb7GLfLVg90H21EOLACvtfcHk0lgGC0IX_87eOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gisr7P&md5=fdff05498fd7415454888cd050ad0968</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0518809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0518809%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DX.%26aulast%3DAugust%26aufirst%3DA.%2BT.%26aulast%3DWolf%26aufirst%3DC.%26atitle%3DRegioselective%2520copper-catalyzed%2520amination%2520of%2520chlorobenzoic%2520acids%253A%2520synthesis%2520and%2520solid-state%2520structures%2520of%2520N-aryl%2520anthranilic%2520acid%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D142%26epage%3D149%26doi%3D10.1021%2Fjo0518809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driver, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl triflates and importance of triflate addition rate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1021/jo961930x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo961930x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1268-1273&author=J.+Louieauthor=M.+Driverauthor=B.+Hamannauthor=J.+Hartwig&title=Palladium-catalyzed+amination+of+aryl+triflates+and+importance+of+triflate+addition+rate&doi=10.1021%2Fjo961930x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Amination of Aryl Triflates and Importance of Triflate Addition Rate</span></div><div class="casAuthors">Louie, Janis; Driver, Michael S.; Hamann, Blake C.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1268-1273</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report that a combination of DPPF (1,1-bis(diphenylphosphino)ferrocene) and Pd(dba)2 leads to the amination of aryl triflates, a reaction that allows for the conversion of phenols to arylamines.  A combination of BINAP and Pd(dba)2 also catalyzes the amination of aryl triflates, but P(o-tolyl)3 complexes were not effective catalysts.  In some cases, slow addn. of the aryl triflate was necessary to prevent cleavage of the triflate and generation of phenol.  We found that added halide, necessary in some cross-coupling chem. of aryl sulfonates, was an unnecessary additive and even inhibited the amination chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq7ziZJFgkl7Vg90H21EOLACvtfcHk0lh-pdmEwOyxMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSrsbc%253D&md5=ee91cd22782b558b4bb1e79937c0d815</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo961930x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo961930x%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DDriver%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DB.%26aulast%3DHartwig%26aufirst%3DJ.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%2520and%2520importance%2520of%2520triflate%2520addition%2520rate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1268%26epage%3D1273%26doi%3D10.1021%2Fjo961930x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gündüz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumbaraci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talinli, N.</span></span> <span> </span><span class="NLM_article-title">Reactions of quino-ketenes with C-nucleophiles: syntheses of (2-hydroxyphenyl)methanols and 2-hydroxyphenyl ketones</span>. <i>Helvetica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1002/hlca.201300391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2Fhlca.201300391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=1097-1106&author=H.+G%C3%BCnd%C3%BCzauthor=V.+Kumbaraciauthor=N.+Talinli&title=Reactions+of+quino-ketenes+with+C-nucleophiles%3A+syntheses+of+%282-hydroxyphenyl%29methanols+and+2-hydroxyphenyl+ketones&doi=10.1002%2Fhlca.201300391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of Quino-Ketenes with C-Nucleophiles: Syntheses of (2-Hydroxyphenyl)methanols and 2-Hydroxyphenyl Ketones</span></div><div class="casAuthors">Guenduez, Hande; Kumbaraci, Volkan; Talinli, Naciye</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1106</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">An efficient, one-step protocol for the synthesis of derivs. of 2-hydroxyphenyl ketones I [R = Bu; R1 = (H3C)2NCH2CH2, BrCH2CH2] and/or 2-hydroxyphenylmethanols II [R = Bu, Ph, Bn; R1 = 4-H3COC6H4CH2, (H3C)2NCH2CH2, BrCH2CH2] and/or 2-hydroxynaphthalenyl methanols III (X = Bu, Ph) starting from benzodioxinones/naphthodioxinones and organolithium compds. was described.  Reactions have been performed under thermal conditions without catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWkn5JAqdkLVg90H21EOLACvtfcHk0lh-pdmEwOyxMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7zE&md5=825f4235ba29f0074b8ea04acdabc2f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhlca.201300391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.201300391%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCnd%25C3%25BCz%26aufirst%3DH.%26aulast%3DKumbaraci%26aufirst%3DV.%26aulast%3DTalinli%26aufirst%3DN.%26atitle%3DReactions%2520of%2520quino-ketenes%2520with%2520C-nucleophiles%253A%2520syntheses%2520of%2520%25282-hydroxyphenyl%2529methanols%2520and%25202-hydroxyphenyl%2520ketones%26jtitle%3DHelvetica%26date%3D2014%26volume%3D97%26spage%3D1097%26epage%3D1106%26doi%3D10.1002%2Fhlca.201300391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foote, K. M.</span>; <span class="NLM_string-name">Theoclitou, M.-E.</span>; <span class="NLM_string-name">Thomas, A. P.</span>; <span class="NLM_string-name">Buttar, D.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. PCT Int. Appl. <span class="NLM_patent">WO2008/075068</span>, June 26, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+M.+Foote&author=M.-E.+Theoclitou&author=A.+P.+Thomas&author=D.+Buttar&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26atitle%3DNovel%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julich-Gruner, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knolker, H. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of clausine-TY</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">4741</span>– <span class="NLM_lpage">4752</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201402495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2Fejoc.201402495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=4741-4752&author=C.+Schusterauthor=C.+B%C3%B6rgerauthor=K.+K.+Julich-Grunerauthor=R.+Hesseauthor=A.+Jagerauthor=G.+Kaufmannauthor=A.+W.+Schmidtauthor=H.+J.+Knolker&title=Synthesis+of+2-hydroxy-7-methylcarbazole%2C+glycozolicine%2C+mukoline%2C+mukolidine%2C+sansoakamine%2C+clausine-H%2C+and+clausine-K+and+structural+revision+of+clausine-TY&doi=10.1002%2Fejoc.201402495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of Clausine-TY</span></div><div class="casAuthors">Schuster, Christian; Boerger, Carsten; Julich-Gruner, Konstanze K.; Hesse, Ronny; Jaeger, Anne; Kaufmann, Gyoerley; Schmidt, Arndt W.; Knoelker, Hans-Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4741-4752</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Buchwald-Hartwig amination and palladium(II)-catalyzed oxidative cyclization reaction sequence provided efficient access to a series of oxygenated tricyclic carbazoles.  In the present work, this approach was applied to the total syntheses of the naturally occurring carbazole alkaloids 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, glycozolidine, clausine-H (clauszoline-C), clausine-K (clauszoline-J), and Me 2-hydroxy-7-methoxycarbazole-3-carboxylate, which was originally proposed as the structure of clausine-TY.  The synthesis of the latter led to the structural reassignment of clausine-TY.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOlrykkK9TyrVg90H21EOLACvtfcHk0lh-pdmEwOyxMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO&md5=09d8d57ecf4f0e676a8ef931b820a178</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402495%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DB%25C3%25B6rger%26aufirst%3DC.%26aulast%3DJulich-Gruner%26aufirst%3DK.%2BK.%26aulast%3DHesse%26aufirst%3DR.%26aulast%3DJager%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DKnolker%26aufirst%3DH.%2BJ.%26atitle%3DSynthesis%2520of%25202-hydroxy-7-methylcarbazole%252C%2520glycozolicine%252C%2520mukoline%252C%2520mukolidine%252C%2520sansoakamine%252C%2520clausine-H%252C%2520and%2520clausine-K%2520and%2520structural%2520revision%2520of%2520clausine-TY%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26spage%3D4741%26epage%3D4752%26doi%3D10.1002%2Fejoc.201402495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lghyqKobqT62A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCrue, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Quinolone-3-diarylethers: a new class of antimalarial drug</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">177ra37</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3005029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscitranslmed.3005029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23515079" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&author=A.+Nilsenauthor=A.+N.+LaCrueauthor=K.+L.+Whiteauthor=I.+P.+Forquerauthor=R.+M.+Crossauthor=J.+Marfurtauthor=M.+W.+Matherauthor=M.+J.+Delvesauthor=D.+M.+Shacklefordauthor=F.+E.+Saenzauthor=J.+M.+Morriseyauthor=J.+Steutenauthor=T.+Mutkaauthor=Y.+Liauthor=G.+Wirjanataauthor=E.+Ryanauthor=S.+Duffyauthor=J.+X.+Kellyauthor=B.+F.+Sebayangauthor=A.+M.+Zeemanauthor=R.+Noviyantiauthor=R.+E.+Sindenauthor=C.+H.+Kockenauthor=R.+N.+Priceauthor=V.+M.+Averyauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=E.+Herrerosauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=I.+Bathurstauthor=J.+N.+Burrowsauthor=P.+Sieglauthor=R.+K.+Guyauthor=R.+W.+Winterauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=D.+E.+Kyleauthor=R.+Manetschauthor=M.+K.+Riscoe&title=Quinolone-3-diarylethers%3A+a+new+class+of+antimalarial+drug&doi=10.1126%2Fscitranslmed.3005029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3005029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3005029%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLaCrue%26aufirst%3DA.%2BN.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DCross%26aufirst%3DR.%2BM.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSaenz%26aufirst%3DF.%2BE.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DSteuten%26aufirst%3DJ.%26aulast%3DMutka%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSebayang%26aufirst%3DB.%2BF.%26aulast%3DZeeman%26aufirst%3DA.%2BM.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DKocken%26aufirst%3DC.%2BH.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DQuinolone-3-diarylethers%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520drug%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26doi%3D10.1126%2Fscitranslmed.3005029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, B.</span></span> <span> </span><span class="NLM_article-title">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino) Quinazoline] as a chemotherapeutic agent: <i>Plasmodium berghei</i>, <i>P. cynomolgi</i>, <i>P. knowlesi</i>, and <i>Trypanosoma cruzi</i></span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/0014-4894(69)90050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0014-4894%2869%2990050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=4983051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1969&pages=32-49&author=P.+E.+Thompsonauthor=A.+Baylesauthor=B.+Olszewski&title=PAM+1392+%5B2%2C4-diamino-6-%283%2C4-dichlorobenzylamino%29+Quinazoline%5D+as+a+chemotherapeutic+agent%3A+Plasmodium+berghei%2C+P.+cynomolgi%2C+P.+knowlesi%2C+and+Trypanosoma+cruzi&doi=10.1016%2F0014-4894%2869%2990050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino)quinazoline] as a chemotherapeutic agent:  Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi</span></div><div class="casAuthors">Thompson, Paul Everett; Bayles, Anita; Olszewski, Bronislawa</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-49</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    </div><div class="casAbstract">PAM 1392 was active orally against blood forms of P. berghei in mice, P. cynomolgi in rhesus monkeys, and P. knowlesi in the latter host.  Against P. berghei, it was 4-11 times as potent as quinine in mice, acted rapidly, suppressed the parasitemia for 6 days in an oral dose of 200 mg./kg., acted synergistically with sulfadiazine without a commensurate increase in apparent toxicity for mice, and was effective against 4 drug-resistant lines.  The latter information suggests that it represents a new mode of action and may be useful in drug-resistant malaria.  In monkeys, it acted somewhat slowly but, when given appropriately, cured infections of P. cynomolgi and knowlesi.  The drug inhibited nuclear division of P. cynomolgi.  Against T. cruzi, PAM 1392 was active in culture against both extracellular and intracellular parasites at nontoxic levels for chick embryo cells.  This activity was partially reversed by folinic acid but not by crithidia factor.  PAM 1392 also was effective in protecting mice against the lethal effects of acute infections by T. cruzi but exhibited little capacity to effect radical cure of the infections.  Based on gross examn., the compd. is of relatively low toxicity to mice and monkeys on short-term administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn4pyMXieVj7Vg90H21EOLACvtfcHk0lghyqKobqT62A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D&md5=6041ddc17743ad3cc13b017d447f497d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0014-4894%2869%2990050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4894%252869%252990050-2%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DBayles%26aufirst%3DA.%26aulast%3DOlszewski%26aufirst%3DB.%26atitle%3DPAM%25201392%2520%255B2%252C4-diamino-6-%25283%252C4-dichlorobenzylamino%2529%2520Quinazoline%255D%2520as%2520a%2520chemotherapeutic%2520agent%253A%2520Plasmodium%2520berghei%252C%2520P.%2520cynomolgi%252C%2520P.%2520knowlesi%252C%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DExp.%2520Parasitol.%26date%3D1969%26volume%3D25%26spage%3D32%26epage%3D49%26doi%3D10.1016%2F0014-4894%2869%2990050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">141</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-13-141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1186%2F1475-2875-13-141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24731238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=141&author=Q.+Liauthor=M.+O%E2%80%99Neilauthor=L.+Xieauthor=D.+Caridhaauthor=Q.+Zengauthor=J.+Zhangauthor=B.+Pybusauthor=M.+Hickmanauthor=V.+Melendez&title=Assessment+of+the+prophylactic+activity+and+pharmacokinetic+profile+of+oral+tafenoquine+compared+to+primaquine+for+inhibition+of+liver+stage+malaria+infections&doi=10.1186%2F1475-2875-13-141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span></div><div class="casAuthors">Li, Qigui; O'Neil, Michael; Xie, Lisa; Caridha, Diana; Zeng, Qiang; Zhang, Jing; Pybus, Brandon; Hickman, Mark; Melendez, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141/1-141/13, 13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: As anti-malarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malaria infections.  The US Army is developing tafenoquine (TQ), an analog of primaquine (PQ), which is expected to be more effective in preventing malaria in deployed military personnel.  Methods: To compare the prophylactic efficacy of TQ and PQ, a transgenic Plasmodium berghei parasite expressing the bioluminescent reporter protein luciferase was utilized to visualize and quantify parasite development in C57BL/6 albino mice treated with PQ and TQ in single or multiple regimens using a real-time in vivo imaging system (IVIS).  As an addnl. endpoint, blood stage parasitemia was monitored by flow cytometry.  Comparative pharmacokinetic (PK) and liver distribution studies of oral and i.v. PQ and TQ were also performed.  Results: Mice treated orally with three doses of TQ at 5 mg/kg three doses of PQ at 25 mg/kg demonstrated no bioluminescence liver signal and no blood stage parasitemia was obsd. suggesting both drugs showed 100% causal activity at the doses tested.  Single dose oral treatment with 5 mg TQ or 25 mg of PQ, however, yielded different results as only TQ treatment resulted in causal prophylaxis in P. berghei sporozoite-infected mice.  TQ is highly effective for causal prophylaxis in mice at a minimal curative single oral dose of 5 mg/kg, which is a five-fold improvement in potency vs. PQ.  PK studies of the two drugs administered orally to mice showed that the abs. bioavailability of oral TQ was 3.5-fold higher than PQ, and the AUC of oral TQ was 94-fold higher than oral PQ.  The elimination half-life of oral TQ in mice was 28 times longer than PQ, and the liver tissue distribution of TQ revealed an AUC that was 188-fold higher than PQ.  Conclusions: The increased drug exposure levels and longer exposure time of oral TQ in the plasma and livers of mice highlight the lead quality attributes that explain the much improved efficacy of TQ when compared to PQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlSzjNwCpw7Vg90H21EOLACvtfcHk0linEbKbqFiRgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE&md5=bcffa149f5d62a5353706c48153899b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-13-141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-13-141%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DMelendez%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520the%2520prophylactic%2520activity%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520tafenoquine%2520compared%2520to%2520primaquine%2520for%2520inhibition%2520of%2520liver%2520stage%2520malaria%2520infections%26jtitle%3DMalar.%2520J.%26date%3D2014%26volume%3D13%26spage%3D141%26doi%3D10.1186%2F1475-2875-13-141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">New imidazolidinedione derivatives as antimalarial agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1541</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.bmc.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=21282058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1541-1549&author=L.+Zhangauthor=R.+Sathunuruauthor=T.+Luongauthor=V.+Melendezauthor=M.+P.+Kozarauthor=A.+J.+Lin&title=New+imidazolidinedione+derivatives+as+antimalarial+agents&doi=10.1016%2Fj.bmc.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New imidazolidinedione derivatives as antimalarial agents</span></div><div class="casAuthors">Zhang, Liang; Sathunuru, Ramadas; Luong, Thu Lan; Melendez, Victor; Kozar, Michael P.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1549</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new N-alky- and N-alkoxy-imidazolidinediones was prepd. and assessed for prophylactic and radical curative activities in mouse and Rhesus monkey models.  New compds. are generally metabolically stable, weakly active in vitro against Plasmodium falciparum clones (D6 and W2) and in mice infected with Plasmodium berghei sporozoites.  Representative compds. 8e and 9c (I) showed good causal prophylactic activity in Rhesus monkeys dosed 30 mg/kg/day for 3 consecutive days by IM, delayed patency for 19-21 days and 54-86 days, resp., as compared to the untreated control.  By oral, 9c showed only marginal activity in causal prophylactic and radical curative tests at 50 mg/kg/day × 3 and 30 mg/kg/day × 7 plus chloroquine 10 mg/kg for 7 days, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDcL_hB_MaLVg90H21EOLACvtfcHk0linEbKbqFiRgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D&md5=64410e36bc5112cdb4f9cedf2453727b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DNew%2520imidazolidinedione%2520derivatives%2520as%2520antimalarial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1541%26epage%3D1549%26doi%3D10.1016%2Fj.bmc.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frueh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koop, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Alkoxycarbonate ester prodrugs of preclinical drug candidate ELQ-300 for prophylaxis and treatment of malaria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFagur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=728-735&author=L.+Fruehauthor=Y.+Liauthor=M.+W.+Matherauthor=Q.+Liauthor=S.+Pouauthor=A.+Nilsenauthor=R.+W.+Winterauthor=I.+P.+Forquerauthor=A.+M.+Pershingauthor=L.+H.+Xieauthor=M.+J.+Smilksteinauthor=D.+Caridhaauthor=D.+R.+Koopauthor=R.+F.+Campbellauthor=R.+J.+Sciottiauthor=M.+Kreishman-Deitrickauthor=J.+X.+Kellyauthor=B.+Veselyauthor=A.+B.+Vaidyaauthor=M.+K.+Riscoe&title=Alkoxycarbonate+ester+prodrugs+of+preclinical+drug+candidate+ELQ-300+for+prophylaxis+and+treatment+of+malaria&doi=10.1021%2Facsinfecdis.7b00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria</span></div><div class="casAuthors">Frueh, Lisa; Li, Yuexin; Mather, Michael W.; Li, Qigui; Pou, Sovitj; Nilsen, Aaron; Winter, Rolf W.; Forquer, Isaac P.; Pershing, April M.; Xie, Lisa H.; Smilkstein, Martin J.; Caridha, Diana; Koop, Dennis R.; Campbell, Robert F.; Sciotti, Richard J.; Kreishman-Deitrick, Mara; Kelly, Jane X.; Vesely, Brian; Vaidya, Akhil B.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ELQ-300 is a preclin. antimalarial drug candidate that is active against liver, blood, and transmission stages of Plasmodium falciparum.  While ELQ-300 is highly effective when administered in a low multidose regimen, poor aq. soly. and high crystallinity have hindered its clin. development.  To overcome its challenging physiochem. properties, a no. of bioreversible alkoxycarbonate ester prodrugs of ELQ-300 were synthesized.  These bioreversible prodrugs are converted to ELQ-300 by host and parasite esterase action in the liver and bloodstream of the host.  One such alkoxycarbonate prodrug, ELQ-331, is curative against Plasmodium yoelii with a single low dose of 3 mg/kg in a murine model of patent malaria infection.  ELQ-331 is at least as fully protective as ELQ-300 in a murine malaria prophylaxis model when delivered 24 h before sporozoite inoculation at an oral dose of 1 mg/kg.  ELQ-331 is a promising prodrug of ELQ-300 with improved physiochem. and metabolic properties and excellent potential for clin. formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCxuLKYFnFrVg90H21EOLACvtfcHk0lgPokTLHmNdJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFagur7M&md5=74e150dd9bf20bedc4e6ff19fd05be70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00062%26sid%3Dliteratum%253Aachs%26aulast%3DFrueh%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DXie%26aufirst%3DL.%2BH.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DKoop%26aufirst%3DD.%2BR.%26aulast%3DCampbell%26aufirst%3DR.%2BF.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DVesely%26aufirst%3DB.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DAlkoxycarbonate%2520ester%2520prodrugs%2520of%2520preclinical%2520drug%2520candidate%2520ELQ-300%2520for%2520prophylaxis%2520and%2520treatment%2520of%2520malaria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D728%26epage%3D735%26doi%3D10.1021%2Facsinfecdis.7b00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span> <span> </span><span class="NLM_article-title">Comparative susceptibility of different mouse strains to liver-stage infection with <i>Plasmodium berghei</i> sporozoites assessed using in vivo imaging</span>. <i>Mil. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.7205/MILMED-D-16-00090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.7205%2FMILMED-D-16-00090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=28291500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=360-368&author=Q.+Liauthor=L.+Xieauthor=D.+Caridhaauthor=N.+Roncalauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=M.+Hickmanauthor=L.+Read&title=Comparative+susceptibility+of+different+mouse+strains+to+liver-stage+infection+with+Plasmodium+berghei+sporozoites+assessed+using+in+vivo+imaging&doi=10.7205%2FMILMED-D-16-00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Susceptibility of Different Mouse Strains to Liver-Stage Infection With Plasmodium berghei Sporozoites Assessed Using In Vivo Imaging</span></div><div class="casAuthors">Li Qigui; Xie Lisa; Caridha Diana; Roncal Norma; Zeng Qiang; Zhang Jing; Zhang Ping; Hickman Mark; Read Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Military medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">360-368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The liver stages of Plasmodium parasites are important targets for the discovery and development of prophylactic drugs.  METHODS:  A real-time in vivo imaging system was used to determine the level of luminescence measured from firefly luciferase expression by sporozoites developing in hepatocytes in different strains of mice.  RESULTS:  The luminescence values (photon counts/sec) measured from the anatomical liver location in the untreated mice infected with 10,000 Plasmodium berghei sporozoites were 8.15 × 10(5) for C57BL/6 Albino, 2.12 × 10(5) for C3H/HeNCrL, 0.91 × 10(5) for C57BL/6 WT, 0.28 × 10(5) for BALB/c, and 0.16 × 10(5) for ICR/CD-1 mice.  This data suggests that the C57BL/6 Albino strain is most susceptible to luminescent photon, mainly because the less light scattering and absorption from deeper tissues and the skin in the strain of mouse.  The photon count observed in black C57BL/6 wild type mice was shown to be 88.83% lower compared to C57BL/6 Albino mice.  Although the highest growth rate of sporozoites in hepatocytes was found for C57BL/6 wild type mice in this study, the black skin of this mouse significantly reduced parasite-associated bioluminescence.  CONCLUSIONS:  The minimal light scattering and absorption and also enhanced susceptibility to liver infection of C57BL/6 Albino mice makes this strain preferable sensitivity for discovery and development of prophylactic antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPtJC26cYkEYhLSh9fo81bfW6udTcc2ebbworTCTLET7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D&md5=9cff5670b545166016ec56d9417dc808</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7205%2FMILMED-D-16-00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7205%252FMILMED-D-16-00090%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DL.%26atitle%3DComparative%2520susceptibility%2520of%2520different%2520mouse%2520strains%2520to%2520liver-stage%2520infection%2520with%2520Plasmodium%2520berghei%2520sporozoites%2520assessed%2520using%2520in%2520vivo%2520imaging%26jtitle%3DMil.%2520Med.%26date%3D2017%26volume%3D182%26spage%3D360%26epage%3D368%26doi%3D10.7205%2FMILMED-D-16-00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3477</span>, <span class="refDoi"> DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+activity+of+phenylthiazolyl-bearing+hydroxamate-based+histone+deacetylase+inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 μM.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0ljh6QEkjpaDrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520activity%2520of%2520phenylthiazolyl-bearing%2520hydroxamate-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heady, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanteri, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabezas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yourick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. S.</span></span> <span> </span><span class="NLM_article-title">Utility of alkylaminoquinolinyl methanols as new antimalarial drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4132</span>– <span class="NLM_lpage">4143</span>, <span class="refDoi"> DOI: 10.1128/AAC.00631-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.00631-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=4132-4143&author=G.+S.+Dowauthor=T.+N.+Headyauthor=A.+K.+Bhattacharjeeauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=C.+A.+Lanteriauthor=N.+Obaldiaauthor=N.+Roncalauthor=T.+Shearerauthor=P.+L.+Smithauthor=A.+Tungtaengauthor=L.+Wolfauthor=M.+Cabezasauthor=D.+Yourickauthor=K.+S.+Smith&title=Utility+of+alkylaminoquinolinyl+methanols+as+new+antimalarial+drugs&doi=10.1128%2FAAC.00631-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.00631-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00631-06%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DHeady%26aufirst%3DT.%2BN.%26aulast%3DBhattacharjee%26aufirst%3DA.%2BK.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DLanteri%26aufirst%3DC.%2BA.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DShearer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DWolf%26aufirst%3DL.%26aulast%3DCabezas%26aufirst%3DM.%26aulast%3DYourick%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DK.%2BS.%26atitle%3DUtility%2520of%2520alkylaminoquinolinyl%2520methanols%2520as%2520new%2520antimalarial%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D4132%26epage%3D4143%26doi%3D10.1128%2FAAC.00631-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korotchenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3411</span>– <span class="NLM_lpage">3431</span>, <span class="refDoi"> DOI: 10.1021/jm501809x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501809x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3411-3431&author=V.+Korotchenkoauthor=R.+Sathunuruauthor=L.+Gerenaauthor=D.+Caridhaauthor=Q.+Liauthor=M.+Kreishman-Deitrickauthor=P.+L.+Smithauthor=A.+J.+Lin&title=Antimalarial+activity+of+4-amidinoquinoline+and+10-amidinobenzonaphthyridine+derivatives&doi=10.1021%2Fjm501809x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial Activity of 4-Amidinoquinoline and 10-Amidinobenzonaphthyridine Derivatives</span></div><div class="casAuthors">Korotchenko, Vasiliy; Sathunuru, Ramadas; Gerena, Lucia; Caridha, Diana; Li, Qigui; Kreishman-Deitrick, Mara; Smith, Philip L.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3411-3431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chloroquine (CQ) has been used as first line malaria therapeutic drug for decades.  Emergence of CQ drug-resistant Plasmodium falciparum malaria throughout endemic areas of the world has limited its clin. value.  Mefloquine (MQ) has been used as an effective malaria prophylactic drug due to its being long-acting and having a high potency against blood stage P. falciparum (Pf).  However, serious CNS toxicity of MQ has compromised its clin. value as a prophylaxis drug.  Therefore, new and inexpensive antimalarial drugs with no cross-resistance to CQ or CNS toxicity are urgently needed to combat this deadly human disease.  In this study, a series of new 4-amidinoquinoline (4-AMQ) and 10-amidinobenzonaphthyridine (10-AMB) derivs. were designed, prepd., and assessed to search for new therapeutic agents to replace CQ and MQ.  The new derivs. displayed high activity in vitro and in vivo, with no cross-resistance to CQ, and none were toxic in mice up to 160 mpk × 3.  The best compd. shows IC50 < 1 ng/mL against D6, W2 and C235 Pf clones, low inhibitory activity in hERG K+ channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk × 3 in mice infected with Plasmodium berghei.  In addn. to these desirable pharmacol. profiles, compd. I, one of the most active compds., is metabolically stable in both human and mouse liver microsomal prepns. and has a plasma t1/2 of 50 h in mice, which made it a good MQ replacement candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-hMlYNpOBpbVg90H21EOLACvtfcHk0liXHdZp_Mnw4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D&md5=b3042cd96745a072ee7631a99fd4ce54</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm501809x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501809x%26sid%3Dliteratum%253Aachs%26aulast%3DKorotchenko%26aufirst%3DV.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DAntimalarial%2520activity%2520of%25204-amidinoquinoline%2520and%252010-amidinobenzonaphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3411%26epage%3D3431%26doi%3D10.1021%2Fjm501809x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Using genetic methods to define the targets of compounds with antimalarial activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7761</span>– <span class="NLM_lpage">7771</span>, <span class="refDoi"> DOI: 10.1021/jm400325j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400325j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Chs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7761-7771&author=E.%0AL.+Flanneryauthor=D.+A.+Fidockauthor=E.+A.+Winzeler&title=Using+genetic+methods+to+define+the+targets+of+compounds+with+antimalarial+activity&doi=10.1021%2Fjm400325j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Using Genetic Methods To Define the Targets of Compounds with Antimalarial Activity</span></div><div class="casAuthors">Flannery, Erika L.; Fidock, David A.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7761-7771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although phenotypic cellular screening has been used to drive antimalarial drug discovery in recent years, in some cases target-based drug discovery remains more attractive.  This is esp. true when appropriate high-throughput cellular assays are lacking, as is the case for drug discovery efforts that aim to provide a replacement for primaquine (4-N-(6-methoxyquinolin-8-yl)-pentane-1,4-diamine), the only drug that can block Plasmodium transmission to Anopheles mosquitoes and eliminate liver-stage hypnozoites.  At present, however, there are no known chem. validated parasite protein targets that are important in all Plasmodium parasite developmental stages and that can be used in traditional biochem. compd. screens.  We propose that a plethora of novel, chem. validated, cross-stage antimalarial targets still remain to be discovered from the ∼5,500 proteins encoded by the Plasmodium genomes.  Here we discuss how in vitro evolution of drug-resistant strains of Plasmodium falciparum and subsequent whole-genome anal. can be used to find the targets of some of the many compds. discovered in whole-cell phenotypic screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGylYC1n7jLVg90H21EOLACvtfcHk0liXHdZp_Mnw4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Chs7bO&md5=89334c4fd625e02c7e8a949440ec6aa9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400325j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400325j%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DUsing%2520genetic%2520methods%2520to%2520define%2520the%2520targets%2520of%2520compounds%2520with%2520antimalarial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7761%26epage%3D7771%26doi%3D10.1021%2Fjm400325j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span> <span> </span><span class="NLM_article-title">Selection of <i>Plasmodium falciparum</i> cytochrome B mutants by putative <i>Pf</i>NDH2 inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">6285</span>– <span class="NLM_lpage">6290</span>, <span class="refDoi"> DOI: 10.1073/pnas.1804492115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1073%2Fpnas.1804492115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=6285-6290&author=K.+D.+Laneauthor=J.+Muauthor=J.+Luauthor=S.+T.+Windleauthor=A.+Liuauthor=P.+D.+Sunauthor=T.+E.+Wellems&title=Selection+of+Plasmodium+falciparum+cytochrome+B+mutants+by+putative+PfNDH2+inhibitors&doi=10.1073%2Fpnas.1804492115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1804492115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1804492115%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWindle%26aufirst%3DS.%2BT.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DP.%2BD.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26atitle%3DSelection%2520of%2520Plasmodium%2520falciparum%2520cytochrome%2520B%2520mutants%2520by%2520putative%2520PfNDH2%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D6285%26epage%3D6290%26doi%3D10.1073%2Fpnas.1804492115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stickles, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meermeier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miley, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.14-0553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4269%2Fajtmh.14-0553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=1195-1201&author=A.+M.+Sticklesauthor=L.+M.+Tingauthor=J.+M.+Morriseyauthor=Y.+Liauthor=M.+W.+Matherauthor=E.+Meermeierauthor=A.+M.+Pershingauthor=I.+P.+Forquerauthor=G.+P.+Mileyauthor=S.+Pouauthor=R.+W.+Winterauthor=D.+J.+Hinrichsauthor=J.+X.+Kellyauthor=K.+Kimauthor=A.+B.+Vaidyaauthor=M.+K.+Riscoeauthor=A.+Nilsen&title=Inhibition+of+cytochrome+bc1+as+a+strategy+for+single-dose%2C+multi-stage+antimalarial+therapy&doi=10.4269%2Fajtmh.14-0553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.14-0553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.14-0553%26sid%3Dliteratum%253Aachs%26aulast%3DStickles%26aufirst%3DA.%2BM.%26aulast%3DTing%26aufirst%3DL.%2BM.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DMeermeier%26aufirst%3DE.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DMiley%26aufirst%3DG.%2BP.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DNilsen%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520cytochrome%2520bc1%2520as%2520a%2520strategy%2520for%2520single-dose%252C%2520multi-stage%2520antimalarial%2520therapy%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2015%26volume%3D92%26spage%3D1195%26epage%3D1201%26doi%3D10.4269%2Fajtmh.14-0553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korsinczky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotecka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieckmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>Plasmodium falciparum</i> cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2108</span>, <span class="refDoi"> DOI: 10.1128/AAC.44.8.2100-2108.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.44.8.2100-2108.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10898682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2100-2108&author=M.+Korsinczkyauthor=N.+Chenauthor=B.+Koteckaauthor=A.+Saulauthor=K.+Rieckmannauthor=Q.+Cheng&title=Mutations+in+Plasmodium+falciparum+cytochrome+b+that+are+associated+with+atovaquone+resistance+are+located+at+a+putative+drug-binding+site&doi=10.1128%2FAAC.44.8.2100-2108.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site</span></div><div class="casAuthors">Korsinczky, Michael; Chen, Nanhua; Kotecka, Barbara; Saul, Allan; Rieckmann, Karl; Cheng, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2100-2108</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Atovaquone is the major active component of the new antimalarial drug Malarone.  Considerable evidence suggests that malaria parasites become resistant to atovaquone quickly if atovaquone is used as a sole agent.  The mechanism by which the parasite develops resistance to atovaquone is not yet fully understood.  Atovaquone has been shown to inhibit the cytochrome bc1 (CYT bc1) complex of the electron transport chain of malaria parasites.  Here the authors report point mutations in Plasmodium falciparum CYT b that are assocd. with atovaquone resistance.  Single or double amino acid mutations were detected from parasites that originated from a cloned line and survived various concns. of atovaquone in vitro.  A single amino acid mutation was detected in parasites isolated from a recrudescent patient following atovaquone treatment.  These mutations are assocd. with a 25- to 9,354-fold range redn. in parasite susceptibility to atovaquone.  Mol. modeling showed that amino acid mutations assocd. with atovaquone resistance are clustered around a putative atovaquone-binding site.  Mutations in these positions are consistent with a reduced binding affinity of atovaquone for malaria parasite CYT b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgzM-cUj0kbVg90H21EOLACvtfcHk0liTPsP7q3fPJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlShsLo%253D&md5=24e0e5753b6db87beb02a0dbe7148940</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.44.8.2100-2108.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.44.8.2100-2108.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKorsinczky%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DKotecka%26aufirst%3DB.%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DRieckmann%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DQ.%26atitle%3DMutations%2520in%2520Plasmodium%2520falciparum%2520cytochrome%2520b%2520that%2520are%2520associated%2520with%2520atovaquone%2520resistance%2520are%2520located%2520at%2520a%2520putative%2520drug-binding%2520site%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2100%26epage%3D2108%26doi%3D10.1128%2FAAC.44.8.2100-2108.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Syafruddin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siregar, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzuki, S.</span></span> <span> </span><span class="NLM_article-title">Mutations in the cytochrome b gene of <i>Plasmodium berghei</i> conferring resistance to atovaquone</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(99)00148-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS0166-6851%2899%2900148-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10593174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK1MXntlelt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=185-194&author=D.+Syafruddinauthor=J.+E.+Siregarauthor=S.+Marzuki&title=Mutations+in+the+cytochrome+b+gene+of+Plasmodium+berghei+conferring+resistance+to+atovaquone&doi=10.1016%2FS0166-6851%2899%2900148-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone</span></div><div class="casAuthors">Syafruddin, D.; Siregar, J. E.; Marzuki, S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The mol. lesions which underlie the resistance of the malaria parasites to atovaquone, a coenzyme Q analog, were investigated.  Resistant clones of Plasmodium berghei ANKA strain were isolated following prolonged propagation in mice in the presence of increasing doses of the drug, and their cytochrome b gene sequenced.  Three mutations were detected, T-C substitution at nt 431, G-A at nt 399 and G-T at nt 850, resulting in amino acid changes in the putative cytochrome b product at residues 133, 144 and 284.  The V284F amino acid change is in the sixth transmembrane helix of the protein and was obsd. in all resistant clones.  An addnl. M133I or L144S amino acid change within the Qo site at an extramembranous amphipathic helix significantly increases the resistance to atovaquone.  Our results (a) provide evidence that the antimalarial activity of atovaquone indeed involves an interaction with the cytochrome b; (b) define atovaquone as an inhibitor of the ubiquinol oxidase activity of the cytochrome bc1 complex; and (c) define amino acid residues in the mammalian cytochrome b which might be crit. in detg. its relative resistance to atovaquone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO477poLQLcLVg90H21EOLACvtfcHk0liTPsP7q3fPJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlelt7g%253D&md5=1ab2045954581209b1f8bb18936c8b68</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2899%2900148-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252899%252900148-6%26sid%3Dliteratum%253Aachs%26aulast%3DSyafruddin%26aufirst%3DD.%26aulast%3DSiregar%26aufirst%3DJ.%2BE.%26aulast%3DMarzuki%26aufirst%3DS.%26atitle%3DMutations%2520in%2520the%2520cytochrome%2520b%2520gene%2520of%2520Plasmodium%2520berghei%2520conferring%2520resistance%2520to%2520atovaquone%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1999%26volume%3D104%26spage%3D185%26epage%3D194%26doi%3D10.1016%2FS0166-6851%2899%2900148-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siregar, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega-Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syafruddin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozijnsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Lorena, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, G. I.</span></span> <span> </span><span class="NLM_article-title">Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1126/science.aad9279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscience.aad9279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=27081071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&pages=349-353&author=C.+D.+Goodmanauthor=J.+E.+Siregarauthor=V.+Mollardauthor=J.+Vega-Rodriguezauthor=D.+Syafruddinauthor=H.+Matsuokaauthor=M.+Matsuzakiauthor=T.+Toyamaauthor=A.+Sturmauthor=A.+Cozijnsenauthor=M.+Jacobs-Lorenaauthor=K.+Kitaauthor=S.+Marzukiauthor=G.+I.+McFadden&title=Parasites+resistant+to+the+antimalarial+atovaquone+fail+to+transmit+by+mosquitoes&doi=10.1126%2Fscience.aad9279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes</span></div><div class="casAuthors">Goodman, Christopher D.; Siregar, Josephine E.; Mollard, Vanessa; Vega-Rodriguez, Joel; Syafruddin, Din; Matsuoka, Hiroyuki; Matsuzaki, Motomichi; Toyama, Tomoko; Sturm, Angelika; Cozijnsen, Anton; Jacobs-Lorena, Marcelo; Kita, Kiyoshi; Marzuki, Sangkot; McFadden, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">6283</span>),
    <span class="NLM_cas:pages">349-353</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Resistance to a commonly used antimalarial medication, atovaquone, is apparently unable to spread.  Atovaquone pressure selects parasites with mutations in cytochrome b, a respiratory protein with low but essential activity in the mammalian blood phase of the parasite life cycle.  Resistance mutations rescue parasites from the drug but later prove lethal in the mosquito phase, where parasites require full respiration.  Unable to respire efficiently, resistant parasites fail to complete mosquito development, arresting their life cycle.  Because cytochrome b is encoded by the maternally inherited parasite mitochondrion, even outcrossing with wild-type strains cannot facilitate spread of resistance.  Lack of transmission suggests that resistance will be unable to spread in the field, greatly enhancing the utility of atovaquone in malaria control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aFESmHx4cbVg90H21EOLACvtfcHk0liTPsP7q3fPJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2isb8%253D&md5=5e31bac1aeb100b6fd018fd3a8aea1c6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.aad9279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aad9279%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DC.%2BD.%26aulast%3DSiregar%26aufirst%3DJ.%2BE.%26aulast%3DMollard%26aufirst%3DV.%26aulast%3DVega-Rodriguez%26aufirst%3DJ.%26aulast%3DSyafruddin%26aufirst%3DD.%26aulast%3DMatsuoka%26aufirst%3DH.%26aulast%3DMatsuzaki%26aufirst%3DM.%26aulast%3DToyama%26aufirst%3DT.%26aulast%3DSturm%26aufirst%3DA.%26aulast%3DCozijnsen%26aufirst%3DA.%26aulast%3DJacobs-Lorena%26aufirst%3DM.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DMarzuki%26aufirst%3DS.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26atitle%3DParasites%2520resistant%2520to%2520the%2520antimalarial%2520atovaquone%2520fail%2520to%2520transmit%2520by%2520mosquitoes%26jtitle%3DScience%26date%3D2016%26volume%3D352%26spage%3D349%26epage%3D353%26doi%3D10.1126%2Fscience.aad9279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumeau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambachew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Open-source discovery of chemical leads for next-generation chemoprotective antimalarials</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>362</i></span>, <span class="NLM_elocation-id">eaat9446</span> <span class="refDoi"> DOI: 10.1126/science.aat9446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscience.aat9446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=30523084" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2018&author=Y.+Antonova-Kochauthor=S.+Meisterauthor=M.+Abrahamauthor=M.+R.+Luthauthor=S.+Ottilieauthor=A.+K.+Lukensauthor=T.+Sakata-Katoauthor=M.+Vanaerschotauthor=E.+Owenauthor=J.+C.+Jadoauthor=S.+P.+Maherauthor=J.+Callaauthor=D.+Plouffeauthor=Y.+Zhongauthor=K.+Chenauthor=V.+Chaumeauauthor=A.+J.+Conwayauthor=C.+W.+McNamaraauthor=M.+Ibanezauthor=K.+Gagaringauthor=F.+N.+Serranoauthor=K.+Eribezauthor=C.+M.+Taggardauthor=A.+L.+Cheungauthor=C.+Lincolnauthor=B.+Ambachewauthor=M.+Rouillierauthor=D.+Siegelauthor=F.+Nostenauthor=D.+E.+Kyleauthor=F.+J.+Gamoauthor=Y.+Zhouauthor=M.+Llinasauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=J.+Burrowsauthor=B.+Campoauthor=E.+A.+Winzeler&title=Open-source+discovery+of+chemical+leads+for+next-generation+chemoprotective+antimalarials&doi=10.1126%2Fscience.aat9446"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat9446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat9446%26sid%3Dliteratum%253Aachs%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DE.%26aulast%3DJado%26aufirst%3DJ.%2BC.%26aulast%3DMaher%26aufirst%3DS.%2BP.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChaumeau%26aufirst%3DV.%26aulast%3DConway%26aufirst%3DA.%2BJ.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DSerrano%26aufirst%3DF.%2BN.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DTaggard%26aufirst%3DC.%2BM.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DLincoln%26aufirst%3DC.%26aulast%3DAmbachew%26aufirst%3DB.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLlinas%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DOpen-source%2520discovery%2520of%2520chemical%2520leads%2520for%2520next-generation%2520chemoprotective%2520antimalarials%26jtitle%3DScience%26date%3D2018%26volume%3D362%26doi%3D10.1126%2Fscience.aat9446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of nitrogen-containing baicalein analogues</span>. <i>Shenyang Yaoke Daxue Xuebao</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1enur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=888-892&author=J.+F.+Feiauthor=W.+Liuauthor=J.+Wang&title=Synthesis+of+nitrogen-containing+baicalein+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of nitrogen-containing Baicalein analogues</span></div><div class="casAuthors">Fei, Jia; Feng, Feng; Liu, Wen-yuan; Wang, Jun-zheng</div><div class="citationInfo"><span class="NLM_cas:title">Shenyang Yaoke Daxue Xuebao</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">888-892</span>CODEN:
                <span class="NLM_cas:coden">SYDXFF</span>;
        ISSN:<span class="NLM_cas:issn">1006-2858</span>.
    
            (<span class="NLM_cas:orgname">Shenyang Yaoke Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">To study the anti-tumor activities of Baicalein analogs, a series of Baicalein derivs. were synthesized from Baicalein via alkylation with nitrogen-contg. side chain (R1R2N( CH2)nCl·HCl).  Ten new Baicalein analogs were prepd. and their structures were confirmed by 1H NMR and ESI-MS.  Cancer cell lines including HepG2 and A549 were incubated with Baicalein analogs of various concns.  The inhibition rate was examd. by MTT (3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide) assay.  The activity tests showed that I and II had more significant upgraded cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgcytsknl6EbVg90H21EOLACvtfcHk0lhrfzyQKOWYqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1enur%252FM&md5=e3e79e26b98666750f9d0f2bdc0b1b3f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520nitrogen-containing%2520baicalein%2520analogues%26jtitle%3DShenyang%2520Yaoke%2520Daxue%2520Xuebao%26date%3D2010%26volume%3D27%26spage%3D888%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, D. A.</span></span> <span> </span><span class="NLM_article-title">Some derivatives of phenothiazine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1944</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/ja01234a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01234a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1944&pages=888-893&author=H.+Gilmanauthor=D.+A.+Shirley&title=Some+derivatives+of+phenothiazine&doi=10.1021%2Fja01234a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja01234a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01234a013%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DShirley%26aufirst%3DD.%2BA.%26atitle%3DSome%2520derivatives%2520of%2520phenothiazine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1944%26volume%3D66%26spage%3D888%26epage%3D893%26doi%3D10.1021%2Fja01234a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornasiero, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isetta, A. M.</span></span> <span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(90)90187-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro&doi=10.1016%2F0022-1759%2890%2990187-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0lhrfzyQKOWYqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172%26doi%3D10.1016%2F0022-1759%2890%2990187-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezise, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worley, J.</span></span> <span> </span><span class="NLM_article-title">Ionworks HT: a new high-throughput electrophysiology measurement platform</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1177/1087057102239667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1177%2F1087057102239667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=12854998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=50-64&author=K.+Schroederauthor=B.+Neagleauthor=D.+J.+Treziseauthor=J.+Worley&title=Ionworks+HT%3A+a+new+high-throughput+electrophysiology+measurement+platform&doi=10.1177%2F1087057102239667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">IonWorks HT: A new high-throughput electrophysiology measurement platform</span></div><div class="casAuthors">Schroeder, Kirk; Neagle, Brad; Trezise, Derek J.; Worley, Jennings</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-64</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">To address the throughput restrictions of classical patch clamp electrophysiol., Essen Instruments has developed a plate-based electrophysiol. measurement platform.  The instrument is an integrated platform that consists of computer-controlled fluid handling, recording electronics, and processing tools capable of voltage clamp whole-cell recordings from thousands of individual cells per day.  To establish a recording, the system uses a planar, multi-well substrate (a PatchPlate).  The system effectively positions 1 cell into a hole sepg. 2 fluid compartments in each well of the substrate.  Voltage control and current recordings from the cell membrane are made subsequent to gaining access to the cell interior by applying a permeabilizing agent to the intracellular side.  Based on the multi-well design of the PatchPlate, voltage clamp recordings of up to 384 individual cells can be made in minutes and are comparable to measurements made using traditional electrophysiol. techniques.  An integrated pipetting system allows for up to 2 addns. of modulation agents.  Typical throughput, measurement fidelity, stability, and comparative pharmacol. of a recombinant voltage-dependent sodium channel (hNav1.3) and a voltage-gated potassium channel (hKv1.5) exogenously expressed in CHO cells are presented.  The IonWorks HT device can be used in biophys. and pharmacol. profiling of ion channels in an environment compatible with high-capacity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99MfVnFuXs7Vg90H21EOLACvtfcHk0lgVxITo4IJR0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D&md5=3a161db49dbb3c39e1db2d74e46e6bfb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057102239667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057102239667%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DK.%26aulast%3DNeagle%26aufirst%3DB.%26aulast%3DTrezise%26aufirst%3DD.%2BJ.%26aulast%3DWorley%26aufirst%3DJ.%26atitle%3DIonworks%2520HT%253A%2520a%2520new%2520high-throughput%2520electrophysiology%2520measurement%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D50%26epage%3D64%26doi%3D10.1177%2F1087057102239667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span> <span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-364&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0lgVxITo4IJR0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D364%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pant, K.</span></span> <span> </span><span class="NLM_article-title">Ames IITM and Ames Liquid Format Mutagenicity Screening Assays</span>. In  <i>High-Throughput Screening Methods in Toxicity Testing</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, P.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley and Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, New Jersey</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">211</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2F9781118538203.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=193-211&author=K.+Pantauthor=P.+Steinberg&title=High-Throughput+Screening+Methods+in+Toxicity+Testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F9781118538203.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118538203.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DPant%26aufirst%3DK.%26atitle%3DAmes%2520IITM%2520and%2520Ames%2520Liquid%2520Format%2520Mutagenicity%2520Screening%2520Assays%26btitle%3DHigh-Throughput%2520Screening%2520Methods%2520in%2520Toxicity%2520Testing%26aulast%3DSteinberg%26aufirst%3DP.%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Inc%26date%3D2013%26spage%3D193%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">P. Holland Alday, Erin V. McConnell, Jan M. Boitz Zarella, Rozalia A. Dodean, Papireddy Kancharla, Jane X. Kelly, <span class="NLM_string-name hlFld-ContribAuthor">J. Stone Doggett</span>. </span><span class="cited-content_cbyCitation_article-title">Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (7)
                                     , 1877-1884. <a href="https://doi.org/10.1021/acsinfecdis.1c00016" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00016%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAcridones%252BAre%252BHighly%252BPotent%252BInhibitors%252Bof%252BToxoplasma%252Bgondii%252BTachyzoites%26aulast%3DAlday%26aufirst%3DP.%2BHolland%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D16032021%26volume%3D7%26issue%3D7%26spage%3D1877%26epage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Papireddy Kancharla, Rozalia A. Dodean, Yuexin Li, Sovitj Pou, Brandon Pybus, Victor Melendez, Lisa Read, Charles E. Bane, Brian Vesely, Mara Kreishman-Deitrick, Chad Black, Qigui Li, Richard J. Sciotti, Raul Olmeda, Thu-Lan Luong, Heather Gaona, Brittney Potter, Jason Sousa, Sean Marcsisin, Diana Caridha, Lisa Xie, Chau Vuong, Qiang Zeng, Jing Zhang, Ping Zhang, Hsiuling Lin, Kirk Butler, Norma Roncal, Lacy Gaynor-Ohnstad, Susan E. Leed, Christina Nolan, Frida G. Ceja, Stephanie A. Rasmussen, Patrick K. Tumwebaze, Philip J. Rosenthal, Jianbing Mu, Brett R. Bayles, Roland A. Cooper, Kevin A. Reynolds, Martin J. Smilkstein, Michael K. Riscoe, <span class="NLM_string-name hlFld-ContribAuthor">Jane X. Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6179-6202. <a href="https://doi.org/10.1021/acs.jmedchem.0c00539" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00539%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Bof%252BSecond-Generation%252BAcridones%252Bas%252BBroad-Spectrum%252BAntimalarials%26aulast%3DKancharla%26aufirst%3DPapireddy%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02042020%26date%3D26052020%26date%3D11052020%26volume%3D63%26issue%3D11%26spage%3D6179%26epage%3D6202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajkumar  Veligeti</span>, <span class="hlFld-ContribAuthor ">Rajesh Bagepalli  Madhu</span>, <span class="hlFld-ContribAuthor ">Jayashree  Anireddy</span>, <span class="hlFld-ContribAuthor ">Visweswara Rao  Pasupuleti</span>, <span class="hlFld-ContribAuthor ">Vijaya Kumar Reddy  Avula</span>, <span class="hlFld-ContribAuthor ">Krishna S.  Ethiraj</span>, <span class="hlFld-ContribAuthor ">Srinivas  Uppalanchi</span>, <span class="hlFld-ContribAuthor ">Sivaprasad  Kasturi</span>, <span class="hlFld-ContribAuthor ">Yogeeswari  Perumal</span>, <span class="hlFld-ContribAuthor ">Hasitha Shilpa  Anantaraju</span>, <span class="hlFld-ContribAuthor ">Naveen  Polkam</span>, <span class="hlFld-ContribAuthor ">Mallilkarjuna Reddy  Guda</span>, <span class="hlFld-ContribAuthor ">Swetha  Vallela</span>, <span class="hlFld-ContribAuthor ">Grigory Vasilievich  Zyryanov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-77590-1" title="DOI URL">https://doi.org/10.1038/s41598-020-77590-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-77590-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-77590-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSynthesis%252Bof%252Bnovel%252Bcytotoxic%252Btetracyclic%252Bacridone%252Bderivatives%252Band%252Bstudy%252Bof%252Btheir%252Bmolecular%252Bdocking%25252C%252BADMET%25252C%252BQSAR%25252C%252Bbioactivity%252Band%252Bprotein%252Bbinding%252Bproperties%26aulast%3DVeligeti%26aufirst%3DRajkumar%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling‐Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenhui  Yang</span>, <span class="hlFld-ContribAuthor ">Zhongyan  Hu</span>, <span class="hlFld-ContribAuthor ">Xian‐Ming  Zhang</span>, <span class="hlFld-ContribAuthor ">Xianxiu  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem Access to Acridones and their Fused Derivatives: [1+2+3] Annulation of Isocyanides with Unsaturated Carbonyls. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (12)
                                     , 2379-2384. <a href="https://doi.org/10.1002/adsc.201901560" title="DOI URL">https://doi.org/10.1002/adsc.201901560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901560%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DTandem%252BAccess%252Bto%252BAcridones%252Band%252Btheir%252BFused%252BDerivatives%25253A%252B%25255B1%25252B2%25252B3%25255D%252BAnnulation%252Bof%252BIsocyanides%252Bwith%252BUnsaturated%252BCarbonyls%26aulast%3DZhang%26aufirst%3DLing%25E2%2580%2590Juan%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D12%26spage%3D2379%26epage%3D2384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Papireddy  Kancharla</span>, <span class="hlFld-ContribAuthor ">Rozalia A.  Dodean</span>, <span class="hlFld-ContribAuthor ">Yuexin  Li</span>, <span class="hlFld-ContribAuthor ">Jane X.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (72)
                                     , 42284-42293. <a href="https://doi.org/10.1039/C9RA09478D" title="DOI URL">https://doi.org/10.1039/C9RA09478D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA09478D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA09478D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBoron%252Btrifluoride%252Betherate%252Bpromoted%252Bmicrowave-assisted%252Bsynthesis%252Bof%252Bantimalarial%252Bacridones%26aulast%3DKancharla%26aufirst%3DPapireddy%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D72%26spage%3D42284%26epage%3D42293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0018.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transition from a dual-function acridone to a broad-spectrum acridone chemotype.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acridones <b>7</b>–<b>15</b>, <b>23</b>, <b>24</b>, and <b>29</b>–<b>32</b> with a Substitution at the 2/3 Position of Ring-A and the (Dialkylamino)alkoxy/chloroalkoxy Moiety at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Cu powder, K<sub>2</sub>CO<sub>3</sub>, pentanol, reflux, 5 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sup>1</sup>/R<sup>2</sup>. HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 5–12 h; (v) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature (rt), 5 h; (vi) Pd(dba)<sub>2</sub>, 1,1′-bis(diphenylphosphino)ferrocene (DPPF), KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (vii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 12 h; (viii) Br-(CH<sub>2</sub>)<sub>3</sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (ix) <i>tert</i>-butylamine, NaI, dimethyl sulfoxide (DMSO), 145 °C, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acridones <b>38</b>–<b>55</b>, <b>62</b>, and <b>63</b> with Disubstitutions at the 1 and 3 Positions of Ring-A and the Alkoxy/(dialkylamino)alkoxy/chloroalkoxy Moiety at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Br-(CH<sub>2</sub>)<i><sub>n</sub></i>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (v) alkylamine, NaI, DMSO, 145 °C, 2 h; (vi) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sup>3</sup>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 3–12 h; (vii) Br-(CH<sub>2</sub>)<sub>2</sub>-Br, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (viii) dipropylamine, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 18 h; (ix) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0017.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acridones <b>70</b>–<b>86</b>, <b>92</b>, <b>93</b>, <b>98</b>, and <b>99</b> with Disubstitutions at the 1 and 2 or the 2 and 3 Positions of Ring-A and (Diethylamino)ethoxy/ethyl-amino/chloroalkoxy at the 6 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dba)<sub>2</sub>, DPPF, KO<i>t</i>Bu, toluene, 100 °C, 8–12 h; (ii) Eaton’s acid, 90 °C, 5–24 h; (iii) HI, phenol, reflux, 3 h; (iv) Br-(CH<sub>2</sub>)<i><sub>n</sub></i>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 24 h; (v) alkylamine, NaI, DMSO, 145 °C, 2 h; (vi) Cl-(CH<sub>2</sub>)<i><sub>n</sub></i>-R<sub>1</sub>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10–24 h; (vii) Cl-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (viii) Br-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>·HBr, TBAC, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4 h; (ix) NH<sub>2</sub>-(CH<sub>2</sub>)<sub>2</sub>-N(Et)<sub>2</sub>, 2-acetylcyclohexanone, Cs<sub>2</sub>CO<sub>3</sub>, CuI, DMF, 100 °C, 4 h; (x) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h; (xi) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 5–8 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 1,4/2,4/3,4-dichloro-acridones <b>100</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acridones <b>109</b>–<b>113</b>, <b>119</b>, <b>120</b>, <b>123</b>, and <b>128</b> with Mono-/Disubstitutions on Ring-A and the (Dialkylamino)alkoxy Moiety at the 7 Position of Ring-B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br-(CH<sub>2</sub>)<sub>2</sub>-Cl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (ii) dipropylamine, NaI, DMSO, 145 °C, 3 h; (iii) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 5 h; (iv) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 5–8 h; (v) Eaton’s acid, 90 °C, 5–24 h; (vi) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 12 h; (vii) Cl-(CH<sub>2</sub>)<sub>2</sub>-<i>N</i>(Et)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (viii) Cl-(CH<sub>2</sub>)<sub>2</sub>-<i>N</i>(Pr)<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 10 h; (ix) Cu powder, K<sub>2</sub>CO<sub>3</sub>, pentanol, reflux, 5 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/medium/jm-2018-01961w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acridone efficacy in the in vivo liver-stage model in C57BL/6 male Albino mice infected with 50 000 luciferase-expressing <i>P. berghei</i> sporozoites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01961/20190404/images/large/jm-2018-01961w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01961&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i155">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26pub%3DWHO%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antony, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parija, S. C.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug resistance: an overview</span>. <i>Trop. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.4103/2229-5070.175081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4103%2F2229-5070.175081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26998432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC28fitlWmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30-41&author=H.+A.+Antonyauthor=S.+C.+Parija&title=Antimalarial+drug+resistance%3A+an+overview&doi=10.4103%2F2229-5070.175081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance: An overview</span></div><div class="casAuthors">Antony Hiasindh Ashmi; Parija Subhash Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Tropical parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-41</span>
        ISSN:<span class="NLM_cas:issn">2229-5070</span>.
    </div><div class="casAbstract">Malaria is a major public health burden throughout the world.  Resistance to the antimalarial drugs has increased the mortality and morbidity rate that is achieved so far through the malaria control program.  Monitoring the drug resistance to the available antimalarial drugs helps to implement effective drug policy, through the in vivo efficacy studies, in vitro drug susceptibility tests and detection of molecular markers.  It is important to understand the mechanism of the antimalarial drugs, as it is one of the key factors in the emergence and spread of drug resistance.  This review summarizes the commonly used antimalarial drugs, their mechanism of action and the genetic markers validated so far for the detection of drug-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU1tKNafHz7OR_TJajKxJDfW6udTcc2eYo6b-8ukvLcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fitlWmug%253D%253D&md5=0df7bac72c7267d5dbd8808c6eea4125</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4103%2F2229-5070.175081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2229-5070.175081%26sid%3Dliteratum%253Aachs%26aulast%3DAntony%26aufirst%3DH.%2BA.%26aulast%3DParija%26aufirst%3DS.%2BC.%26atitle%3DAntimalarial%2520drug%2520resistance%253A%2520an%2520overview%26jtitle%3DTrop.%2520Parasitol.%26date%3D2016%26volume%3D6%26spage%3D30%26epage%3D41%26doi%3D10.4103%2F2229-5070.175081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, R.</span></span> <span> </span><span class="NLM_article-title">Challenges of drug-resistant malaria</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1051/parasite/2014059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1051%2Fparasite%2F2014059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=25402734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmvVKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=61&author=S.+Sinhaauthor=B.+Medhiauthor=R.+Sehgal&title=Challenges+of+drug-resistant+malaria&doi=10.1051%2Fparasite%2F2014059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges of drug-resistant malaria</span></div><div class="casAuthors">Sinha Shweta; Sehgal Rakesh; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Parasite (Paris, France)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past six decades, the drug resistance of Plasmodium falciparum has become an issue of utmost concern.  Despite the remarkable progress that has been made in recent years in reducing the mortality rate to about 30% with the scaling-up of vector control, introduction of artemisinin-based combination therapies and other malaria control strategies, the confirmation of artemisinin resistance on the Cambodia-Thailand border threatened all the previous success.  This review addresses the global scenario of antimalarial resistance and factors associated with it, with the main emphasis on futuristic approaches like nanotechnology and stem cell therapy that may impede resistant malaria, along with novel medications which are preparing to enter the global antimalarial market.  These novel studies are likely to escalate over the coming years and will hopefully help to reduce the burden of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHDI3EqIaZ_y86Js-BCLiifW6udTcc2eZV8v9gvEoIMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmvVKmtA%253D%253D&md5=377ddbcb4c00babc048ad4eb189d3c0a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2014059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2014059%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DMedhi%26aufirst%3DB.%26aulast%3DSehgal%26aufirst%3DR.%26atitle%3DChallenges%2520of%2520drug-resistant%2520malaria%26jtitle%3DParasite%26date%3D2014%26volume%3D21%26spage%3D61%26doi%3D10.1051%2Fparasite%2F2014059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F. H.</span></span> <span> </span><span class="NLM_article-title">Combating multi-drug resistant <i>Plasmodium falciparum</i> malaria</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">2569</span>– <span class="NLM_lpage">2578</span>, <span class="refDoi"> DOI: 10.1111/febs.14127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Ffebs.14127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=2569-2578&author=A.+M.+Thuauthor=A.+P.+Phyoauthor=J.+Landierauthor=D.+M.+Parkerauthor=F.+H.+Nosten&title=Combating+multi-drug+resistant+Plasmodium+falciparum+malaria&doi=10.1111%2Ffebs.14127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14127%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DA.%2BM.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DLandier%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DD.%2BM.%26aulast%3DNosten%26aufirst%3DF.%2BH.%26atitle%3DCombating%2520multi-drug%2520resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D2569%26epage%3D2578%26doi%3D10.1111%2Ffebs.14127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(13)60024-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS0140-6736%2813%2960024-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23953767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgs1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=723-735&author=N.+J.+Whiteauthor=S.+Pukrittayakameeauthor=T.+T.+Hienauthor=M.+A.+Faizauthor=O.+A.+Mokuoluauthor=A.+M.+Dondorp&title=Malaria&doi=10.1016%2FS0140-6736%2813%2960024-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">White Nicholas J; Pukrittayakamee Sasithon; Hien Tran Tinh; Faiz M Abul; Mokuolu Olugbenga A; Dondorp Arjen M</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">9918</span>),
    <span class="NLM_cas:pages">723-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although global morbidity and mortality have decreased substantially, malaria, a parasite infection of red blood cells, still kills roughly 2000 people per day, most of whom are children in Africa.  Two factors largely account for these decreases; increased deployment of insecticide-treated bednets and increased availability of highly effective artemisinin combination treatments.  In large trials, parenteral artesunate (an artemisinin derivative) reduced severe malaria mortality by 22·5% in Africa and 34·7% in Asia compared with quinine, whereas adjunctive interventions have been uniformly unsuccessful.  Rapid tests have been an important addition to microscopy for malaria diagnosis.  Chemopreventive strategies have been increasingly deployed in Africa, notably intermittent sulfadoxine-pyrimethamine treatment in pregnancy, and monthly amodiaquine-sulfadoxine-pyrimethamine during the rainy season months in children aged between 3 months and 5 years across the sub-Sahel.  Enthusiasm for malaria elimination has resurfaced.  This ambitious but laudable goal faces many challenges, including the worldwide economic downturn, difficulties in elimination of vivax malaria, development of pyrethroid resistance in some anopheline mosquitoes, and the emergence of artemisinin resistance in Plasmodium falciparum in southeast Asia.  We review the epidemiology, clinical features, pathology, prevention, and treatment of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUNJZs6BRXR-kdrW1FkXG-fW6udTcc2eZV8v9gvEoIMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgs1Grug%253D%253D&md5=bd84954e5e034997111401f4dcdc69fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2960024-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252960024-0%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26atitle%3DMalaria%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D723%26epage%3D735%26doi%3D10.1016%2FS0140-6736%2813%2960024-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poespoprodjo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium vivax</i>: clinical spectrum, risk factors and pathogenesis</span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-397900-1.00003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FB978-0-12-397900-1.00003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23199488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=151-201&author=N.+M.+Ansteyauthor=N.+M.+Douglasauthor=J.+R.+Poespoprodjoauthor=R.+N.+Price&title=Plasmodium+vivax%3A+clinical+spectrum%2C+risk+factors+and+pathogenesis&doi=10.1016%2FB978-0-12-397900-1.00003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium vivax: clinical spectrum, risk factors and pathogenesis</span></div><div class="casAuthors">Anstey Nicholas M; Douglas Nicholas M; Poespoprodjo Jeanne R; Price Ric N</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vivax malaria was historically described as 'benign tertian malaria' because individual clinical episodes were less likely to cause severe illness than Plasmodium falciparum.  Despite this, Plasmodium vivax was, and remains, responsible for major morbidity and significant mortality in vivax-endemic areas.  Single infections causing febrile illness in otherwise healthy individuals rarely progress to severe disease.  Nevertheless, in the presence of co-morbidities, P. vivax can cause severe illness and fatal outcomes.  Recurrent or chronic infections in endemic areas can cause severe anaemia and malnutrition, particularly in early childhood.  Other severe manifestations include acute lung injury, acute kidney injury and uncommonly, coma.  Multiorgan failure and shock are described but further studies are needed to investigate the role of bacterial and other co-infections in these syndromes.  In pregnancy, P. vivax infection can cause maternal anaemia, miscarriage, low birth weight and congenital malaria.  Compared to P. falciparum, P. vivax has a greater capacity to elicit an inflammatory response, resulting in a lower pyrogenic threshold.  Conversely, cytoadherence of P. vivax to endothelial cells is less frequent and parasite sequestration is not thought to be a significant cause of severe illness in vivax malaria.  With a predilection for young red cells, P. vivax does not result in the high parasite biomass associated with severe disease in P. falciparum, but a four to fivefold greater removal of uninfected red cells from the circulation relative to P. falciparum is associated with a similar risk of severe anaemia.  Mechanisms underlying the pathogenesis of severe vivax syndromes remain incompletely understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0v8nZQMi1iLt7lRqEFUJVfW6udTcc2eYodXd4v2DIt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtQ%253D%253D&md5=c93c9389270b7507d13d0c18591f19be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397900-1.00003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-397900-1.00003-7%26sid%3Dliteratum%253Aachs%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26aulast%3DDouglas%26aufirst%3DN.%2BM.%26aulast%3DPoespoprodjo%26aufirst%3DJ.%2BR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26atitle%3DPlasmodium%2520vivax%253A%2520clinical%2520spectrum%252C%2520risk%2520factors%2520and%2520pathogenesis%26jtitle%3DAdv.%2520Parasitol.%26date%3D2012%26volume%3D80%26spage%3D151%26epage%3D201%26doi%3D10.1016%2FB978-0-12-397900-1.00003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span> <span> </span><span class="NLM_article-title">Malaria caused by <i>Plasmodium vivax</i>: recurrent, difficult to treat, disabling, and threatening to life-the infectious bite preempts these hazards</span>. <i>Pathog. Global Health</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1179/2047772413Z.000000000179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1179%2F2047772413Z.000000000179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24428831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2013&pages=475-479&author=J.+K.+Baird&title=Malaria+caused+by+Plasmodium+vivax%3A+recurrent%2C+difficult+to+treat%2C+disabling%2C+and+threatening+to+life-the+infectious+bite+preempts+these+hazards&doi=10.1179%2F2047772413Z.000000000179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1179%2F2047772413Z.000000000179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047772413Z.000000000179%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DMalaria%2520caused%2520by%2520Plasmodium%2520vivax%253A%2520recurrent%252C%2520difficult%2520to%2520treat%252C%2520disabling%252C%2520and%2520threatening%2520to%2520life-the%2520infectious%2520bite%2520preempts%2520these%2520hazards%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2013%26volume%3D107%26spage%3D475%26epage%3D479%26doi%3D10.1179%2F2047772413Z.000000000179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battle, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gething, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elyazar, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinka, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, S. I.</span></span> <span> </span><span class="NLM_article-title">The global public health significance of <i>Plasmodium vivax</i></span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-397900-1.00001-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fb978-0-12-397900-1.00001-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23199486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1-111&author=K.+E.+Battleauthor=P.+W.+Gethingauthor=I.+R.+Elyazarauthor=C.+L.+Moyesauthor=M.+E.+Sinkaauthor=R.+E.+Howesauthor=C.+A.+Guerraauthor=R.+N.+Priceauthor=K.+J.+Bairdauthor=S.+I.+Hay&title=The+global+public+health+significance+of+Plasmodium+vivax&doi=10.1016%2Fb978-0-12-397900-1.00001-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The global public health significance of Plasmodium vivax</span></div><div class="casAuthors">Battle Katherine E; Gething Peter W; Elyazar Iqbal R F; Moyes Catherine L; Sinka Marianne E; Howes Rosalind E; Guerra Carlos A; Price Ric N; Baird Kevin J; Hay Simon I</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-111</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium vivax occurs globally and thrives in both temperate and tropical climates.  Here, we review the evidence of the biological limits of its contemporary distribution and the global population at risk (PAR) of the disease within endemic countries.  We also review the most recent evidence for the endemic level of transmission within its range and discuss the implications for burden of disease assessments.  Finally, the evidence-base for defining the contemporary distribution and PAR of P. vivax are discussed alongside a description of the vectors of human malaria within the limits of risk.  This information along with recent data documenting the severe morbid and fatal consequences of P. vivax infection indicates that the public health significance of P. vivax is likely to have been seriously underestimated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0v8nZQMi1iJagfuraLLzSfW6udTcc2eYodXd4v2DIt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nvFOrtw%253D%253D&md5=df8d5bc086839b20f0adb593193eeeac</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-397900-1.00001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-397900-1.00001-3%26sid%3Dliteratum%253Aachs%26aulast%3DBattle%26aufirst%3DK.%2BE.%26aulast%3DGething%26aufirst%3DP.%2BW.%26aulast%3DElyazar%26aufirst%3DI.%2BR.%26aulast%3DMoyes%26aufirst%3DC.%2BL.%26aulast%3DSinka%26aufirst%3DM.%2BE.%26aulast%3DHowes%26aufirst%3DR.%2BE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DBaird%26aufirst%3DK.%2BJ.%26aulast%3DHay%26aufirst%3DS.%2BI.%26atitle%3DThe%2520global%2520public%2520health%2520significance%2520of%2520Plasmodium%2520vivax%26jtitle%3DAdv.%2520Parasitol.%26date%3D2012%26volume%3D80%26spage%3D1%26epage%3D111%26doi%3D10.1016%2Fb978-0-12-397900-1.00001-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinski, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Portillo, H. A.</span></span> <span> </span><span class="NLM_article-title">Key gaps in the knowledge of <i>Plasmodium vivax</i>, a neglected human malaria parasite</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(09)70177-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS1473-3099%2809%2970177-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=19695492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=555-566&author=I.+Muellerauthor=M.+R.+Galinskiauthor=J.+K.+Bairdauthor=J.+M.+Carltonauthor=D.+K.+Kocharauthor=P.+L.+Alonsoauthor=H.+A.+del+Portillo&title=Key+gaps+in+the+knowledge+of+Plasmodium+vivax%2C+a+neglected+human+malaria+parasite&doi=10.1016%2FS1473-3099%2809%2970177-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite</span></div><div class="casAuthors">Mueller, Ivo; Galinski, Mary R.; Baird, J. Kevin; Carlton, Jane M.; Kochar, Dhanpat K.; Alonso, Pedro L.; del Portillo, Hernando A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Plasmodium vivax is geog. the most widely distributed cause of malaria in people, with up to 2.5 billion people at risk and an estd. 80 million to 300 million clin. cases every year-including severe disease and death.  Despite this large burden of disease, P vivax is overlooked and left in the shadow of the enormous problem caused by Plasmodium falciparum in sub-Saharan Africa.  The technol. advances enabling the sequencing of the P vivax genome and a recent call for worldwide malaria eradication have together placed new emphasis on the importance of addressing P vivax as a major public health problem.  However, because of this parasite's biol., it is esp. difficult to interrupt the transmission of P vivax, and experts agree that the available methods for preventing and treating infections with P vivax are inadequate.  It is thus imperative that the development of new methods and strategies become a priority.  Advancing the development of such methods needs renewed emphasis on understanding the biol., pathogenesis, and epidemiol. of P vivax.  This Review critically examines what is known about P vivax, focusing on identifying the crucial gaps that create obstacles to the elimination of this parasite in human populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIkotAgyOhy7Vg90H21EOLACvtfcHk0lif_UZIVWINwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vE&md5=f3a1621c7b69c8b9e838648a1bbbd3b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2809%2970177-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252809%252970177-X%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DI.%26aulast%3DGalinski%26aufirst%3DM.%2BR.%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DKochar%26aufirst%3DD.%2BK.%26aulast%3DAlonso%26aufirst%3DP.%2BL.%26aulast%3Ddel%2BPortillo%26aufirst%3DH.%2BA.%26atitle%3DKey%2520gaps%2520in%2520the%2520knowledge%2520of%2520Plasmodium%2520vivax%252C%2520a%2520neglected%2520human%2520malaria%2520parasite%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2009%26volume%3D9%26spage%3D555%26epage%3D566%26doi%3D10.1016%2FS1473-3099%2809%2970177-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjitra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstey, N. M.</span></span> <span> </span><span class="NLM_article-title">Vivax malaria: neglected and not benign</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.2007.77.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4269%2Fajtmh.2007.77.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2007&pages=79-87&author=R.+N.+Priceauthor=E.+Tjitraauthor=C.+A.+Guerraauthor=S.+Yeungauthor=N.+J.+Whiteauthor=N.+M.+Anstey&title=Vivax+malaria%3A+neglected+and+not+benign&doi=10.4269%2Fajtmh.2007.77.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.2007.77.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.2007.77.79%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DTjitra%26aufirst%3DE.%26aulast%3DGuerra%26aufirst%3DC.%2BA.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DAnstey%26aufirst%3DN.%2BM.%26atitle%3DVivax%2520malaria%253A%2520neglected%2520and%2520not%2520benign%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2007%26volume%3D77%26spage%3D79%26epage%3D87%26doi%3D10.4269%2Fajtmh.2007.77.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">WHO</span>. International Travel and Health, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO.+International+Travel+and+Health%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeching, N. J.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>J. R. Army Med. Corps</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1136/jramc-2013-000112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1136%2Fjramc-2013-000112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24109136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmsFWjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2013&pages=158-166&author=T.+E.+Fletcherauthor=N.+J.+Beeching&title=Malaria&doi=10.1136%2Fjramc-2013-000112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Fletcher Tom E; Beeching N J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Army Medical Corps</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-66</span>
        ISSN:<span class="NLM_cas:issn">0035-8665</span>.
    </div><div class="casAbstract">Malaria is a life-threatening disease, with its largest impact being due to Plasmodium falciparum infection in Africa.  Military populations continue to be at a high risk of malaria and reported case series have frequently revealed poor compliance with preventative measures.  The symptoms of malaria are non-specific and its management depends on awareness of the diagnosis and early recognition and treatment.  This is aided by new and simple rapid diagnostic tests, but these should not replace the examination of blood films if these are available.  Artemisinin combination therapy provides a more rapid and dependable cure of uncomplicated P falciparum infection, with artesunate now being the drug of choice in severe infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSD59E4HP_jcTEC-75aqa5AfW6udTcc2eby-kGV4UUKnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmsFWjsA%253D%253D&md5=1f593fe2dcb3f114ef5fefb4ed91a78c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fjramc-2013-000112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjramc-2013-000112%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DT.%2BE.%26aulast%3DBeeching%26aufirst%3DN.%2BJ.%26atitle%3DMalaria%26jtitle%3DJ.%2520R.%2520Army%2520Med.%2520Corps%26date%3D2013%26volume%3D159%26spage%3D158%26epage%3D166%26doi%3D10.1136%2Fjramc-2013-000112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acremont, V.</span></span> <span> </span><span class="NLM_article-title">Malaria prevention in travelers</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.idc.2012.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=22963775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC38bls1Srug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=637-654&author=B.+Gentonauthor=V.+D%E2%80%99Acremont&title=Malaria+prevention+in+travelers&doi=10.1016%2Fj.idc.2012.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria prevention in travelers</span></div><div class="casAuthors">Genton Blaise; D'Acremont Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A common approach to malaria prevention is to follow the "A, B, C, D" rule: Awareness of risk, Bite avoidance, Compliance with chemoprophylaxis, and prompt Diagnosis in case of fever.  The risk of acquiring malaria depends on the length and intensity of exposure; the risk of developing severe disease is primarily determined by the health status of the traveler.  These parameters need to be assessed before recommending chemoprophylaxis and/or stand-by emergency treatment.  This review discusses the different strategies and drug options available for the prevention of malaria during and post travel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO_FeYyDg75ZHZzFRCXxVKfW6udTcc2eby-kGV4UUKnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bls1Srug%253D%253D&md5=e7b19901ec7ae829eed95a2a1758e38e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Acremont%26aufirst%3DV.%26atitle%3DMalaria%2520prevention%2520in%2520travelers%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D637%26epage%3D654%26doi%3D10.1016%2Fj.idc.2012.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Touze, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debonne, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. P.</span></span> <span> </span><span class="NLM_article-title">Current situation and future perspectives for malaria prophylaxis among travellers and military personnel</span>. <i>Bull. Acad. Natl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1302</span>, discussion 1302–1303.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=18447051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BD1c3osFGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2007&pages=1293-1302&author=J.+E.+Touzeauthor=J.+M.+Debonneauthor=J.+P.+Boutin&title=Current+situation+and+future+perspectives+for+malaria+prophylaxis+among+travellers+and+military+personnel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Current situation and future perspectives for malaria prophylaxis among travellers and military personnel</span></div><div class="casAuthors">Touze Jean-Etienne; Debonne Jean-Marc; Boutin Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin de l'Academie nationale de medecine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1293-302; discussion 1302-3</span>
        ISSN:<span class="NLM_cas:issn">0001-4079</span>.
    </div><div class="casAbstract">Malaria remains a major public health problem, both for travellers and for the 40,000 French soldiers deployed each year to endemic areas.  Epidemiological data show that imported malaria (IM) is on the increase, and that migrants account for more than 60% of malaria cases notified each year in France.  The increase in IM among French military personnel is explained by prematurely terminated chemoprophylaxis on return, repeated short missions, and more cases of P. vivax and P. ovale infection.  The choice of chemoprophylaxis depends mainly on the level of chloroquine resistance in the country visited.  The atovaquone-proguanil combination is well tolerated and only requires 7 days of intake on return from the endemic area.  Doxycycline monohydrate is cheaper and better-tolerated than mefloquine, and is thus preferred for French military personnel.  However, its short half-life necessitates very good compliance.  Chemoprophylaxis should be combined with vector control measures and with personal protection (impregnated bednets, protective clothing, repellents, and indoor insecticide spraying).  The need for these measures should be clearly explained before departure, during the stay, and after return.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlC7lvJGoqKiSm0e6ZOaemfW6udTcc2eaBC2o96o2i1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3osFGhuw%253D%253D&md5=740e8cf96bf44777802c7b885087fcc8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTouze%26aufirst%3DJ.%2BE.%26aulast%3DDebonne%26aufirst%3DJ.%2BM.%26aulast%3DBoutin%26aufirst%3DJ.%2BP.%26atitle%3DCurrent%2520situation%2520and%2520future%2520perspectives%2520for%2520malaria%2520prophylaxis%2520among%2520travellers%2520and%2520military%2520personnel%26jtitle%3DBull.%2520Acad.%2520Natl.%2520Med.%26date%3D2007%26volume%3D191%26spage%3D1293%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troye-Blomberg, M.</span></span> <span> </span><span class="NLM_article-title">The path of malaria vaccine development: challenges and perspectives</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1111/joim.12223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Fjoim.12223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24635625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2crkt12isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=456-466&author=C.+Aramaauthor=M.+Troye-Blomberg&title=The+path+of+malaria+vaccine+development%3A+challenges+and+perspectives&doi=10.1111%2Fjoim.12223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The path of malaria vaccine development: challenges and perspectives</span></div><div class="casAuthors">Arama C; Troye-Blomberg M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">456-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is a life-threatening disease caused by parasites of the Plasmodium genus.  In many parts of the world, the parasites have developed resistance to a number of antimalarial agents.  Key interventions to control malaria include prompt and effective treatment with artemisinin-based combination therapies, use of insecticidal nets by individuals at risk and active research into malaria vaccines.  Protection against malaria through vaccination was demonstrated more than 30 years ago when individuals were vaccinated via repeated bites by Plasmodium falciparum-infected and irradiated but still metabolically active mosquitoes.  However, vaccination with high doses of irradiated sporozoites injected into humans has long been considered impractical.  Yet, following recent success using whole-organism vaccines, the approach has received renewed interest; it was recently reported that repeated injections of irradiated sporozoites increased protection in 80 vaccinated individuals.  Other approaches include subunit malaria vaccines, such as the current leading candidate RTS,S (consisting of fusion between a portion of the P. falciparum-derived circumsporozoite protein and the hepatitis B surface antigen), which has been demonstrated to induce reasonably good protection.  Although results have been encouraging, the level of protection is generally considered to be too low to achieve eradication of malaria.  There is great interest in developing new and better formulations and stable delivery systems to improve immunogenicity.  In this review, we will discuss recent strategies to develop efficient malaria vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7FGGGGW1blJZoeNcnHOQ9fW6udTcc2eaBC2o96o2i1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crkt12isA%253D%253D&md5=e9aa43d3a3af5f0909f55a1ed5127e32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12223%26sid%3Dliteratum%253Aachs%26aulast%3DArama%26aufirst%3DC.%26aulast%3DTroye-Blomberg%26aufirst%3DM.%26atitle%3DThe%2520path%2520of%2520malaria%2520vaccine%2520development%253A%2520challenges%2520and%2520perspectives%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D456%26epage%3D466%26doi%3D10.1111%2Fjoim.12223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Malaria medicines: a glass half full?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1038/nrd4573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnrd4573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26000721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=424-442&author=T.+N.+Wellsauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhis&title=Malaria+medicines%3A+a+glass+half+full%3F&doi=10.1038%2Fnrd4573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria medicines: a glass half full?</span></div><div class="casAuthors">Wells, Timothy N. C.; Hooft van Huijsduijnen, Rob; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">424-442</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite substantial scientific progress over the past two decades, malaria remains a worldwide burden that causes hundreds of thousands of deaths every year.  New, affordable and safe drugs are required to overcome increasing resistance against artemisinin-based treatments, treat vulnerable populations, interrupt the parasite life cycle by blocking transmission to the vectors, prevent infection and target malaria species that transiently remain dormant in the liver.  In this Review, we discuss how the antimalarial drug discovery pipeline has changed over the past 10 years, grouped by the various target compd. or product profiles, to assess progress and gaps, and to recommend priorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJNZa5gyvg7Vg90H21EOLACvtfcHk0lj47_6LeaeCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM&md5=43f35590f86c240a4150b5cb4f5670ad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd4573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4573%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DMalaria%2520medicines%253A%2520a%2520glass%2520half%2520full%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D424%26epage%3D442%26doi%3D10.1038%2Fnrd4573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alano, P.</span></span> <span> </span><span class="NLM_article-title">Discovering new transmission-blocking antimalarial compounds: challenges and opportunities</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.pt.2016.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=27209388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1eiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=669-681&author=L.+M.+Birkholtzauthor=T.+L.+Coetzerauthor=D.+Mancamaauthor=D.+Leroyauthor=P.+Alano&title=Discovering+new+transmission-blocking+antimalarial+compounds%3A+challenges+and+opportunities&doi=10.1016%2Fj.pt.2016.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities</span></div><div class="casAuthors">Birkholtz, Lyn-Marie; Coetzer, Theresa L.; Mancama, Dalu; Leroy, Didier; Alano, Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The ability to target human-mosquito parasite transmission challenges global malaria elimination.  However, it is not obvious what a transmission-blocking drug will look like; should it target only parasite transmission stages; be combined with a partner drug killing the pathogenic asexual stages; or kill both the sexual and asexual blood stages, preferably displaying polypharmacol.  The development of transmission-blocking antimalarials requires objective analyses of the current strategies.  Here, pertinent issues and questions regarding the target candidate profile of a transmission-blocking compd., and its role in malaria elimination strategies, are highlighted and novel perspectives proposed.  The essential role of a test cascade that integrates screening and validation strategies to identify next-generation transmission-blocking antimalarials is emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Fn14sWlrr7Vg90H21EOLACvtfcHk0lj47_6LeaeCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1eiu7g%253D&md5=e68c731ef23c285475bea63012aff641</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DAlano%26aufirst%3DP.%26atitle%3DDiscovering%2520new%2520transmission-blocking%2520antimalarial%2520compounds%253A%2520challenges%2520and%2520opportunities%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.pt.2016.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span> <span> </span><span class="NLM_article-title">Killing the hypnozoite-drug discovery approaches to prevent relapse in <i>Plasmodium vivax</i></span>. <i>Pathog. Global Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1179/2047773215Y.0000000013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1179%2F2047773215Y.0000000013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=25891812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2015&pages=107-122&author=B.+Campoauthor=O.+Vandalauthor=D.+L.+Wescheauthor=J.+N.+Burrows&title=Killing+the+hypnozoite-drug+discovery+approaches+to+prevent+relapse+in+Plasmodium+vivax&doi=10.1179%2F2047773215Y.0000000013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax</span></div><div class="casAuthors">Campo, Brice; Vandal, Omar; Wesche, David L.; Burrows, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Pathogens and Global Health</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-122</span>CODEN:
                <span class="NLM_cas:coden">PGHAB7</span>;
        ISSN:<span class="NLM_cas:issn">2047-7724</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients.  Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compds. has been hampered by the dearth of biol. tools and assays, which in turn has been limited by the immense scientific and logistical challenges assocd. with accessing relevant human tissue and sporozoites.  This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZobuvLqmY8rVg90H21EOLACvtfcHk0liFBqyZb3AXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D&md5=5b8e1091c3df8331cc6b72fb943fdbb6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1179%2F2047773215Y.0000000013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047773215Y.0000000013%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DVandal%26aufirst%3DO.%26aulast%3DWesche%26aufirst%3DD.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26atitle%3DKilling%2520the%2520hypnozoite-drug%2520discovery%2520approaches%2520to%2520prevent%2520relapse%2520in%2520Plasmodium%2520vivax%26jtitle%3DPathog.%2520Global%2520Health%26date%3D2015%26volume%3D109%26spage%3D107%26epage%3D122%26doi%3D10.1179%2F2047773215Y.0000000013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">Supporting malaria elimination with 21st century antimalarial agent drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_fpage">1265</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.drudis.2015.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=26103616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmtV2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1265&author=T.+T.+Diagana&title=Supporting+malaria+elimination+with+21st+century+antimalarial+agent+drug+discovery&doi=10.1016%2Fj.drudis.2015.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Supporting malaria elimination with 21st century antimalarial agent drug discovery</span></div><div class="casAuthors">Diagana Thierry T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The burden of malaria has been considerably reduced over recent years.  However, to achieve disease elimination, drug discovery for the next generation needs to focus on blocking disease transmission and on targeting the liver-stage forms of the parasite.  Properties of the 'ideal' new antimalarial drug and the key scientific and technological advances that have led to recent progress in antimalarial drug discovery are reviewed.  Using these advances, Novartis has built a robust pipeline of next-generation antimalarials.  The preclinical and clinical development of two candidate drugs: KAE609 and KAF156, provide a framework for the path to breakthrough treatments that could be taking us a step closer to the vision of malaria elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOKlg0cqm-HTDnmmyUf5qOfW6udTcc2ebjqUcmtbXdcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmtV2itw%253D%253D&md5=071c685d9c873f3ebc58ac2b4db39f25</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSupporting%2520malaria%2520elimination%2520with%252021st%2520century%2520antimalarial%2520agent%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26spage%3D1265%26doi%3D10.1016%2Fj.drudis.2015.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2011.01734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1111%2Fj.1462-5822.2011.01734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=22151703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=316-324&author=S.+E.+Lindnerauthor=J.+L.+Millerauthor=S.+H.+Kappe&title=Malaria+parasite+pre-erythrocytic+infection%3A+preparation+meets+opportunity&doi=10.1111%2Fj.1462-5822.2011.01734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span></div><div class="casAuthors">Lindner, Scott E.; Miller, Jessica L.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  For those stricken with malaria, the classic clin. symptoms are caused by the parasite's cyclic infection of red blood cells.  However, this erythrocytic phase of the parasite's life cycle initiates from an asymptomatic pre-erythrocytic phase: the injection of sporozoites via the bite of a parasite-carrying Anopheline mosquito, and the ensuing infection of the liver.  With the increased capabilities of studying liver stages in mice, much progress was made elucidating the cellular and mol. basis of the parasite's progression through this bottleneck of its life cycle.  Here we review relevant findings on how sporozoites prep. for infection of the liver and factors crucial to liver stage development as well as key host/parasite interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0M19yfzes2bVg90H21EOLACvtfcHk0liFBqyZb3AXow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D&md5=12008701e239bba5150a4792d215bf21</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01734.x%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DKappe%26aufirst%3DS.%2BH.%26atitle%3DMalaria%2520parasite%2520pre-erythrocytic%2520infection%253A%2520preparation%2520meets%2520opportunity%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D316%26epage%3D324%26doi%3D10.1111%2Fj.1462-5822.2011.01734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snounou, G.</span></span> <span> </span><span class="NLM_article-title">A pre-emptive strike against malaria’s stealthy hepatic forms</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1038/nrd2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnrd2960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=854-864&author=D.+Mazierauthor=L.+Reniaauthor=G.+Snounou&title=A+pre-emptive+strike+against+malaria%E2%80%99s+stealthy+hepatic+forms&doi=10.1038%2Fnrd2960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2960%26sid%3Dliteratum%253Aachs%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSnounou%26aufirst%3DG.%26atitle%3DA%2520pre-emptive%2520strike%2520against%2520malaria%25E2%2580%2599s%2520stealthy%2520hepatic%2520forms%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D854%26epage%3D864%26doi%3D10.1038%2Fnrd2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudencio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the liver stage of malaria parasites: a yet unmet goal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1012</span>, <span class="refDoi"> DOI: 10.1021/jm201095h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201095h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=995-1012&author=T.+Rodriguesauthor=M.+Prudencioauthor=R.+Moreiraauthor=M.+M.+Motaauthor=F.+Lopes&title=Targeting+the+liver+stage+of+malaria+parasites%3A+a+yet+unmet+goal&doi=10.1021%2Fjm201095h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal</span></div><div class="casAuthors">Rodrigues, Tiago; Prudencio, Miguel; Moreira, Rui; Mota, Maria M.; Lopes, Francisca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An overview of Plasmodium liver stages malaria (LS) and inhibitors targeting the LS; special emphasis is given to structure-activity relationships (SARs) and to recent developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3to30Pz23MLVg90H21EOLACvtfcHk0lgqkqp9nXYk4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE&md5=3a24c7c84968b0801fb56a4d90fb177f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201095h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201095h%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DPrudencio%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DLopes%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520liver%2520stage%2520of%2520malaria%2520parasites%253A%2520a%2520yet%2520unmet%2520goal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D995%26epage%3D1012%26doi%3D10.1021%2Fjm201095h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual function acridones as a new antimalarial chemotype</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/nature07937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1038%2Fnature07937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=19357645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=270-273&author=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Brunauthor=S.+Wittlinauthor=R.+A.+Cooperauthor=K.+D.+Laneauthor=A.+Janowskyauthor=R.+A.+Johnsonauthor=R.+A.+Dodeanauthor=R.+Winterauthor=D.+J.+Hinrichsauthor=M.+K.+Riscoe&title=Discovery+of+dual+function+acridones+as+a+new+antimalarial+chemotype&doi=10.1038%2Fnature07937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dual function acridones as a new antimalarial chemotype</span></div><div class="casAuthors">Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7244</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new antimalarial chemotype was described that combined the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs.  Beyond the essential intrinsic characteristics common to deserving candidate antimalarials (high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favorable physicochem. properties), the initial lead compd. I demonstrated unique synergistic properties.  In addn. to verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, I also resulted in an apparently mechanistically distinct synergism with quinine and with piperaquine.  This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, was demonstrated both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNhD1G8U2cbVg90H21EOLACvtfcHk0lgqkqp9nXYk4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D&md5=436e58e6dab0365b88144f83e990b4d1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature07937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07937%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520of%2520dual%2520function%2520acridones%2520as%2520a%2520new%2520antimalarial%2520chemotype%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fnature07937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagby, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathbun, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Evaluation and lead optimization of anti-malarial acridones</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.exppara.2006.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=16828746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2gurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2006&pages=47-56&author=R.+W.+Winterauthor=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Dodeanauthor=G.+C.+Bagbyauthor=R.+K.+Rathbunauthor=J.+I.+Levinauthor=D.+Hinrichsauthor=M.+K.+Riscoe&title=Evaluation+and+lead+optimization+of+anti-malarial+acridones&doi=10.1016%2Fj.exppara.2006.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and lead optimization of antimalarial acridones</span></div><div class="casAuthors">Winter, Rolf W.; Kelly, Jane X.; Smilkstein, Martin J.; Dodean, Rozalia; Bagby, Grover C.; Rathbun, R. Keaney; Levin, Joshua I.; Hinrichs, David; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-56</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">With 2-methoxy-6-chloroacridone as a lead compd., the authors synthesized and tested acridone derivs. to develop a better understanding of the antimalarial structure-activity relationships.  Over 30 acridone derivs. were synthesized.  The most potent compds. contained extended alkyl chains terminated by trifluoromethyl groups and located at the 3-position of the tricyclic system.  Acridones optimized in the length of the side chain and the nature of the terminal fluorinated moiety exhibited in vitro antimalarial IC50 values in the low nanomolar and picomolar range and were without cytotoxic effects on the proliferation and differentiation of human bone marrow progenitors or mitogen-activated murine lymphocytes at concns. up to 100,000-fold higher.  Based on a structural similarity to known antimalarial agents it is proposed that the haloalkoxyacridones exert their antimalarial effects through inhibition of the Plasmodium cytochrome bc1 complex.  Haloalkoxyacridones represent an extraordinarily potent novel class of chem. compds. with the potential for development as therapeutic agents to treat or prevent malaria in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU62H0aHnzELVg90H21EOLACvtfcHk0lgqkqp9nXYk4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2gurw%253D&md5=301a5109dda84dbbaa4c8efec68c30ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DDodean%26aufirst%3DR.%26aulast%3DBagby%26aufirst%3DG.%2BC.%26aulast%3DRathbun%26aufirst%3DR.%2BK.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DHinrichs%26aufirst%3DD.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DEvaluation%2520and%2520lead%2520optimization%2520of%2520anti-malarial%2520acridones%26jtitle%3DExp.%2520Parasitol.%26date%3D2006%26volume%3D114%26spage%3D47%26epage%3D56%26doi%3D10.1016%2Fj.exppara.2006.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, C.</span></span> <span> </span><span class="NLM_article-title">Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1021/jo0518809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0518809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=142-149&author=X.+Meiauthor=A.+T.+Augustauthor=C.+Wolf&title=Regioselective+copper-catalyzed+amination+of+chlorobenzoic+acids%3A+synthesis+and+solid-state+structures+of+N-aryl+anthranilic+acid+derivatives&doi=10.1021%2Fjo0518809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Copper-Catalyzed Amination of Chlorobenzoic Acids: Synthesis and Solid-State Structures of N-Aryl Anthranilic Acid Derivatives</span></div><div class="casAuthors">Mei, Xuefeng; August, Adam T.; Wolf, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-149</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chemo- and regioselective copper-catalyzed cross-coupling reaction for effective amination of 2-chlorobenzoic acids with aniline derivs. was developed.  The method eliminates the need for acid protection and produces a wide range of N-aryl anthranilic acid derivs. in up to 99% yield.  The amination proceeds with both electron-rich and electron-deficient aryl chlorides and anilines and also uses sterically hindered anilines such as 2,6-dimethylaniline and 2-tert-butylaniline.  The conformational isomerism of appropriately substituted N-aryl anthranilic acids was studied in the solid state.  Crystallog. anal. of seven anthranilic acid derivs. showed formation of two distinct supramol. architectures exhibiting trans-anti and unprecedented trans-syn dimeric structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrjZmb7GLfLVg90H21EOLACvtfcHk0lhvacwhA9H5BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gisr7P&md5=fdff05498fd7415454888cd050ad0968</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0518809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0518809%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DX.%26aulast%3DAugust%26aufirst%3DA.%2BT.%26aulast%3DWolf%26aufirst%3DC.%26atitle%3DRegioselective%2520copper-catalyzed%2520amination%2520of%2520chlorobenzoic%2520acids%253A%2520synthesis%2520and%2520solid-state%2520structures%2520of%2520N-aryl%2520anthranilic%2520acid%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D142%26epage%3D149%26doi%3D10.1021%2Fjo0518809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driver, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl triflates and importance of triflate addition rate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1021/jo961930x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo961930x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1268-1273&author=J.+Louieauthor=M.+Driverauthor=B.+Hamannauthor=J.+Hartwig&title=Palladium-catalyzed+amination+of+aryl+triflates+and+importance+of+triflate+addition+rate&doi=10.1021%2Fjo961930x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Amination of Aryl Triflates and Importance of Triflate Addition Rate</span></div><div class="casAuthors">Louie, Janis; Driver, Michael S.; Hamann, Blake C.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1268-1273</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report that a combination of DPPF (1,1-bis(diphenylphosphino)ferrocene) and Pd(dba)2 leads to the amination of aryl triflates, a reaction that allows for the conversion of phenols to arylamines.  A combination of BINAP and Pd(dba)2 also catalyzes the amination of aryl triflates, but P(o-tolyl)3 complexes were not effective catalysts.  In some cases, slow addn. of the aryl triflate was necessary to prevent cleavage of the triflate and generation of phenol.  We found that added halide, necessary in some cross-coupling chem. of aryl sulfonates, was an unnecessary additive and even inhibited the amination chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq7ziZJFgkl7Vg90H21EOLACvtfcHk0lhvacwhA9H5BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSrsbc%253D&md5=ee91cd22782b558b4bb1e79937c0d815</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo961930x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo961930x%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DDriver%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DB.%26aulast%3DHartwig%26aufirst%3DJ.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%2520and%2520importance%2520of%2520triflate%2520addition%2520rate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1268%26epage%3D1273%26doi%3D10.1021%2Fjo961930x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gündüz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumbaraci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talinli, N.</span></span> <span> </span><span class="NLM_article-title">Reactions of quino-ketenes with C-nucleophiles: syntheses of (2-hydroxyphenyl)methanols and 2-hydroxyphenyl ketones</span>. <i>Helvetica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1002/hlca.201300391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2Fhlca.201300391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=1097-1106&author=H.+G%C3%BCnd%C3%BCzauthor=V.+Kumbaraciauthor=N.+Talinli&title=Reactions+of+quino-ketenes+with+C-nucleophiles%3A+syntheses+of+%282-hydroxyphenyl%29methanols+and+2-hydroxyphenyl+ketones&doi=10.1002%2Fhlca.201300391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of Quino-Ketenes with C-Nucleophiles: Syntheses of (2-Hydroxyphenyl)methanols and 2-Hydroxyphenyl Ketones</span></div><div class="casAuthors">Guenduez, Hande; Kumbaraci, Volkan; Talinli, Naciye</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1106</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">An efficient, one-step protocol for the synthesis of derivs. of 2-hydroxyphenyl ketones I [R = Bu; R1 = (H3C)2NCH2CH2, BrCH2CH2] and/or 2-hydroxyphenylmethanols II [R = Bu, Ph, Bn; R1 = 4-H3COC6H4CH2, (H3C)2NCH2CH2, BrCH2CH2] and/or 2-hydroxynaphthalenyl methanols III (X = Bu, Ph) starting from benzodioxinones/naphthodioxinones and organolithium compds. was described.  Reactions have been performed under thermal conditions without catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWkn5JAqdkLVg90H21EOLACvtfcHk0lhvacwhA9H5BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7zE&md5=825f4235ba29f0074b8ea04acdabc2f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhlca.201300391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.201300391%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCnd%25C3%25BCz%26aufirst%3DH.%26aulast%3DKumbaraci%26aufirst%3DV.%26aulast%3DTalinli%26aufirst%3DN.%26atitle%3DReactions%2520of%2520quino-ketenes%2520with%2520C-nucleophiles%253A%2520syntheses%2520of%2520%25282-hydroxyphenyl%2529methanols%2520and%25202-hydroxyphenyl%2520ketones%26jtitle%3DHelvetica%26date%3D2014%26volume%3D97%26spage%3D1097%26epage%3D1106%26doi%3D10.1002%2Fhlca.201300391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foote, K. M.</span>; <span class="NLM_string-name">Theoclitou, M.-E.</span>; <span class="NLM_string-name">Thomas, A. P.</span>; <span class="NLM_string-name">Buttar, D.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. PCT Int. Appl. <span class="NLM_patent">WO2008/075068</span>, June 26, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+M.+Foote&author=M.-E.+Theoclitou&author=A.+P.+Thomas&author=D.+Buttar&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26atitle%3DNovel%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julich-Gruner, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knolker, H. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of clausine-TY</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">4741</span>– <span class="NLM_lpage">4752</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201402495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2Fejoc.201402495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=4741-4752&author=C.+Schusterauthor=C.+B%C3%B6rgerauthor=K.+K.+Julich-Grunerauthor=R.+Hesseauthor=A.+Jagerauthor=G.+Kaufmannauthor=A.+W.+Schmidtauthor=H.+J.+Knolker&title=Synthesis+of+2-hydroxy-7-methylcarbazole%2C+glycozolicine%2C+mukoline%2C+mukolidine%2C+sansoakamine%2C+clausine-H%2C+and+clausine-K+and+structural+revision+of+clausine-TY&doi=10.1002%2Fejoc.201402495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of Clausine-TY</span></div><div class="casAuthors">Schuster, Christian; Boerger, Carsten; Julich-Gruner, Konstanze K.; Hesse, Ronny; Jaeger, Anne; Kaufmann, Gyoerley; Schmidt, Arndt W.; Knoelker, Hans-Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4741-4752</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Buchwald-Hartwig amination and palladium(II)-catalyzed oxidative cyclization reaction sequence provided efficient access to a series of oxygenated tricyclic carbazoles.  In the present work, this approach was applied to the total syntheses of the naturally occurring carbazole alkaloids 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, glycozolidine, clausine-H (clauszoline-C), clausine-K (clauszoline-J), and Me 2-hydroxy-7-methoxycarbazole-3-carboxylate, which was originally proposed as the structure of clausine-TY.  The synthesis of the latter led to the structural reassignment of clausine-TY.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOlrykkK9TyrVg90H21EOLACvtfcHk0ljyGDA6bTfSkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO&md5=09d8d57ecf4f0e676a8ef931b820a178</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402495%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DB%25C3%25B6rger%26aufirst%3DC.%26aulast%3DJulich-Gruner%26aufirst%3DK.%2BK.%26aulast%3DHesse%26aufirst%3DR.%26aulast%3DJager%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DKnolker%26aufirst%3DH.%2BJ.%26atitle%3DSynthesis%2520of%25202-hydroxy-7-methylcarbazole%252C%2520glycozolicine%252C%2520mukoline%252C%2520mukolidine%252C%2520sansoakamine%252C%2520clausine-H%252C%2520and%2520clausine-K%2520and%2520structural%2520revision%2520of%2520clausine-TY%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26spage%3D4741%26epage%3D4752%26doi%3D10.1002%2Fejoc.201402495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0ljyGDA6bTfSkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCrue, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Quinolone-3-diarylethers: a new class of antimalarial drug</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">177ra37</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3005029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscitranslmed.3005029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=23515079" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&author=A.+Nilsenauthor=A.+N.+LaCrueauthor=K.+L.+Whiteauthor=I.+P.+Forquerauthor=R.+M.+Crossauthor=J.+Marfurtauthor=M.+W.+Matherauthor=M.+J.+Delvesauthor=D.+M.+Shacklefordauthor=F.+E.+Saenzauthor=J.+M.+Morriseyauthor=J.+Steutenauthor=T.+Mutkaauthor=Y.+Liauthor=G.+Wirjanataauthor=E.+Ryanauthor=S.+Duffyauthor=J.+X.+Kellyauthor=B.+F.+Sebayangauthor=A.+M.+Zeemanauthor=R.+Noviyantiauthor=R.+E.+Sindenauthor=C.+H.+Kockenauthor=R.+N.+Priceauthor=V.+M.+Averyauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=E.+Herrerosauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=I.+Bathurstauthor=J.+N.+Burrowsauthor=P.+Sieglauthor=R.+K.+Guyauthor=R.+W.+Winterauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=D.+E.+Kyleauthor=R.+Manetschauthor=M.+K.+Riscoe&title=Quinolone-3-diarylethers%3A+a+new+class+of+antimalarial+drug&doi=10.1126%2Fscitranslmed.3005029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3005029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3005029%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLaCrue%26aufirst%3DA.%2BN.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DCross%26aufirst%3DR.%2BM.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSaenz%26aufirst%3DF.%2BE.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DSteuten%26aufirst%3DJ.%26aulast%3DMutka%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSebayang%26aufirst%3DB.%2BF.%26aulast%3DZeeman%26aufirst%3DA.%2BM.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DKocken%26aufirst%3DC.%2BH.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DQuinolone-3-diarylethers%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520drug%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26doi%3D10.1126%2Fscitranslmed.3005029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, B.</span></span> <span> </span><span class="NLM_article-title">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino) Quinazoline] as a chemotherapeutic agent: <i>Plasmodium berghei</i>, <i>P. cynomolgi</i>, <i>P. knowlesi</i>, and <i>Trypanosoma cruzi</i></span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/0014-4894(69)90050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0014-4894%2869%2990050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=4983051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1969&pages=32-49&author=P.+E.+Thompsonauthor=A.+Baylesauthor=B.+Olszewski&title=PAM+1392+%5B2%2C4-diamino-6-%283%2C4-dichlorobenzylamino%29+Quinazoline%5D+as+a+chemotherapeutic+agent%3A+Plasmodium+berghei%2C+P.+cynomolgi%2C+P.+knowlesi%2C+and+Trypanosoma+cruzi&doi=10.1016%2F0014-4894%2869%2990050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino)quinazoline] as a chemotherapeutic agent:  Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi</span></div><div class="casAuthors">Thompson, Paul Everett; Bayles, Anita; Olszewski, Bronislawa</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-49</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    </div><div class="casAbstract">PAM 1392 was active orally against blood forms of P. berghei in mice, P. cynomolgi in rhesus monkeys, and P. knowlesi in the latter host.  Against P. berghei, it was 4-11 times as potent as quinine in mice, acted rapidly, suppressed the parasitemia for 6 days in an oral dose of 200 mg./kg., acted synergistically with sulfadiazine without a commensurate increase in apparent toxicity for mice, and was effective against 4 drug-resistant lines.  The latter information suggests that it represents a new mode of action and may be useful in drug-resistant malaria.  In monkeys, it acted somewhat slowly but, when given appropriately, cured infections of P. cynomolgi and knowlesi.  The drug inhibited nuclear division of P. cynomolgi.  Against T. cruzi, PAM 1392 was active in culture against both extracellular and intracellular parasites at nontoxic levels for chick embryo cells.  This activity was partially reversed by folinic acid but not by crithidia factor.  PAM 1392 also was effective in protecting mice against the lethal effects of acute infections by T. cruzi but exhibited little capacity to effect radical cure of the infections.  Based on gross examn., the compd. is of relatively low toxicity to mice and monkeys on short-term administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn4pyMXieVj7Vg90H21EOLACvtfcHk0lhXmoUtRH1-lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D&md5=6041ddc17743ad3cc13b017d447f497d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0014-4894%2869%2990050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4894%252869%252990050-2%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DBayles%26aufirst%3DA.%26aulast%3DOlszewski%26aufirst%3DB.%26atitle%3DPAM%25201392%2520%255B2%252C4-diamino-6-%25283%252C4-dichlorobenzylamino%2529%2520Quinazoline%255D%2520as%2520a%2520chemotherapeutic%2520agent%253A%2520Plasmodium%2520berghei%252C%2520P.%2520cynomolgi%252C%2520P.%2520knowlesi%252C%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DExp.%2520Parasitol.%26date%3D1969%26volume%3D25%26spage%3D32%26epage%3D49%26doi%3D10.1016%2F0014-4894%2869%2990050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">141</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-13-141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1186%2F1475-2875-13-141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=24731238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=141&author=Q.+Liauthor=M.+O%E2%80%99Neilauthor=L.+Xieauthor=D.+Caridhaauthor=Q.+Zengauthor=J.+Zhangauthor=B.+Pybusauthor=M.+Hickmanauthor=V.+Melendez&title=Assessment+of+the+prophylactic+activity+and+pharmacokinetic+profile+of+oral+tafenoquine+compared+to+primaquine+for+inhibition+of+liver+stage+malaria+infections&doi=10.1186%2F1475-2875-13-141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span></div><div class="casAuthors">Li, Qigui; O'Neil, Michael; Xie, Lisa; Caridha, Diana; Zeng, Qiang; Zhang, Jing; Pybus, Brandon; Hickman, Mark; Melendez, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141/1-141/13, 13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: As anti-malarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malaria infections.  The US Army is developing tafenoquine (TQ), an analog of primaquine (PQ), which is expected to be more effective in preventing malaria in deployed military personnel.  Methods: To compare the prophylactic efficacy of TQ and PQ, a transgenic Plasmodium berghei parasite expressing the bioluminescent reporter protein luciferase was utilized to visualize and quantify parasite development in C57BL/6 albino mice treated with PQ and TQ in single or multiple regimens using a real-time in vivo imaging system (IVIS).  As an addnl. endpoint, blood stage parasitemia was monitored by flow cytometry.  Comparative pharmacokinetic (PK) and liver distribution studies of oral and i.v. PQ and TQ were also performed.  Results: Mice treated orally with three doses of TQ at 5 mg/kg three doses of PQ at 25 mg/kg demonstrated no bioluminescence liver signal and no blood stage parasitemia was obsd. suggesting both drugs showed 100% causal activity at the doses tested.  Single dose oral treatment with 5 mg TQ or 25 mg of PQ, however, yielded different results as only TQ treatment resulted in causal prophylaxis in P. berghei sporozoite-infected mice.  TQ is highly effective for causal prophylaxis in mice at a minimal curative single oral dose of 5 mg/kg, which is a five-fold improvement in potency vs. PQ.  PK studies of the two drugs administered orally to mice showed that the abs. bioavailability of oral TQ was 3.5-fold higher than PQ, and the AUC of oral TQ was 94-fold higher than oral PQ.  The elimination half-life of oral TQ in mice was 28 times longer than PQ, and the liver tissue distribution of TQ revealed an AUC that was 188-fold higher than PQ.  Conclusions: The increased drug exposure levels and longer exposure time of oral TQ in the plasma and livers of mice highlight the lead quality attributes that explain the much improved efficacy of TQ when compared to PQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlSzjNwCpw7Vg90H21EOLACvtfcHk0lhXmoUtRH1-lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE&md5=bcffa149f5d62a5353706c48153899b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-13-141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-13-141%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DMelendez%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520the%2520prophylactic%2520activity%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520tafenoquine%2520compared%2520to%2520primaquine%2520for%2520inhibition%2520of%2520liver%2520stage%2520malaria%2520infections%26jtitle%3DMalar.%2520J.%26date%3D2014%26volume%3D13%26spage%3D141%26doi%3D10.1186%2F1475-2875-13-141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">New imidazolidinedione derivatives as antimalarial agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1541</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2Fj.bmc.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=21282058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1541-1549&author=L.+Zhangauthor=R.+Sathunuruauthor=T.+Luongauthor=V.+Melendezauthor=M.+P.+Kozarauthor=A.+J.+Lin&title=New+imidazolidinedione+derivatives+as+antimalarial+agents&doi=10.1016%2Fj.bmc.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New imidazolidinedione derivatives as antimalarial agents</span></div><div class="casAuthors">Zhang, Liang; Sathunuru, Ramadas; Luong, Thu Lan; Melendez, Victor; Kozar, Michael P.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1549</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new N-alky- and N-alkoxy-imidazolidinediones was prepd. and assessed for prophylactic and radical curative activities in mouse and Rhesus monkey models.  New compds. are generally metabolically stable, weakly active in vitro against Plasmodium falciparum clones (D6 and W2) and in mice infected with Plasmodium berghei sporozoites.  Representative compds. 8e and 9c (I) showed good causal prophylactic activity in Rhesus monkeys dosed 30 mg/kg/day for 3 consecutive days by IM, delayed patency for 19-21 days and 54-86 days, resp., as compared to the untreated control.  By oral, 9c showed only marginal activity in causal prophylactic and radical curative tests at 50 mg/kg/day × 3 and 30 mg/kg/day × 7 plus chloroquine 10 mg/kg for 7 days, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDcL_hB_MaLVg90H21EOLACvtfcHk0lhXmoUtRH1-lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D&md5=64410e36bc5112cdb4f9cedf2453727b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DNew%2520imidazolidinedione%2520derivatives%2520as%2520antimalarial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1541%26epage%3D1549%26doi%3D10.1016%2Fj.bmc.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frueh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koop, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Alkoxycarbonate ester prodrugs of preclinical drug candidate ELQ-300 for prophylaxis and treatment of malaria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFagur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=728-735&author=L.+Fruehauthor=Y.+Liauthor=M.+W.+Matherauthor=Q.+Liauthor=S.+Pouauthor=A.+Nilsenauthor=R.+W.+Winterauthor=I.+P.+Forquerauthor=A.+M.+Pershingauthor=L.+H.+Xieauthor=M.+J.+Smilksteinauthor=D.+Caridhaauthor=D.+R.+Koopauthor=R.+F.+Campbellauthor=R.+J.+Sciottiauthor=M.+Kreishman-Deitrickauthor=J.+X.+Kellyauthor=B.+Veselyauthor=A.+B.+Vaidyaauthor=M.+K.+Riscoe&title=Alkoxycarbonate+ester+prodrugs+of+preclinical+drug+candidate+ELQ-300+for+prophylaxis+and+treatment+of+malaria&doi=10.1021%2Facsinfecdis.7b00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria</span></div><div class="casAuthors">Frueh, Lisa; Li, Yuexin; Mather, Michael W.; Li, Qigui; Pou, Sovitj; Nilsen, Aaron; Winter, Rolf W.; Forquer, Isaac P.; Pershing, April M.; Xie, Lisa H.; Smilkstein, Martin J.; Caridha, Diana; Koop, Dennis R.; Campbell, Robert F.; Sciotti, Richard J.; Kreishman-Deitrick, Mara; Kelly, Jane X.; Vesely, Brian; Vaidya, Akhil B.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ELQ-300 is a preclin. antimalarial drug candidate that is active against liver, blood, and transmission stages of Plasmodium falciparum.  While ELQ-300 is highly effective when administered in a low multidose regimen, poor aq. soly. and high crystallinity have hindered its clin. development.  To overcome its challenging physiochem. properties, a no. of bioreversible alkoxycarbonate ester prodrugs of ELQ-300 were synthesized.  These bioreversible prodrugs are converted to ELQ-300 by host and parasite esterase action in the liver and bloodstream of the host.  One such alkoxycarbonate prodrug, ELQ-331, is curative against Plasmodium yoelii with a single low dose of 3 mg/kg in a murine model of patent malaria infection.  ELQ-331 is at least as fully protective as ELQ-300 in a murine malaria prophylaxis model when delivered 24 h before sporozoite inoculation at an oral dose of 1 mg/kg.  ELQ-331 is a promising prodrug of ELQ-300 with improved physiochem. and metabolic properties and excellent potential for clin. formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCxuLKYFnFrVg90H21EOLACvtfcHk0liWS_u6JEYS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFagur7M&md5=74e150dd9bf20bedc4e6ff19fd05be70</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00062%26sid%3Dliteratum%253Aachs%26aulast%3DFrueh%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DXie%26aufirst%3DL.%2BH.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DKoop%26aufirst%3DD.%2BR.%26aulast%3DCampbell%26aufirst%3DR.%2BF.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DVesely%26aufirst%3DB.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DAlkoxycarbonate%2520ester%2520prodrugs%2520of%2520preclinical%2520drug%2520candidate%2520ELQ-300%2520for%2520prophylaxis%2520and%2520treatment%2520of%2520malaria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D728%26epage%3D735%26doi%3D10.1021%2Facsinfecdis.7b00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span> <span> </span><span class="NLM_article-title">Comparative susceptibility of different mouse strains to liver-stage infection with <i>Plasmodium berghei</i> sporozoites assessed using in vivo imaging</span>. <i>Mil. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.7205/MILMED-D-16-00090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.7205%2FMILMED-D-16-00090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=28291500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=360-368&author=Q.+Liauthor=L.+Xieauthor=D.+Caridhaauthor=N.+Roncalauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=M.+Hickmanauthor=L.+Read&title=Comparative+susceptibility+of+different+mouse+strains+to+liver-stage+infection+with+Plasmodium+berghei+sporozoites+assessed+using+in+vivo+imaging&doi=10.7205%2FMILMED-D-16-00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Susceptibility of Different Mouse Strains to Liver-Stage Infection With Plasmodium berghei Sporozoites Assessed Using In Vivo Imaging</span></div><div class="casAuthors">Li Qigui; Xie Lisa; Caridha Diana; Roncal Norma; Zeng Qiang; Zhang Jing; Zhang Ping; Hickman Mark; Read Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Military medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">360-368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The liver stages of Plasmodium parasites are important targets for the discovery and development of prophylactic drugs.  METHODS:  A real-time in vivo imaging system was used to determine the level of luminescence measured from firefly luciferase expression by sporozoites developing in hepatocytes in different strains of mice.  RESULTS:  The luminescence values (photon counts/sec) measured from the anatomical liver location in the untreated mice infected with 10,000 Plasmodium berghei sporozoites were 8.15 × 10(5) for C57BL/6 Albino, 2.12 × 10(5) for C3H/HeNCrL, 0.91 × 10(5) for C57BL/6 WT, 0.28 × 10(5) for BALB/c, and 0.16 × 10(5) for ICR/CD-1 mice.  This data suggests that the C57BL/6 Albino strain is most susceptible to luminescent photon, mainly because the less light scattering and absorption from deeper tissues and the skin in the strain of mouse.  The photon count observed in black C57BL/6 wild type mice was shown to be 88.83% lower compared to C57BL/6 Albino mice.  Although the highest growth rate of sporozoites in hepatocytes was found for C57BL/6 wild type mice in this study, the black skin of this mouse significantly reduced parasite-associated bioluminescence.  CONCLUSIONS:  The minimal light scattering and absorption and also enhanced susceptibility to liver infection of C57BL/6 Albino mice makes this strain preferable sensitivity for discovery and development of prophylactic antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPtJC26cYkEYhLSh9fo81bfW6udTcc2ebgUWbpalCpYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D&md5=9cff5670b545166016ec56d9417dc808</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7205%2FMILMED-D-16-00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7205%252FMILMED-D-16-00090%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DL.%26atitle%3DComparative%2520susceptibility%2520of%2520different%2520mouse%2520strains%2520to%2520liver-stage%2520infection%2520with%2520Plasmodium%2520berghei%2520sporozoites%2520assessed%2520using%2520in%2520vivo%2520imaging%26jtitle%3DMil.%2520Med.%26date%3D2017%26volume%3D182%26spage%3D360%26epage%3D368%26doi%3D10.7205%2FMILMED-D-16-00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>– <span class="NLM_lpage">3477</span>, <span class="refDoi"> DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+activity+of+phenylthiazolyl-bearing+hydroxamate-based+histone+deacetylase+inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 μM.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0liWS_u6JEYS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520activity%2520of%2520phenylthiazolyl-bearing%2520hydroxamate-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heady, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanteri, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabezas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yourick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. S.</span></span> <span> </span><span class="NLM_article-title">Utility of alkylaminoquinolinyl methanols as new antimalarial drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4132</span>– <span class="NLM_lpage">4143</span>, <span class="refDoi"> DOI: 10.1128/AAC.00631-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.00631-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=4132-4143&author=G.+S.+Dowauthor=T.+N.+Headyauthor=A.+K.+Bhattacharjeeauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=C.+A.+Lanteriauthor=N.+Obaldiaauthor=N.+Roncalauthor=T.+Shearerauthor=P.+L.+Smithauthor=A.+Tungtaengauthor=L.+Wolfauthor=M.+Cabezasauthor=D.+Yourickauthor=K.+S.+Smith&title=Utility+of+alkylaminoquinolinyl+methanols+as+new+antimalarial+drugs&doi=10.1128%2FAAC.00631-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.00631-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00631-06%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DHeady%26aufirst%3DT.%2BN.%26aulast%3DBhattacharjee%26aufirst%3DA.%2BK.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DLanteri%26aufirst%3DC.%2BA.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DShearer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DWolf%26aufirst%3DL.%26aulast%3DCabezas%26aufirst%3DM.%26aulast%3DYourick%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DK.%2BS.%26atitle%3DUtility%2520of%2520alkylaminoquinolinyl%2520methanols%2520as%2520new%2520antimalarial%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D4132%26epage%3D4143%26doi%3D10.1128%2FAAC.00631-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korotchenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3411</span>– <span class="NLM_lpage">3431</span>, <span class="refDoi"> DOI: 10.1021/jm501809x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501809x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3411-3431&author=V.+Korotchenkoauthor=R.+Sathunuruauthor=L.+Gerenaauthor=D.+Caridhaauthor=Q.+Liauthor=M.+Kreishman-Deitrickauthor=P.+L.+Smithauthor=A.+J.+Lin&title=Antimalarial+activity+of+4-amidinoquinoline+and+10-amidinobenzonaphthyridine+derivatives&doi=10.1021%2Fjm501809x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial Activity of 4-Amidinoquinoline and 10-Amidinobenzonaphthyridine Derivatives</span></div><div class="casAuthors">Korotchenko, Vasiliy; Sathunuru, Ramadas; Gerena, Lucia; Caridha, Diana; Li, Qigui; Kreishman-Deitrick, Mara; Smith, Philip L.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3411-3431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chloroquine (CQ) has been used as first line malaria therapeutic drug for decades.  Emergence of CQ drug-resistant Plasmodium falciparum malaria throughout endemic areas of the world has limited its clin. value.  Mefloquine (MQ) has been used as an effective malaria prophylactic drug due to its being long-acting and having a high potency against blood stage P. falciparum (Pf).  However, serious CNS toxicity of MQ has compromised its clin. value as a prophylaxis drug.  Therefore, new and inexpensive antimalarial drugs with no cross-resistance to CQ or CNS toxicity are urgently needed to combat this deadly human disease.  In this study, a series of new 4-amidinoquinoline (4-AMQ) and 10-amidinobenzonaphthyridine (10-AMB) derivs. were designed, prepd., and assessed to search for new therapeutic agents to replace CQ and MQ.  The new derivs. displayed high activity in vitro and in vivo, with no cross-resistance to CQ, and none were toxic in mice up to 160 mpk × 3.  The best compd. shows IC50 < 1 ng/mL against D6, W2 and C235 Pf clones, low inhibitory activity in hERG K+ channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk × 3 in mice infected with Plasmodium berghei.  In addn. to these desirable pharmacol. profiles, compd. I, one of the most active compds., is metabolically stable in both human and mouse liver microsomal prepns. and has a plasma t1/2 of 50 h in mice, which made it a good MQ replacement candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-hMlYNpOBpbVg90H21EOLACvtfcHk0ljkNnmZMeEs3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D&md5=b3042cd96745a072ee7631a99fd4ce54</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm501809x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501809x%26sid%3Dliteratum%253Aachs%26aulast%3DKorotchenko%26aufirst%3DV.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DAntimalarial%2520activity%2520of%25204-amidinoquinoline%2520and%252010-amidinobenzonaphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3411%26epage%3D3431%26doi%3D10.1021%2Fjm501809x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Using genetic methods to define the targets of compounds with antimalarial activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7761</span>– <span class="NLM_lpage">7771</span>, <span class="refDoi"> DOI: 10.1021/jm400325j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400325j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Chs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7761-7771&author=E.%0AL.+Flanneryauthor=D.+A.+Fidockauthor=E.+A.+Winzeler&title=Using+genetic+methods+to+define+the+targets+of+compounds+with+antimalarial+activity&doi=10.1021%2Fjm400325j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Using Genetic Methods To Define the Targets of Compounds with Antimalarial Activity</span></div><div class="casAuthors">Flannery, Erika L.; Fidock, David A.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7761-7771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although phenotypic cellular screening has been used to drive antimalarial drug discovery in recent years, in some cases target-based drug discovery remains more attractive.  This is esp. true when appropriate high-throughput cellular assays are lacking, as is the case for drug discovery efforts that aim to provide a replacement for primaquine (4-N-(6-methoxyquinolin-8-yl)-pentane-1,4-diamine), the only drug that can block Plasmodium transmission to Anopheles mosquitoes and eliminate liver-stage hypnozoites.  At present, however, there are no known chem. validated parasite protein targets that are important in all Plasmodium parasite developmental stages and that can be used in traditional biochem. compd. screens.  We propose that a plethora of novel, chem. validated, cross-stage antimalarial targets still remain to be discovered from the ∼5,500 proteins encoded by the Plasmodium genomes.  Here we discuss how in vitro evolution of drug-resistant strains of Plasmodium falciparum and subsequent whole-genome anal. can be used to find the targets of some of the many compds. discovered in whole-cell phenotypic screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGylYC1n7jLVg90H21EOLACvtfcHk0ljkNnmZMeEs3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Chs7bO&md5=89334c4fd625e02c7e8a949440ec6aa9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400325j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400325j%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DUsing%2520genetic%2520methods%2520to%2520define%2520the%2520targets%2520of%2520compounds%2520with%2520antimalarial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7761%26epage%3D7771%26doi%3D10.1021%2Fjm400325j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T. E.</span></span> <span> </span><span class="NLM_article-title">Selection of <i>Plasmodium falciparum</i> cytochrome B mutants by putative <i>Pf</i>NDH2 inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">6285</span>– <span class="NLM_lpage">6290</span>, <span class="refDoi"> DOI: 10.1073/pnas.1804492115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1073%2Fpnas.1804492115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=6285-6290&author=K.+D.+Laneauthor=J.+Muauthor=J.+Luauthor=S.+T.+Windleauthor=A.+Liuauthor=P.+D.+Sunauthor=T.+E.+Wellems&title=Selection+of+Plasmodium+falciparum+cytochrome+B+mutants+by+putative+PfNDH2+inhibitors&doi=10.1073%2Fpnas.1804492115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1804492115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1804492115%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DMu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWindle%26aufirst%3DS.%2BT.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DP.%2BD.%26aulast%3DWellems%26aufirst%3DT.%2BE.%26atitle%3DSelection%2520of%2520Plasmodium%2520falciparum%2520cytochrome%2520B%2520mutants%2520by%2520putative%2520PfNDH2%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D6285%26epage%3D6290%26doi%3D10.1073%2Fpnas.1804492115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stickles, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meermeier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pershing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miley, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.14-0553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.4269%2Fajtmh.14-0553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=1195-1201&author=A.+M.+Sticklesauthor=L.+M.+Tingauthor=J.+M.+Morriseyauthor=Y.+Liauthor=M.+W.+Matherauthor=E.+Meermeierauthor=A.+M.+Pershingauthor=I.+P.+Forquerauthor=G.+P.+Mileyauthor=S.+Pouauthor=R.+W.+Winterauthor=D.+J.+Hinrichsauthor=J.+X.+Kellyauthor=K.+Kimauthor=A.+B.+Vaidyaauthor=M.+K.+Riscoeauthor=A.+Nilsen&title=Inhibition+of+cytochrome+bc1+as+a+strategy+for+single-dose%2C+multi-stage+antimalarial+therapy&doi=10.4269%2Fajtmh.14-0553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.14-0553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.14-0553%26sid%3Dliteratum%253Aachs%26aulast%3DStickles%26aufirst%3DA.%2BM.%26aulast%3DTing%26aufirst%3DL.%2BM.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DMeermeier%26aufirst%3DE.%26aulast%3DPershing%26aufirst%3DA.%2BM.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DMiley%26aufirst%3DG.%2BP.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DNilsen%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520cytochrome%2520bc1%2520as%2520a%2520strategy%2520for%2520single-dose%252C%2520multi-stage%2520antimalarial%2520therapy%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2015%26volume%3D92%26spage%3D1195%26epage%3D1201%26doi%3D10.4269%2Fajtmh.14-0553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korsinczky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotecka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieckmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>Plasmodium falciparum</i> cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2108</span>, <span class="refDoi"> DOI: 10.1128/AAC.44.8.2100-2108.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1128%2FAAC.44.8.2100-2108.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10898682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2100-2108&author=M.+Korsinczkyauthor=N.+Chenauthor=B.+Koteckaauthor=A.+Saulauthor=K.+Rieckmannauthor=Q.+Cheng&title=Mutations+in+Plasmodium+falciparum+cytochrome+b+that+are+associated+with+atovaquone+resistance+are+located+at+a+putative+drug-binding+site&doi=10.1128%2FAAC.44.8.2100-2108.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site</span></div><div class="casAuthors">Korsinczky, Michael; Chen, Nanhua; Kotecka, Barbara; Saul, Allan; Rieckmann, Karl; Cheng, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2100-2108</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Atovaquone is the major active component of the new antimalarial drug Malarone.  Considerable evidence suggests that malaria parasites become resistant to atovaquone quickly if atovaquone is used as a sole agent.  The mechanism by which the parasite develops resistance to atovaquone is not yet fully understood.  Atovaquone has been shown to inhibit the cytochrome bc1 (CYT bc1) complex of the electron transport chain of malaria parasites.  Here the authors report point mutations in Plasmodium falciparum CYT b that are assocd. with atovaquone resistance.  Single or double amino acid mutations were detected from parasites that originated from a cloned line and survived various concns. of atovaquone in vitro.  A single amino acid mutation was detected in parasites isolated from a recrudescent patient following atovaquone treatment.  These mutations are assocd. with a 25- to 9,354-fold range redn. in parasite susceptibility to atovaquone.  Mol. modeling showed that amino acid mutations assocd. with atovaquone resistance are clustered around a putative atovaquone-binding site.  Mutations in these positions are consistent with a reduced binding affinity of atovaquone for malaria parasite CYT b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgzM-cUj0kbVg90H21EOLACvtfcHk0lgm3jEJ6NwdUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlShsLo%253D&md5=24e0e5753b6db87beb02a0dbe7148940</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FAAC.44.8.2100-2108.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.44.8.2100-2108.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKorsinczky%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DKotecka%26aufirst%3DB.%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DRieckmann%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DQ.%26atitle%3DMutations%2520in%2520Plasmodium%2520falciparum%2520cytochrome%2520b%2520that%2520are%2520associated%2520with%2520atovaquone%2520resistance%2520are%2520located%2520at%2520a%2520putative%2520drug-binding%2520site%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2100%26epage%3D2108%26doi%3D10.1128%2FAAC.44.8.2100-2108.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Syafruddin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siregar, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzuki, S.</span></span> <span> </span><span class="NLM_article-title">Mutations in the cytochrome b gene of <i>Plasmodium berghei</i> conferring resistance to atovaquone</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(99)00148-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2FS0166-6851%2899%2900148-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10593174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK1MXntlelt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=185-194&author=D.+Syafruddinauthor=J.+E.+Siregarauthor=S.+Marzuki&title=Mutations+in+the+cytochrome+b+gene+of+Plasmodium+berghei+conferring+resistance+to+atovaquone&doi=10.1016%2FS0166-6851%2899%2900148-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone</span></div><div class="casAuthors">Syafruddin, D.; Siregar, J. E.; Marzuki, S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The mol. lesions which underlie the resistance of the malaria parasites to atovaquone, a coenzyme Q analog, were investigated.  Resistant clones of Plasmodium berghei ANKA strain were isolated following prolonged propagation in mice in the presence of increasing doses of the drug, and their cytochrome b gene sequenced.  Three mutations were detected, T-C substitution at nt 431, G-A at nt 399 and G-T at nt 850, resulting in amino acid changes in the putative cytochrome b product at residues 133, 144 and 284.  The V284F amino acid change is in the sixth transmembrane helix of the protein and was obsd. in all resistant clones.  An addnl. M133I or L144S amino acid change within the Qo site at an extramembranous amphipathic helix significantly increases the resistance to atovaquone.  Our results (a) provide evidence that the antimalarial activity of atovaquone indeed involves an interaction with the cytochrome b; (b) define atovaquone as an inhibitor of the ubiquinol oxidase activity of the cytochrome bc1 complex; and (c) define amino acid residues in the mammalian cytochrome b which might be crit. in detg. its relative resistance to atovaquone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO477poLQLcLVg90H21EOLACvtfcHk0lgm3jEJ6NwdUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlelt7g%253D&md5=1ab2045954581209b1f8bb18936c8b68</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2899%2900148-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252899%252900148-6%26sid%3Dliteratum%253Aachs%26aulast%3DSyafruddin%26aufirst%3DD.%26aulast%3DSiregar%26aufirst%3DJ.%2BE.%26aulast%3DMarzuki%26aufirst%3DS.%26atitle%3DMutations%2520in%2520the%2520cytochrome%2520b%2520gene%2520of%2520Plasmodium%2520berghei%2520conferring%2520resistance%2520to%2520atovaquone%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1999%26volume%3D104%26spage%3D185%26epage%3D194%26doi%3D10.1016%2FS0166-6851%2899%2900148-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siregar, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega-Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syafruddin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozijnsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Lorena, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, G. I.</span></span> <span> </span><span class="NLM_article-title">Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1126/science.aad9279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscience.aad9279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=27081071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&pages=349-353&author=C.+D.+Goodmanauthor=J.+E.+Siregarauthor=V.+Mollardauthor=J.+Vega-Rodriguezauthor=D.+Syafruddinauthor=H.+Matsuokaauthor=M.+Matsuzakiauthor=T.+Toyamaauthor=A.+Sturmauthor=A.+Cozijnsenauthor=M.+Jacobs-Lorenaauthor=K.+Kitaauthor=S.+Marzukiauthor=G.+I.+McFadden&title=Parasites+resistant+to+the+antimalarial+atovaquone+fail+to+transmit+by+mosquitoes&doi=10.1126%2Fscience.aad9279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes</span></div><div class="casAuthors">Goodman, Christopher D.; Siregar, Josephine E.; Mollard, Vanessa; Vega-Rodriguez, Joel; Syafruddin, Din; Matsuoka, Hiroyuki; Matsuzaki, Motomichi; Toyama, Tomoko; Sturm, Angelika; Cozijnsen, Anton; Jacobs-Lorena, Marcelo; Kita, Kiyoshi; Marzuki, Sangkot; McFadden, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">6283</span>),
    <span class="NLM_cas:pages">349-353</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Resistance to a commonly used antimalarial medication, atovaquone, is apparently unable to spread.  Atovaquone pressure selects parasites with mutations in cytochrome b, a respiratory protein with low but essential activity in the mammalian blood phase of the parasite life cycle.  Resistance mutations rescue parasites from the drug but later prove lethal in the mosquito phase, where parasites require full respiration.  Unable to respire efficiently, resistant parasites fail to complete mosquito development, arresting their life cycle.  Because cytochrome b is encoded by the maternally inherited parasite mitochondrion, even outcrossing with wild-type strains cannot facilitate spread of resistance.  Lack of transmission suggests that resistance will be unable to spread in the field, greatly enhancing the utility of atovaquone in malaria control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aFESmHx4cbVg90H21EOLACvtfcHk0lir7kNLRR95xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2isb8%253D&md5=5e31bac1aeb100b6fd018fd3a8aea1c6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.aad9279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aad9279%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DC.%2BD.%26aulast%3DSiregar%26aufirst%3DJ.%2BE.%26aulast%3DMollard%26aufirst%3DV.%26aulast%3DVega-Rodriguez%26aufirst%3DJ.%26aulast%3DSyafruddin%26aufirst%3DD.%26aulast%3DMatsuoka%26aufirst%3DH.%26aulast%3DMatsuzaki%26aufirst%3DM.%26aulast%3DToyama%26aufirst%3DT.%26aulast%3DSturm%26aufirst%3DA.%26aulast%3DCozijnsen%26aufirst%3DA.%26aulast%3DJacobs-Lorena%26aufirst%3DM.%26aulast%3DKita%26aufirst%3DK.%26aulast%3DMarzuki%26aufirst%3DS.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26atitle%3DParasites%2520resistant%2520to%2520the%2520antimalarial%2520atovaquone%2520fail%2520to%2520transmit%2520by%2520mosquitoes%26jtitle%3DScience%26date%3D2016%26volume%3D352%26spage%3D349%26epage%3D353%26doi%3D10.1126%2Fscience.aad9279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata-Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumeau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribez, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambachew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Open-source discovery of chemical leads for next-generation chemoprotective antimalarials</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>362</i></span>, <span class="NLM_elocation-id">eaat9446</span> <span class="refDoi"> DOI: 10.1126/science.aat9446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1126%2Fscience.aat9446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=30523084" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2018&author=Y.+Antonova-Kochauthor=S.+Meisterauthor=M.+Abrahamauthor=M.+R.+Luthauthor=S.+Ottilieauthor=A.+K.+Lukensauthor=T.+Sakata-Katoauthor=M.+Vanaerschotauthor=E.+Owenauthor=J.+C.+Jadoauthor=S.+P.+Maherauthor=J.+Callaauthor=D.+Plouffeauthor=Y.+Zhongauthor=K.+Chenauthor=V.+Chaumeauauthor=A.+J.+Conwayauthor=C.+W.+McNamaraauthor=M.+Ibanezauthor=K.+Gagaringauthor=F.+N.+Serranoauthor=K.+Eribezauthor=C.+M.+Taggardauthor=A.+L.+Cheungauthor=C.+Lincolnauthor=B.+Ambachewauthor=M.+Rouillierauthor=D.+Siegelauthor=F.+Nostenauthor=D.+E.+Kyleauthor=F.+J.+Gamoauthor=Y.+Zhouauthor=M.+Llinasauthor=D.+A.+Fidockauthor=D.+F.+Wirthauthor=J.+Burrowsauthor=B.+Campoauthor=E.+A.+Winzeler&title=Open-source+discovery+of+chemical+leads+for+next-generation+chemoprotective+antimalarials&doi=10.1126%2Fscience.aat9446"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat9446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat9446%26sid%3Dliteratum%253Aachs%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DM.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DSakata-Kato%26aufirst%3DT.%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DE.%26aulast%3DJado%26aufirst%3DJ.%2BC.%26aulast%3DMaher%26aufirst%3DS.%2BP.%26aulast%3DCalla%26aufirst%3DJ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChaumeau%26aufirst%3DV.%26aulast%3DConway%26aufirst%3DA.%2BJ.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DSerrano%26aufirst%3DF.%2BN.%26aulast%3DEribez%26aufirst%3DK.%26aulast%3DTaggard%26aufirst%3DC.%2BM.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DLincoln%26aufirst%3DC.%26aulast%3DAmbachew%26aufirst%3DB.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLlinas%26aufirst%3DM.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DOpen-source%2520discovery%2520of%2520chemical%2520leads%2520for%2520next-generation%2520chemoprotective%2520antimalarials%26jtitle%3DScience%26date%3D2018%26volume%3D362%26doi%3D10.1126%2Fscience.aat9446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of nitrogen-containing baicalein analogues</span>. <i>Shenyang Yaoke Daxue Xuebao</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1enur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=888-892&author=J.+F.+Feiauthor=W.+Liuauthor=J.+Wang&title=Synthesis+of+nitrogen-containing+baicalein+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of nitrogen-containing Baicalein analogues</span></div><div class="casAuthors">Fei, Jia; Feng, Feng; Liu, Wen-yuan; Wang, Jun-zheng</div><div class="citationInfo"><span class="NLM_cas:title">Shenyang Yaoke Daxue Xuebao</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">888-892</span>CODEN:
                <span class="NLM_cas:coden">SYDXFF</span>;
        ISSN:<span class="NLM_cas:issn">1006-2858</span>.
    
            (<span class="NLM_cas:orgname">Shenyang Yaoke Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">To study the anti-tumor activities of Baicalein analogs, a series of Baicalein derivs. were synthesized from Baicalein via alkylation with nitrogen-contg. side chain (R1R2N( CH2)nCl·HCl).  Ten new Baicalein analogs were prepd. and their structures were confirmed by 1H NMR and ESI-MS.  Cancer cell lines including HepG2 and A549 were incubated with Baicalein analogs of various concns.  The inhibition rate was examd. by MTT (3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide) assay.  The activity tests showed that I and II had more significant upgraded cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgcytsknl6EbVg90H21EOLACvtfcHk0lir7kNLRR95xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1enur%252FM&md5=e3e79e26b98666750f9d0f2bdc0b1b3f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520nitrogen-containing%2520baicalein%2520analogues%26jtitle%3DShenyang%2520Yaoke%2520Daxue%2520Xuebao%26date%3D2010%26volume%3D27%26spage%3D888%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, D. A.</span></span> <span> </span><span class="NLM_article-title">Some derivatives of phenothiazine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1944</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/ja01234a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01234a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1944&pages=888-893&author=H.+Gilmanauthor=D.+A.+Shirley&title=Some+derivatives+of+phenothiazine&doi=10.1021%2Fja01234a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja01234a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01234a013%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DShirley%26aufirst%3DD.%2BA.%26atitle%3DSome%2520derivatives%2520of%2520phenothiazine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1944%26volume%3D66%26spage%3D888%26epage%3D893%26doi%3D10.1021%2Fja01234a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornasiero, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isetta, A. M.</span></span> <span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(90)90187-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro&doi=10.1016%2F0022-1759%2890%2990187-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0ljATT5Cfc9UTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172%26doi%3D10.1016%2F0022-1759%2890%2990187-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezise, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worley, J.</span></span> <span> </span><span class="NLM_article-title">Ionworks HT: a new high-throughput electrophysiology measurement platform</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1177/1087057102239667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1177%2F1087057102239667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=12854998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=50-64&author=K.+Schroederauthor=B.+Neagleauthor=D.+J.+Treziseauthor=J.+Worley&title=Ionworks+HT%3A+a+new+high-throughput+electrophysiology+measurement+platform&doi=10.1177%2F1087057102239667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">IonWorks HT: A new high-throughput electrophysiology measurement platform</span></div><div class="casAuthors">Schroeder, Kirk; Neagle, Brad; Trezise, Derek J.; Worley, Jennings</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-64</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">To address the throughput restrictions of classical patch clamp electrophysiol., Essen Instruments has developed a plate-based electrophysiol. measurement platform.  The instrument is an integrated platform that consists of computer-controlled fluid handling, recording electronics, and processing tools capable of voltage clamp whole-cell recordings from thousands of individual cells per day.  To establish a recording, the system uses a planar, multi-well substrate (a PatchPlate).  The system effectively positions 1 cell into a hole sepg. 2 fluid compartments in each well of the substrate.  Voltage control and current recordings from the cell membrane are made subsequent to gaining access to the cell interior by applying a permeabilizing agent to the intracellular side.  Based on the multi-well design of the PatchPlate, voltage clamp recordings of up to 384 individual cells can be made in minutes and are comparable to measurements made using traditional electrophysiol. techniques.  An integrated pipetting system allows for up to 2 addns. of modulation agents.  Typical throughput, measurement fidelity, stability, and comparative pharmacol. of a recombinant voltage-dependent sodium channel (hNav1.3) and a voltage-gated potassium channel (hKv1.5) exogenously expressed in CHO cells are presented.  The IonWorks HT device can be used in biophys. and pharmacol. profiling of ion channels in an environment compatible with high-capacity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99MfVnFuXs7Vg90H21EOLACvtfcHk0ljATT5Cfc9UTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D&md5=3a161db49dbb3c39e1db2d74e46e6bfb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057102239667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057102239667%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DK.%26aulast%3DNeagle%26aufirst%3DB.%26aulast%3DTrezise%26aufirst%3DD.%2BJ.%26aulast%3DWorley%26aufirst%3DJ.%26atitle%3DIonworks%2520HT%253A%2520a%2520new%2520high-throughput%2520electrophysiology%2520measurement%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D50%26epage%3D64%26doi%3D10.1177%2F1087057102239667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span> <span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-364&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0lh9vBgENiD0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D364%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pant, K.</span></span> <span> </span><span class="NLM_article-title">Ames IITM and Ames Liquid Format Mutagenicity Screening Assays</span>. In  <i>High-Throughput Screening Methods in Toxicity Testing</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, P.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley and Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, New Jersey</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">211</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;key=10.1002%2F9781118538203.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=193-211&author=K.+Pantauthor=P.+Steinberg&title=High-Throughput+Screening+Methods+in+Toxicity+Testing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F9781118538203.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118538203.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DPant%26aufirst%3DK.%26atitle%3DAmes%2520IITM%2520and%2520Ames%2520Liquid%2520Format%2520Mutagenicity%2520Screening%2520Assays%26btitle%3DHigh-Throughput%2520Screening%2520Methods%2520in%2520Toxicity%2520Testing%26aulast%3DSteinberg%26aufirst%3DP.%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Inc%26date%3D2013%26spage%3D193%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i150"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01961">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88081"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01961">10.1021/acs.jmedchem.8b01961</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Summary of single nucleotide polymorphisms (SNPs) in <b>73</b>-resistant clones of Dd2-V259L relative to the Dd2 parental line and reference line 3D7; spectra (NMR and HRMS) of all final compounds; HPLC chromatograms of key target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and in vitro data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_001.pdf">jm8b01961_si_001.pdf (8.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01961/suppl_file/jm8b01961_si_002.csv">jm8b01961_si_002.csv (6.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01961%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01961" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c96fc844d1cf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
